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THE DOMAINS OF THE CATALYTIC SUBUNIT OF THE EUKARYOTIC RNA
DEGRADING EXOSOME, RRP44P, HAVE DISTINCT FUNCTIONS

Publication No. _______
Daneen Lynn Schaeffer, B.S.
Supervisory Professor, Ambro van Hoof, Ph.D.
The exosome is a 3’ to 5’ exoribonuclease complex that consists of ten essential
subunits. In the cytoplasm, the exosome degrades mRNA in a general mRNA turnover pathway
and in several mRNA surveillance pathways. In the nucleus, the exosome processes RNA
precursors to form small, stable, mature RNA species, including rRNA, snRNA, and snoRNA. In
addition to processing these RNAs, the nuclear exosome is also involved in degrading aberrantly
processed forms of these RNAs, and others, including mRNA.
The 3’ to 5’ exoribonuclease activity of the exosome is contributed by the RNB domain
of the only catalytically active subunit, Rrp44p, a member of the RNase II family of enzymes. In
addition to the RNB domain, Rrp44p consists of three putative RNA binding domains and has an
uncharacterized N-terminus, which includes a CR3 region and PIN domain. In an effort to
characterize the cellular functions of the domains of Rrp44p, this study identified a second
nuclease active site in the PIN domain. Specifically, the PIN domain exhibits endoribonuclease
activity in vitro and is essential for exosome function. Further analysis of the nuclease activities
of Rrp44p indicate a role for the exoribonuclease activity of Rrp44p in the cytoplasmic and
nuclear exosome.
This work has also characterized the CR3 region of Rrp44p, a region that has not yet
been characterized in any other protein. This region is needed for the majority, if not all, of the
cytoplasmic exosome functions as well as for interaction with the exosome. The CR3 region,
along with a histidine residue in the N-terminus of Rrp44p, may coordinate a zinc atom.
Preliminary evidence supports a role for this coordination in exosome function. Further
investigation, however, is needed to determine the molecular dependence of the exosome on the
CR3 region of Rrp44p.
Despite its initial discovery thirteen years ago, the essential function of Rrp44p, and the
exosome, is not yet known. The studies presented here, however, indicate that the essential
function of Rrp44p and the exosome is in the nucleus and depends on the nuclease activities of
Rrp44p.
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Chapter 1: Introduction
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INTRODUCTION AND BACKGROUND
Eukaryotic RNA metabolism and surveillance
RNA metabolism and function in eukaryotes requires a transition of RNAs between
different cellular compartments and protein complexes. For example, mRNA metabolism
involves transcription, nuclear processing, nuclear-cytoplasmic transport, translation, and
ultimately cytoplasmic degradation. During these processes, mRNA associates with a variety of
complexes that are needed for mRNA biogenesis, function, and degradation. In addition, these
complexes promote the association and disassociation of cofactors that regulate these steps of
mRNA metabolism and, thus, dictate the function and half-life of an mRNA (Dreyfuss et al.,
2002; Moore, 2005).
Similarly, the small, stable RNAs of the nucleus, including small nuclear (sn)RNA,
small nucleolar (sno)RNA, rRNA, and tRNA, are subject to the same mechanisms of
metabolism. In the nucleus, however, the biogenesis of these RNAs, as well as the protein
complexes they encounter, differ from that of mRNAs. These nuclear complexes are not only
responsible for the synthesis of nuclear RNAs, but they also serve as a checkpoint to ensure
RNAs are functional prior to their export into the cytoplasm (Nazar, 2004; Wolin and Matera,
1999).
Aberrant RNAs arise through mistakes in gene expression, and not surprisingly, there
are many ways in which gene expression can be faulty. For example, aberrant mRNAs can arise
from mutations in the gene, which can lead to transcripts that lack termination codons or contain
premature termination codons. Typically these transcripts produce truncated proteins and/or
proteins that have a dominant-negative effect. Aberrant RNAs can also arise due to a defect in
ribonucleoprotein (RNP) assembly or nuclear pre-RNA processing, from the inherent error rate
of transcription, or through transcription of intergenic regions. To prevent the harmful effects of
these aberrant RNAs, the cell has adopted specialized RNA degradation pathways, termed RNA
surveillance. Interestingly, the same cellular machinery can degrade normal and aberrant RNAs.
Therefore, it is important to understand the regulation of RNA turnover, how normal and
aberrant RNAs are differentiated, and what factors are involved.
One protein complex that is involved in both cytoplasmic and nuclear RNA metabolism
is the eukaryotic exosome. This complex of proteins associates with a variety of cofactors to
promote the processing and degradation of RNAs, and also acts as a quality control mechanism
to rapidly degrade aberrant RNAs.
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The eukaryotic exosome
The eukaryotic exosome consists of 10 essential subunits. These subunits were initially
identified genetically in the budding yeast Saccharomyces cerevisiae in independent screens for
mutants that were defective in rRNA maturation (Mitchell et al., 1996) and cytoplasmic mRNA
transport, mutants that accumulated poly(A) RNA in the nucleus (Kadowaki et al., 1994), and for
mutants that expressed viral toxins (Ridley et al., 1984). Although these studies identified the
exosome subunits for their unique mutant phenotypes, further genetic and biochemical analysis
was required to show that these subunits are a part of a large complex that was subsequently
named the exosome (Mitchell et al., 1997). Further analysis indicated that the exosome is highly
conserved in eukaryotes. Additionally, the 10 subunit exosome was found to be present in both
the cytoplasm and the nucleus (Allmang et al., 1999b).
The composition and structure of the eukaryotic exosome
Sequence analysis of several exosome subunits revealed similarities to bacterial RNase
PH, PNPase, RNase II, and RNase R. Specifically, six of the subunits (Rrp41p, Rrp42p, Rrp43p,
Rrp45p, Rrp46p, and Mtr3p; Table 1.1) assemble into three distinct heterodimers to form a ring,
or channel structure (Figure 1.1), that structurally resembles the PH ring in bacterial PNPase and
the archaeal exosome (Buttner et al., 2005; Liu et al., 2006; Lorentzen and Conti, 2005). The
subunits that constitute the PH ring were named for their homology to RNase PH (Zuo and
Deutscher, 2001). RNase PH is a phosphorolytic 3’ to 5’ exoribonuclease, in that it uses an
inorganic phosphate to cleave RNA from the 3’-end. Specifically, RNase PH processes, or trims,
bacterial tRNA precursors to form mature tRNA species (Wen et al., 2005). Although these
subunits are catalytically active in PNPase and the archaeal exosome (Buttner et al., 2005;
Lorentzen and Conti, 2005; Navarro et al., 2008; Symmons et al., 2000), the six PH subunits of
the yeast and human exosome are catalytically inactive due to mutations the RNase PH-like
active sites (Dziembowski et al., 2007; Liu et al., 2006). This suggests that the ring of the
exosome is not the catalytic center of the exosome, but rather acts as a protein scaffold that may
be needed for the recruitment of exosome cofactors. This, however, is not the case in all
eukaryotes. Interestingly, Arabidopsis thaliana Rrp41p has retained the phosphorolytic 3’ to 5’
exonuclease activity of RNase PH (Chekanova et al., 2000). It is not yet known how the
enzymatic activity of this subunit contributes to the overall activity of the exosome in plants.
The PH ring of the eukaryotic exosome is not stable on its own in vitro. Specifically,
formation of the ring requires three additional proteins (Rrp4p, Rrp40p, and Csl4p; Table 1.1)
that bind to one side of the PH ring, forming a cap (Figure 1.1; Liu et al., 2006). These subunits
3
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Figure 1.1: Schematic representation of the eukaryotic exosome and domain
organization of Rrp44p.
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Figure 1.1: Schematic representation of the eukaryotic exosome and domain organization
of Rrp44p. A, A top view, looking down through the exosome. B, A side view of the exosome.
The exosome contains a PH ring of six proteins that have RNase PH domains. Assembly and/or
stability of the PH ring require three additional proteins that form a cap on top of the ring.
Between the cap proteins, there are five putative RNA binding domains. The exoribonuclease
activity of the exosome is provided by a tenth subunit, Rrp44p, that associates with the bottom of
the PH ring. RNA substrates are thought to associate with the cap proteins, pass through the
central channel, and are degraded by Rrp44p after they emerge from the bottom of the ring. C,
Rrp44p consists of six putative regions/domains. In the N-terminus, is a CR3 region, which
consists of at least three conserved cysteine residues, and a PIN domain, which is a putative
nuclease domain. Rrp44p has homology to two bacterial proteins, RNase II and RNase R. In the
RNase II/R homology region, are three putative RNA binding domains, including two
consecutive Cold Shock Domains (CSD1 and CSD2) and an S1 domain. Separating the putative
RNA binding domains is the 3’ to 5’ exoribonucleolytic RNB domain. This domain is solely
responsible for the 3’ to 5’ exoribonuclease activity of the exosome.
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are not homologous to any known nucleases, and instead contain RNA binding domains of either
the KH (K-homology domain; Grishin, 2001) or S1 (ribosomal protein S1) type (Suryanarayana
and Subramanian, 1984). Therefore, in addition to stabilizing the exosome, these cap proteins are
thought to bind the RNA substrates of the exosome.
The catalytic subunit of the eukaryotic exosome, Rrp44p
The tenth subunit of the exosome, Rrp44p, is the only catalytically active subunit of the
yeast (Dziembowski et al., 2007; Liu et al., 2006) and Drosophila exosome (Mamolen and
Andrulis, 2009) with its 3’ to 5’ exoribonuclease activity contributed by the RNB domain
(Dziembowski et al., 2007). This is also likely the case in humans, where the other nine exosome
subunits are catalytically inactive (Liu et al., 2006). The RNB domain is also found in two
bacterial enzymes that are homologous to Rrp44p, RNase II and RNase R (Table 1.1). These
enzymes are hydrolytic 3’ to 5’ exoribonucleases, in that they use a water molecule to degrade
mRNA from the 3’-end (Cannistraro and Kennell, 1994; Cheng and Deutscher, 2002). In
addition to sharing the RNB domain, these proteins also share three putative RNA binding
domains, two consecutive cold shock domains (CSDs) and a C-terminal S1 domain (Figure 1.1).
In all three proteins, these domains are positioned on one side of the RNB domain, with ssRNA
threaded through the putative RNA binding domains such that the 3’-end of the RNA rests in the
catalytic site of the RNB domain (Bonneau et al., 2009; Frazao et al., 2006; Lorentzen et al.,
2008; Zuo et al., 2006). Biochemically, Rrp44p is more similar to RNase R. Unlike RNase II,
RNase R and Rrp44p are able to degrade structured RNAs and double stranded RNAs that
contain a single stranded 3’ overhang (Dziembowski et al., 2007; Vincent and Deutscher, 2006).
While the RNase II/R homologous region of Rrp44p constitutes the middle- and Cterminal portion of the protein, the N-terminus of Rrp44p is not well characterized. This is due,
in part, to a lack of functional and structural data on this region. Despite the large number of
recent studies on the catalytic subunit of the exosome, these reports have focused only on the
nuclease activities of the Rrp44p (Dziembowski et al., 2007; Lorentzen et al., 2008; Mamolen
and Andrulis, 2009; Schneider et al., 2007) or on the structure of the exosome (Bonneau et al.,
2009; Liu et al., 2006; Lorentzen et al., 2008; Wang et al., 2007). Recently, crystal structures of
Rrp44p were published (Bonneau et al., 2009; Lorentzen et al., 2008), however, both structures
lack the first 33 residues (Bonneau et al., 2009). Sequence analysis shows that the far N-terminus
of Rrp44p, which includes residues 1-46, contains a linker region of a conserved stretch of
residues, residues 34-46. This region is then followed by a CR3 region, which consists of three
conserved cysteine residues (C47, C52, and C55; Figure 1.1). Currently, no information exists on
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the CR3 region in Rrp44p or in any other protein, and because the crystal structure of Rrp44p
lacks the first 33 residues, it is not yet known whether the CR3 region consists of more than the
three cysteine residues or if this region has a unique fold.
Sequence analysis of the N-terminus of Rrp44p also revealed the presence of a PIN
domain (Figure 1.1). PIN domains, named for their homology to a bacterial pilus biosynthetic
protein, are found in all three kingdoms of life. These domains are approximately 100 residues in
length and are characterized by a motif of four conserved acidic residues (Clissold and Ponting,
2000; Makarova et al., 1999). Similar acidic residue conservation occurs in enzymes that ligate
divalent cations, including nucleases. In support of this, several PIN domain-containing proteins
exhibit nuclease activity in vitro and in vivo (Arcus et al., 2004; Bleichert et al., 2006; Daines et
al., 2007; Fatica et al., 2004; Glavan et al., 2006; Levin et al., 2004). Because the PIN domain of
Rrp44p has these four conserved acidic residues, this domain may also have nuclease activity.
Despite the little information that is available on the N-terminus of Rrp44p, sequence analysis
shows a possible link between the CR3 region and the PIN domain, as CR3 regions are present
in most eukaryotic homologs of Rrp44p that have a PIN domain.
The association of Rrp44p with the exosome is controversial and seems to depend on the
organism. For example, in yeast and Drosophila, Rrp44p only loosely associates with the
exosome (Allmang et al., 1999b; Graham et al., 2009). In contrast, although homologs of Rrp44p
are present in humans, Arabidopsis, and trypanosomes, Rrp44p does not associate with the
exosome in these organisms (Allmang et al., 1999b; Chekanova et al., 2002; Estevez et al.,
2001). This lack of interaction, however, could be an artifact of the biochemical assays used to
detect exosome interaction. Regardless of its interaction with the exosome, Rrp44p is clearly
important for the exosome in a variety of eukaryotes (Mamolen and Andrulis, 2009; Shiomi et
al., 1998).
Eukaryotic exosome cofactors
The cellular localization of the exosome dictates its association with exosome cofactors.
These cofactors play a dual role in regulating exosome activity. First, because the intrinsic
exonucleolytic activity of the exosome is low, exosome cofactors are required to stimulate the
catalytic activity of the exosome. Additionally, exosome cofactors are needed to direct the
exosome to specific RNA substrates.
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Cytoplasmic exosome cofactors
In the cytoplasm, the exosome is solely involved in mRNA degradation (see below).
Here the exosome associates with, and is activated, by the Ski complex and Ski7p (Table 1.1).
The Ski complex consists of Ski2p, Ski3p, and Ski8p. Ski2p is a putative DEVH-box RNA
helicase (Widner and Wickner, 1993) that may function to remove mRNA-bound proteins or
secondary structures from mRNAs. Ski7p is a small GTPase that is homologous to eEF1A and
eRF3 (Benard et al., 1999) and interacts with both the Ski complex and the exosome (Araki et
al., 2001). Because Ski7p can interact with both complexes, it may bridge the interactions
between the Ski complex and the exosome. Additionally, Ski7p is thought to aid in the
recognition of specific RNA substrates, causing recruitment of the exosome, and ultimately
leading to the 3’ to 5’ decay of these mRNAs (Frischmeyer et al., 2002; Mitchell and Tollervey,
2003; van Hoof et al., 2002). Thus far, it is not yet known how the Ski complex and Ski7
activate the exosome.
Nuclear exosome cofactors
In contrast to the cytoplasmic exosome, the nuclear exosome is involved in RNA
processing and RNA degradation. In RNA processing, an RNA precursor is trimmed to form a
mature RNA, however, in RNA degradation, an RNA substrate is completely degraded to
nucleotide monophosphates. The nuclear exosome processes and degrades “normal” RNAs,
however, the major role of the nuclear exosome is its degradation of aberrantly processed RNAs
(see below). The association of nuclear exosome cofactors determines whether the nuclear
exosome processes or degrades a specific RNA substrate.
The nuclear exosome associates with at least three proteins, Rrp6p, Rrp47p, and Mpp6,
and at least one protein complex called TRAMP (Table 1.1). Rrp6p is the only other catalytically
active nuclease subunit that associates with the exosome. Specifically, Rrp6p is a hydrolytic 3’ to
5’ exoribonuclease that is needed for most, if not all, of the nuclear exosome functions (Allmang
et al., 1999a; Briggs et al., 1998; Butler, 2002; Fatica et al., 2000; van Hoof et al., 2000a).
Rrp47p also associates with the nuclear exosome and is required for nuclear RNA processing,
but not for nuclear RNA surveillance (Mitchell et al., 2003). Mpp6p is an RNA binding protein
that, like Rrp47p, is only needed for specific nuclear exosome functions. Specifically, Mpp6p is
needed for the recognition of specific RNA elements in nuclear RNA surveillance (Milligan et
al., 2008; Schilders et al., 2005). Lastly, the nuclear exosome associates with, and is activated
by, a complex of proteins called TRAMP (for Trf4/5-Air1/2-Mtr4). This complex constitutes a
non-canonical poly(A) polymerase (Trf4p or Trf5), a zinc knuckle protein (Air1p or Air2p), and
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a DEVH-box RNA helicase (Mtr4p). The TRAMP complex is solely involved in nuclear RNA
surveillance, whereby Air1/2 is thought to bind an RNA substrate, which is then polyadenylated
by Trf4/5, and subsequently degraded by the nuclear exosome (Davis and Ares, 2006; Egecioglu
et al., 2006; Houseley and Tollervey, 2006; LaCava et al., 2005; Vanacova et al., 2005; Wyers et
al., 2005). Mtr4p is thought to unwind any secondary structures and also directly associates with
the exosome (Milligan et al., 2008; Peng et al., 2003; Schilders et al., 2007), providing a link
between the TRAMP complex and the exosome.
One similarity between the cytoplasmic and nuclear exosome is that both associate with
a helicase. This association may facilitate the degradation of structured RNA substrates or
protein-bound RNAs. Not surprisingly, a similar association is seen in the RNA degradation
machine in E. coli, termed the degradosome. Here, the RhlB helicase is a key component of the
at least four-member complex (Py et al., 1996). Therefore, the association of additional
enzymatic activities with RNA degradation systems seems to be a common theme in nature.
Not surprisingly, exosome cofactors also impart differences between the cytoplasmic
and nuclear exosome. Specifically, the cofactors influence how polyadenylation ultimately
affects the fate of an RNA. In the cytoplasm, polyadenylation stabilizes transcripts, making them
resistant to nucleolytic cleavage, and more amenable to translation. In contrast, polyadenylation
in the nucleus is similar to that in bacteria, where polyadenylation triggers rapid degradation
(Carpousis, 2007; Dreyfus and Regnier, 2002). This difference is one of many between the
cytoplasmic and nuclear exosome. In fact, the cofactors exist in the cytoplasm and nucleus to
direct the exosome to different RNA substrates and help tailor the catalytic activity of the
exosome to these distinct RNAs.
Functions of the cytoplasmic exosome
General 3’ to 5’ mRNA degradation
Two general pathways of eukaryotic mRNA degradation have been identified using S.
cerevisiae as a model system (Figure 1.2; Decker and Parker, 1993; Muhlrad and Parker, 1994).
The initiating and rate-limiting step in both of the degradation pathways is the shortening of the
poly(A) tail, in a process termed deadenylation. In yeast, the initial shortening of the poly(A) tail
is catalyzed by the Pan2p/Pan3p complex, whereas the majority of deadenylation is performed
by the Ccr4p/NOT complex (Muhlrad and Parker, 1992; Tucker et al., 2001). Removal of the
poly(A) tail triggers cytoplasmic 5’ to 3’ decay in yeast. In this pathway, the 5’ cap is removed
by the decapping complex, which consists of Dcp1p and Dcp2p. This exposes the 5’-end of an
mRNA to the 5’ to 3’ exoribonuclease, Xrn1p, which is responsible for degrading an mRNA
10

Figure 1.2: Schematic representation of the two cytoplasmic mRNA degradation
pathways in eukaryotes.
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Figure 1.2: Schematic representation of the two cytoplasmic mRNA degradation pathways
in eukaryotes. Two general pathways exist in the cytoplasm to degrade eukaryotic transcripts.
Both pathways require removal of the poly(A) tail (deadenylation) as the first step. In one
pathway, deadenylation is followed by removal of the 5’ cap (decapping) and degradation of the
body of the mRNA by the 5’ to 3’ exoribonuclease, Xrn1p. In the second pathway, the body of
the mRNA is degraded by the 3’ to 5’ exoribonucleolytic complex, the exosome.
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from its 5’-end (Decker and Parker, 1993; Hsu and Stevens, 1993; Muhlrad et al., 1994).
Deadenylation can also trigger the degradation of an mRNA from its 3’-end, a process catalyzed
by the cytoplasmic exosome and the cytoplasmic exosome cofactors, Ski7p and the Ski complex
(Anderson and Parker, 1998; Mukherjee et al., 2002; Rodgers et al., 2002). Following decay of
the body of the transcript, the scavenger decapping complex, which consists of Dcs1p and
Dcs2p, removes the 5’ cap from the remaining oligonucleotide (Wang and Kiledjian, 2001). The
enzymes involved in these decay pathways are conserved in other eukaryotes and inactivation of
both mRNA decay pathways results in loss of viability (Anderson and Parker, 1998; Johnson and
Kolodner, 1995). This conservation and the requirement for cellular mRNA decay underscore
the importance of eukaryotic mRNA turnover.
Cytoplasmic degradation of aberrant transcripts
The cytoplasmic exosome is also involved in mRNA surveillance pathways, whereby
exosome cofactors and adaptor proteins distinguish aberrant mRNAs from normal mRNAs, and
ultimately direct the aberrant transcripts to the exosome for rapid degradation. Specifically, the
cytoplasmic exosome degrades transcripts that lack termination codons (Frischmeyer et al.,
2002; van Hoof et al., 2002) or poly(A) tails (Meaux and van Hoof, 2006), and transcripts that
have premature termination codons (Mitchell and Tollervey, 2003; Takahashi et al., 2003) or
cause stalls in translation elongation (Doma and Parker, 2006). Not surprisingly, the rate-limiting
step of deadenylation is bypassed in these mRNA surveillance pathways to rapidly rid the cell of
these potentially harmful transcripts.
Transcripts that lack termination codons, termed nonstop transcripts, can arise from
mistakes in gene expression, including genetic mutations, defects in transcription, or premature
polyadenylation, due to inaccurate 3’-end formation or through the use of a cryptic
polyadenylation site (Bucheli et al., 2007). These transcripts are degraded in a process termed
the nonstop mRNA degradation pathway (Figure 1.3; Frischmeyer et al., 2002; van Hoof et al.,
2002). In the current model of nonstop decay, the translating ribosome reads through the poly(A)
tail and stalls at the 3’-end. The cytoplasmic exosome cofactor, Ski7p, is then believed to
recognize the ribosome with an empty A-site, and along with the Ski complex, recruits the
exosome to rapidly degrade the transcript from the 3’-end (van Hoof et al., 2002).
Transcripts that cause stalls in translation elongation, perhaps due to secondary structure,
are also degraded by the cytoplasmic exosome in a process termed no-go decay (Doma and
Parker, 2006). In the current model of no-go decay, a ribosome stalls during translation
elongation. Hbs1p and Dom34p, paralogs of eRF3 and eRF1, respectively, then recognize the
13

Figure 1.3: Schematic representation of the cytoplasmic nonstop mRNA degradation
pathway in eukaryotes.
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Figure 1.3: Schematic representation of the cytoplasmic nonstop mRNA degradation
pathway in eukaryotes. In the current model of nonstop mRNA decay, a translating ribosome
stalls at the 3’-end of an mRNA that lacks in-frame termination codons, termed a nonstop
transcript. The stalled ribosome is then thought to be recognized by the cytoplasmic exosome
cofactors, Ski7p and the Ski complex. Ski7p then recruits the exosome, which rapidly degrades
the nonstop transcript from its 3’-end. This mRNA surveillance pathway differs from general 3’
to 5’ mRNA degradation in that prior removal of the poly(A) tail is not required.
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stalled ribosome. The ribosome is then released by endonucleolytic cleavage, which generates a
5’- and 3’-degradation intermediate. The 5’-degradation fragment is degraded by the exosome,
with help from the cytoplasmic exosome cofactors, Ski7p and the Ski complex. The 3’degradation fragment is degraded by the 5’ to 3’ exoribonuclease, Xrn1p (Figure 1.4; Doma and
Parker, 2006). The endoribonuclease responsible for the initial cleavage of the transcript has not
yet been identified. Additionally, it is not yet known how Hbs1p and Dom34p recognize the
stalled ribosome or recruit the endonuclease.
Several of the aberrant transcripts targeted by the cytoplasmic exosome have harmful
and deleterious effects on the cell, and can even lead to disease (Ameri et al., 2007; Bulman et
al., 1991; Chatr-Aryamontri et al., 2004; Kerem et al., 1990; Yasuda et al., 2003). The
participation of the exosome in the cytoplasmic mRNA surveillance pathways used to degrade
these aberrant mRNAs ensures that these transcripts are rapidly degraded and are, thus, unable to
exert their negative effects on the cell.
Antiviral activity of the cytoplasmic exosome
Many yeast strains contain the L-A virus and the M satellite RNA. The L-A virus
encodes an RNA-dependent RNA polymerase. The M satellite RNA encodes a protein toxin that
is secreted from infected cells that ultimately kills uninfected cells. In a screen for “superkiller”
mutants, or mutants that were able to kill uninfected cells more efficiently, several SKI genes
were identified (Toh and Wickner, 1980). Many of these SKI genes encode exosome subunits
and cytoplasmic exosome cofactors, including Ski7p and components of the Ski complex (Ski2p,
Ski3, and Ski8p). The molecular mechanism of the exosome/Ski complex antiviral function is
not completely understood, however, it seems that the cytoplasmic exosome limits killer toxin
secretion by degrading unadenylated viral RNA (Brown et al., 2000; Meaux and van Hoof,
2006). Future studies are needed to determine whether the exoribonuclease activity of the
exosome is needed for this degradation and, thus, for the antiviral function of the cytoplasmic
exosome.
Functions of the nuclear exosome
General nuclear RNA processing and degradation
The nuclear exosome processes and degrades RNA. Specifically, the nuclear exosome
processes RNA precursors, including snRNA, snoRNA and rRNA to form small, stable, mature
RNA species. In yeast, ribosomal RNA processing begins with the 35S rRNA precursor, which
contains the sequences for the mature 18S, 5.8S, and 25S rRNAs, which are separated by two
16

Figure 1.4: Schematic representation of the cytoplasmic no-go decay pathway in
eukaryotes.
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Figure 1.4: Schematic representation of the cytoplasmic no-go decay pathway in
eukaryotes. In the current model of no-go decay, a translating ribosome stalls during translation
elongation, possibly due to secondary structure in the transcript. The stalled ribosome is then
thought to be recognized by the eRF3 and eRF1 paralogs, Hbs1p and Dom34p, respectively. An
unidentified endoribonuclease then cleaves the transcript, releasing the stalled ribosome, and
generating a 5’- and 3’-degradation fragment. The 5’- and 3’-degradation fragments are
degraded by the cytoplasmic exosome and the 5’ to 3’ exoribonuclease, Xrn1p, respectively.
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internal transcribed spacers, the ITS1 and the ITS2. On either ends of the 35S rRNA precursor,
are two external transcribed spacers, the 5’ ETS and the 3’ ETS. Processing of 35S rRNA
precursor liberates the mature rRNAs, which are subsequently packaged into the small and large
ribosomal subunits. The nuclear exosome and the nuclear exosome cofactor, Rrp6p, are involved
in two steps of 35S rRNA processing (Figure 1.5). In the first cleavage event, the 35S rRNA
precursor is cleaved at site A0, liberating the 5’ ETS. The nuclear exosome and Rrp6p then
degrade the 5’ ETS to completion (de la Cruz et al., 1998).
The nuclear exosome and Rrp6p are also involved in processing the 7S rRNA precursor
to form the mature 5.8S rRNA (Figure 1.5). Cleavage at the B1L and B1S sites generates the long
and short forms of the 7S rRNA precursor (7SL and 7SS). The nuclear exosome then converts the
7SL/S pre-rRNAs to 5.8SL/S+30 [5.8S pre-rRNA species that are 3’-extended by approximately 30
nucleotides] (Allmang et al., 1999a). Rrp6p then processes the 5.8SL/S+30 pre-rRNAs to 6SL/S
[5.8S pre-rRNA species that are 3’-extended by approximately five to eight nucleotides] (Briggs
et al., 1998). The 6SL/S pre-rRNAs are then exported to the cytoplasm where the final maturation
step is completed to form the mature 5.8SL/S rRNA (Thomson and Tollervey, 2010).
Nuclear RNA surveillance
Aberrant nuclear RNAs are typically generated due to defects in nuclear pre-RNA
processing. There are three nuclear quality control systems to prevent the function of these
defective RNAs, including export to the cytoplasm for cytoplasmic RNA decay, nuclear
retention, and nuclear RNA degradation. The majority of transcripts that are targeted to the latter
quality control system are degraded by the nuclear exosome, with the help of the nuclear
exosome cofactors, Rrp6p and the TRAMP complex (Table 1.1). Specifically, the nuclear
exosome degrades mRNAs that have defects in 3’-end processing (Libri et al., 2002; Torchet et
al., 2002) or splicing (Bousquet-Antonelli et al., 2000). The nuclear exosome also degrades
improperly modified tRNAs, including the hypomodified initiator tRNAiMet (Kadaba et al., 2004;
Kadaba et al., 2006), as well as improperly processed rRNA, snRNA and snoRNA precursors
(Egecioglu et al., 2006; LaCava et al., 2005). In addition to degrading RNAs that are improperly
processed or modified, the nuclear exosome also degrades cryptic unstable transcripts (CUTs),
which result from the transcription of intergenic regions. These transcripts ultimately result in
small noncoding RNAs that are highly unstable in wild-type cells (Davis and Ares, 2006; Wyers
et al., 2005).
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Figure 1.5: Nuclear 35S pre-rRNA processing in S. cerevisiae
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Figure 1.5: Nuclear 35S pre-rRNA processing in S. cerevisiae. A, The 35S rRNA precursor
contains the sequences for the mature 18S, 5.8S, and 25S rRNAs. These rRNA sequences are
separated by two internal transcribed spacers, ITS1 and ITS2, and are flanked by two external
transcribed spacers, the 5’ ETS and the 3’ ETS. There are 11 processing sites in the 35S rRNA
precursor, which are used to generate the mature rRNAs. B, The 35S pre-rRNA is cleaved at
sites A0 and A1, generating the 5’ ETS fragment and the 32S pre-rRNA. This RNA is
subsequently processed at sites A2, D, A3, B2, and B1L/S, resulting in the production of the long
and short forms of the 27SB rRNA precursor (27SBL and 27SBS). The 27SBL/S pre-rRNAs are
cleaved at site C2, generating the 7S L/S pre-rRNAs. The nuclear exosome then processes these
rRNA precursors to form the 5.8SL/S+30 (5.8S pre-rRNA species that are 3’ extended by
approximately 30 nucleotides). The nuclear exosome cofactor, Rrp6p, then further processes the
5.8SL/S+30 pre-rRNA to 6SL/S (5.8S pre-rRNA species that are 3’ extended by approximately five
to eight nucleotides). The 6SL/S pre-rRNAs are then exported to the cytoplasm where they
undergo the final step of maturation, which generates the mature 5.8S rRNA.
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The nuclear retention and degradation of these aberrant RNAs is an important
checkpoint because cytoplasmic export of these defective RNAs could lead to deleterious effects
on the cell if these RNAs escape the cytoplasmic RNA degradation machinery.
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SIGNIFICANCE OF THE STUDY
Eukaryotic RNA metabolism is important in the post-transcriptional regulation of gene
expression and is required to maintain the fidelity of gene expression. Not surprisingly, the key
components involved in RNA metabolism are conserved in other eukaryotes and are required for
optimal cell growth or viability. One key component of eukaryotic RNA metabolism is the
exosome, a complex of ten essential proteins that is present in the nucleus and the cytoplasm.
When this study started, little was known about the catalytic subunit of the exosome,
Rrp44p, and its involvement in regulating RNA metabolism. Specifically, it was not known
which regions of the protein were needed for viability, exosome association, or exosome
function. The data presented in these studies have uncovered new regions and activities of
Rrp44p that influence the function of not only Rrp44p, but of the exosome.
Thirteen years after the discovery of the exosome, this study has demonstrated the
presence of an additional nuclease active site in Rrp44p. Specifically, Chapter 3 describes the
endoribonuclease active site of Rrp44p, the physiological importance of this nuclease activity,
and how the endoribonucleolytic PIN domain interacts with the well-characterized
exoribonucleolytic RNB domain of Rrp44p. This breakthrough finding will force the RNA
metabolism field to re-evaluate how eukaryotic RNAs are recognized and degraded by the
exosome.
Prior to this study, it was not known why Rrp44p was required for viability. Here,
several Chapters describe the regions of Rrp44p that are needed for optimal cell growth and
viability. Specifically, the N-terminus of Rrp44p, as well as the nuclease activities of the protein,
are needed for cell survival. Most importantly, data in Chapter 6 suggest that the essential
function of Rrp44p is likely nuclear.
Before this study was started, Rrp44p was known to loosely associate with the yeast
exosome, however, it was not known which regions of the protein mediated this interaction. The
data presented here show that not just one region of Rrp44p is needed for exosome interaction.
Specifically, Chapters 5 and 6 show that two separate regions in the N-terminus of Rrp44p are
needed for exosome association. These results, combined with several other biochemical and
genetic analyses, demonstrate that multiple regions of Rrp44p are involved in exosome
interaction, suggesting that these regions may be redundant for exosome association.
Lastly, this study uncovered a novel region of Rrp44p, the CR3 region, which has not
yet been described in any other protein. The data in Chapter 5 suggest that CR3 region is needed
for a large number of exosome functions, including the essential function. Additionally, recent
structural data, coupled with in vitro biochemical analysis, suggest that this region is needed to
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coordinate a zinc ion. The implications of this coordination may help to explain why mutating
the CR3 region results in numerous exosome defects.
Taken together, the results of these studies show that the catalytic subunit of the
eukaryotic RNA degrading exosome, Rrp44p, has novel nuclease activity and has a region that is
important for the function of Rrp44p and the exosome. The studies presented in this dissertation
contribute to a better understanding of eukaryotic RNA metabolism, both its role as a posttranscriptional regulator of gene expression and as a quality control mechanism to maintain the
fidelity of gene expression. These studies also provide a foundation for further studies on the
CR3 region, and nuclease activities, of Rrp44p and how they are involved in exosome function.
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Chapter 2: Materials and Methods
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Strains and Plasmids
The yeast strains used in these studies are described in Table 2.1. All of the S. cerevisiae
strains were grown on rich yeast extract-peptone dextrose (YPD) [1% yeast extract, 2% peptone,
2% dextrose (or galactose, as indicated)] or synthetic complete (SC) media lacking the
appropriate nutrient for plasmid selection (Sunrise Science Products). SC media was also
supplemented with 5-fluoroorotic acid (5-FOA; 5.74 mM) during complementation growth
assays. Unless otherwise noted, yeast strains were grown at 30°C. The heterozygous diploid
RRP44/ rrp44 deletion has been previously described and was obtained from Open Biosystems
(Giaever et al., 2002). This strain was transformed with a URA3 plasmid that encoded wild-type
RRP44.
The temperature-sensitive mRNA decapping mutant, dcp1-2, has been previously
described (Anderson and Parker, 1998). To create a dcp1-2, rrp44 deletion strain, the dcp1-2
parent strain was crossed with an rrp44 deletion strain that contained a URA3 plasmid that
encoded wild-type RRP44.
To create a ski7, rrp44 deletion strain, a ski7 deletion parent strain was crossed with an
rrp44 deletion strain that contained a URA3 plasmid that encoded wild-type RRP44.
All diploid strains were sporulated, and haploid progeny spores were obtained by the
hydrophobic spore isolation method as described (Rockmill et al., 1991). Isolated spores were
germinated to generate a strain containing a genomic rrp44 deletion, complemented with the
RRP44, URA3 plasmid, and where indicated, a second mutation.
The GAL::rrp44 strains have been previously described and were obtained from Phil
Mitchell and David Tollervey (Allmang et al., 1999b; Mitchell et al., 1997).
Rrp43p was C-terminally Myc-tagged using the one-step PCR system with pFA6a13myc-His3MX6 as a template essentially as described (Longtine et al., 1998).
The plasmids used in these studies, and their creation, are described in Table 2.2. All
plasmids were built using standard PCR and restriction enzyme cloning techniques, or were built
using homologous recombination of PCR products or restriction digestion fragments of
plasmids. All plasmids contained a yeast centromere, the endogenous promoter and 3’ flanking
region to control expression of Rrp44p and were verified by sequencing the insert.
For plasmids constructed using PCR and restriction enzyme cloning, the sites used are
listed in Table 2.2 and the oligonucleotides used are listed in Table 2.3. To generate Rrp44p Cterminal truncations, 180 base pairs of the 3’ flanking region was PCR amplified and cloned into
pRS415 (Sikorski and Hieter, 1989), which contains a LEU2 marker. 500 base pairs of the
promoter and desired part of the coding region was PCR amplified and cloned into the plasmid
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Strain Name
BY4741
yAV862
yAV1115
yAV1144
yAV1137
yAV313
yAV1143
yAV856
yAV1166
yAV1179
yAV1183
yAV1193
yAV1194
yAV1117

Genotype
MATa; his3!1; leu2!0; met15!0; ura3!
MATa; his3!200; leu2!1; trp1; ura3-52; gal2; gal!108; GAL10::RRP44
MATa; his3!1; leu2!0; ura3!0; rrp44!::NEO [RRP44, URA3]
MATa; his3!1; leu2!0; met15, ura3!; rrp6!::NEO
MATa; his3!1; leu2!0; ura3!; rrp6!::NEO; rrp44!::HYG [RRP44, URA3]
MAT!; leu2-3,112; lys2-201; trp1; ura3-52; cup1::LEU2/PGK1pG/MFA2pG; dcp1-2::TRP1; ski7!::NEO
MAT!; leu2!0; trp1; ura3!0; dcp1-2::TRP1; rrp44!::NEO [RRP44, URA3]
MATa; his3!1; leu2!0; met15!0; ura3!0; ski7!::NEO
MAT!; leu2!0; lys2!0; ura3!0; ski7!::HYG; rrp44!::NEO [RRP44, URA3]
MAT!; leu2!0; lys2!0; ura3!0; ski7!::HYG; rrp44!::NEO [RRP44, LEU2]
MAT!; leu2!0; lys2!0; ura3!0; ski7!::HYG; rrp44!::NEO [RRP44 (D171A), LEU2]
MAT!; leu2!0; ura3!0; xrn1!::NEO; rrp44!::HYG [RRP44, LEU2]
MAT!; leu2!0; ura3!0; xrn1!::NEO; rrp44!::HYG [RRP44 (D171A), LEU2]
MATa; his3!1; leu2!0; met15!0; ura3!0; RRP43myc::HIS3

Table 2.1: Yeast strains used
Reference
Giaever et al., 2002
Mitchell et al., 1997
This study
This study
This study
van Hoof et al., 2000
This study
This study
This study
This study
This study
This study
This study
This study
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Description
RRP44 promoter
RRP44 promoter
RRP44 3' flanking region
RRP44 promoter, RRP44 3' flanking region
RRP44 promoter, residues 1-1001, RRP44 3' flanking region
RRP44 promoter, residues 1-1001, RRP44 3' flanking region
RRP44 promoter, residues 792-909, RRP44 3' flanking region
RRP44 promoter, residues 1-909, RRP44 3' flanking region
RRP44 promoter, residues 1-440, RRP44 3' flanking region
RRP44 promoter, residues 1-440, RRP44 3' flanking region
RRP44 promoter, residues 1-474, RRP44 3' flanking region
RRP44 promoter, residues 1-400, RRP44 3' flanking region
RRP44 promoter, residues 1-400, RRP44 3' flanking region
RRP44 promoter, residues 1-360, RRP44 3' flanking region
RRP44 promoter, residues 1-360, RRP44 3' flanking region
RRP44 promoter, residues 1-324, RRP44 3' flanking region
RRP44 promoter, residues 1-324, RRP44 3' flanking region
RRP44 promoter, residues 1-235, RRP44 3' flanking region
RRP44 promoter, residues 1-235, RRP44 3' flanking region
RRP44 promoter, residues 1-203, RRP44 3' flanking region
RRP44 promoter, residues 13-1001, RRP44 3' flanking region
RRP44 promoter, residues 34-1001, RRP44 3' flanking region
RRP44 promoter, residues 47-1001, RRP44 3' flanking region
RRP44 promoter, residues 84-1001, RRP44 3' flanking region
RRP44 promoter, residues 360-1001, RRP44 3' flanking region
RRP44 promoter, residues 360-1001, RRP44 3' flanking region
RRP44 promoter, residues 13-235
RRP44 promoter, residues 13-235, RRP44 3' flanking region
RRP44 promoter, residues 1-1001 TAP, RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (C47S, C52S, C55S) TAP, RRP44 3' flanking region
RRP44 promoter, residues 1-235 TAP, RRP44 3' flanking region
RRP44 promoter, residues 1-203 TAP, RRP44 3' flanking region
RRP44 promoter, residues 34-1001 TAP, RRP44 3' flanking region
RRP44 promoter, residues 47-1001 TAP, RRP44 3' flanking region
RRP44 promoter, residues 13-235 TAP, RRP44 3' flanking region
RRP44 promoter, residues 1-1001, RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (E38A), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (Y40A), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (L41A), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (R42A), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (D44A), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (I45A), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (C47S), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (C52S), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (C55S), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (C47S, C52S, C55S), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (D91A), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (E120A), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (D171A), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (D198A), RRP44 3' flanking region
RRP44 promoter, residues 360-1001 (D551N), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (C47S, C52S, C55S, D171A), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (E38A), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (Y40A), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (L41A), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (R42A), RRP44 3' flanking region
RRP44 promoter, residues 1-1001 (D44A), RRP44 3' flanking region

Table 2.2: Plasmids used

Name
pAV317
pAV587
pAV318
pAV473
pAV344
pAV361
pAV363
pAV370
pAV331
pAV343
pAV364
pAV405
pAV423
pAV329
pAV342
pAV404
pAV422
pAV414
pAV454
pAV362
pAV577
pAV586
pAV578
PAV549
pAV328
PAV341
pAV658
pAV659
pAV498
pAV622
pAV499
pAV500
pAV660
pAV661
pAV713
pAV483
pAV588
pAV589
pAV590
pAV591
pAV592
pAV593
pAV594
pAV595
pAV596
pAV506
pAV484
pAV505
pAV485
pAV486
pAV482
pAV629
pAV597
pAV598
pAV599
pAV600
pAV601

Marker
URA3
LEU2
URA3
URA3
LEU2
URA3
URA3
LEU2
URA3
LEU2
LEU2
URA3
LEU2
URA3
LEU2
URA3
LEU2
URA3
LEU2
LEU2
LEU2
LEU2
LEU2
LEU2
URA3
LEU2
LEU2
LEU2
URA3
URA3
URA3
URA3
URA3
URA3
URA3
LEU2
LEU2
LEU2
LEU2
LEU2

Insert/ Origin of plasmid
oAV185 and oAV188 PCR
oAV185 and oAV188 PCR
oAV189 and oAV186 PCR
Digest pAV318
oAV185 and oAV186 PCR
Digest pAV344
oAV354 and oAV452 PCR
Digest pAV363
oAV185 and oAV190 PCR
Digest pAV331
oAV185 and oAV356 PCR
oAV185 and oAV472 PCR
Digest pAV405
oAV185 and oAV282 PCR
Digest pAV329
oAV185 and oAV470 PCR
Digest pAV404
oAV185 and oAV468 PCR
Digest pAV414
oAV271 and oAV451
oAV186 and oAV663 PCR
oAV186 and oAV678 PCR
oAV186 and oAV664 PCR
oAV541 and oAV186 PCR
oAV186 and oAV187 PCR
Digest pAV328
oAV720 and oAV721 PCR
oAV186 and oAV722 PCR
oAV542 and oAV545 (coding region) oAV546 and oAV549 (TAP)
Digest pAV515
oAV542 and oAV547 (coding region) oAV548 and oAV549 (TAP)
oAV542 and oAV543 (coding region) oAV544 and oAV549 (TAP)
Digest pAV586
Digest pAV578
oAV542 and oAV757 (coding region) oAV549 and oAV758 (TAP)
oAV185 and oAV186 PCR
oAV679 and oAV680 mutagenesis
oAV681 and oAV682 mutagenesis
oAV683 and oAV684 mutagenesis
oAV685 and oAV686 mutagenesis
oAV687 and oAV688 mutagenesis
oAV689 and oAV690 mutagenesis
oAV691 and oAV692 mutagenesis
oAV693 and oAV694 mutagenesis
oAV695 and oAV696 mutagenesis
oAV482 and oAV569 mutagenesis
oAV570 and oAV571 mutagenesis
oAV484 and oAV578 mutagenesis
oAV572 and oAV573 mutagenesis
oAV574 and oAV575 mutagenesis
oAV565 and oAV566 mutagenesis
oAV482 and oAV569 mutagenesis
Digest pAV588
Digest pAV589
Digest pAV590
Digest pAV591
Digest pAV592

Parent plasmid
pRS416
pRS415
pRS415
pAV317
pRS415
pRS416
pAV318
pAV344
pAV318
pRS415
pAV343
pAV318
pRS415
pAV318
pRS415
pAV318
pRS415
pAV318
pRS415
pAV342
pAV549
pAV549
pAV549
pAV341
pAV317
pRS415
pAV587
pAV658
pAV473
pAV498
pAV473
pAV473
pAV498
pAV498
pAV473
pBluescript SKpAV483
pAV483
pAV483
pAV483
pAV483
pAV483
pAV483
pAV483
pAV483
pAV483
pAV483
pAV483
pAV483
pAV483
pAV328
pAV485
pRS415
pRS415
pRS415
pRS415
pRS415
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Name
Description
pAV602
RRP44 promoter, residues 1-1001 (I45A), RRP44 3' flanking region
pAV603
RRP44 promoter, residues 1-1001 (C47S), RRP44 3' flanking region
pAV604
RRP44 promoter, residues 1-1001 (C52S), RRP44 3' flanking region
pAV605
RRP44 promoter, residues 1-1001 (C55S), RRP44 3' flanking region
pAV515
RRP44 promoter, residues 1-1001 (C47S, C52S, C55S), RRP44 3' flanking region
pAV502
RRP44 promoter, residues 1-1001 (D91A), RRP44 3' flanking region
pAV514
RRP44 promoter, residues 1-1001 (E120A), RRP44 3' flanking region
pAV503
RRP44 promoter, residues 1-1001 (D171A), RRP44 3' flanking region
pAV656
RRP44 promoter, residues 1-1001 (D171A), RRP44 3' flanking region
pAV504
RRP44 promoter, residues 1-1001 (D198A), RRP44 3' flanking region
pAV501
RRP44 promoter, residues 1-1001 (D551N), RRP44 3' flanking region
pAV657
RRP44 promoter, residues 1-1001 (D551N), RRP44 3' flanking region
pAV709
RRP44 promoter, residues 1-1001 (Y40A, D551N), RRP44 3' flanking region
pAV710
RRP44 promoter, residues 1-1001 (L41A, D551N), RRP44 3' flanking region
pAV711
RRP44 promoter, residues 1-1001 (R42A, D551N), RRP44 3' flanking region
pAV633
RRP44 promoter, residues 1-1001 (C47S, C52S, C55S, D171A), RRP44 3' flanking region
pAV536
RRP44 promoter, residues 1-1001 (C47S, C52S, C55S, D551N), RRP44 3' flanking region
pAV537
RRP44 promoter, residues 1-1001 (D91A, D551N), RRP44 3' flanking region
pAV538
RRP44 promoter, residues 1-1001 (E120A, D551N), RRP44 3' flanking region
pAV539
RRP44 promoter, residues 1-1001 (D171A, D551N), RRP44 3' flanking region
pAV740
RRP44 promoter, residues 1-1001 (D171A, D551N), RRP44 3' flanking region
pAV540
RRP44 promoter, residues 1-1001 (D198A, D551N), RRP44 3' flanking region
pAV528
RRP44 promoter, residues 1-324 (D91A), RRP44 3' flanking region
pAV529
RRP44 promoter, residues 1-324 (E120A), RRP44 3' flanking region
pAV530
RRP44 promoter, residues 1-324 (D171A), RRP44 3' flanking region
pAV531
RRP44 promoter, residues 1-324 (D198A), RRP44 3' flanking region
pAV606
RRP44 promoter, residues 1-235 (E38A), RRP44 3' flanking region
pAV607
RRP44 promoter, residues 1-235 (Y40A), RRP44 3' flanking region
pAV608
RRP44 promoter, residues 1-235 (L41A), RRP44 3' flanking region
pAV609
RRP44 promoter, residues 1-235 (R42A), RRP44 3' flanking region
pAV610
RRP44 promoter, residues 1-235 (D44A), RRP44 3' flanking region
pAV611
RRP44 promoter, residues 1-235 (I45A), RRP44 3' flanking region
pAV513
RRP44 promoter, residues 1-235 (C47S, C52S, C55S), RRP44 3' flanking region
pAV615
RRP44 promoter, residues 1-235 (C47S, C52S, C55S), RRP44 3' flanking region
pAV714
RRP44 promoter, residues 34-1001 (D171A), RRP44 3' flanking region
pAV715
RRP44 promoter, residues 34-1001 (D551N), RRP44 3' flanking region
pGEX-454 GST-RRP44 residues 1-235
pAV575
GST-RRP44 residues 1-235 (C47S, C52S, C55S)
pAV576
GST-RRP44 residues 84-235
Reporter Plasmids
pAV700
his3-nonstop
pAV188
his3-nonstop
pAV175
GAL::pgk1-nonstop
pAV701
GAL::pgk1
pAV702
GAL::pgk1-SL
Other plasmids
pAV476
TAP
pAV139
SKI7 promoter, residues 1-748, SKI7 3' flanking region
pAV179
SKI7 promoter, residues 1-748 (P265*), SKI7 3' flanking region
pAV402
GPD promoter, A. thaliana RRP41 residues 1-241
pAV349
E. coli RNase II residues 1-644
pAV375
GPD promoter, E. coli RNase II residues 1-644
pAV350
E. coli RNase R residues 1-813
pAV376
GPD promoter, E. coli RNase R residues 1-813
pAV474
GPD promoter, RRP6 residues 1-734

Table 2.2: Plasmids used (continued)
Insert/ Origin of plasmid
Digest pAV593
Digest pAV594
Digest pAV595
Digest pAV596
Digest pAV506
Digest pAV484
Digest pAV505
Digest pAV485
Digest pAV503
Digest pAV486
Digest pAV482
Digest pAV501
Digest pAV598
Digest pAV599
Digest pAV600
Digest pAV629
Digest pAV515
Digest pAV502
Digest pAV514
Digest pAV503
Digest pAV539
Digest pAV504
oAV185 and oAV470 PCR
oAV185 and oAV470 PCR
oAV185 and oAV470 PCR
oAV185 and oAV470 PCR
oAV185 and oAV468 PCR
oAV185 and oAV468 PCR
oAV185 and oAV468 PCR
oAV185 and oAV468 PCR
oAV185 and oAV468 PCR
oAV185 and oAV468 PCR
oAV185 and oAV468 PCR
Digest pAV513
oAV186 and oAV678 PCR
Digest pAV501
Schaeffer et al., 2009
oAV647 and oAV648 PCR
oAV662 and oAV648 PCR
Digest pAV188
van Hoof et al., 2002
Frischmeyer et al., 2002
Doma and Parker, 2006
Doma and Parker, 2006
oAV556 and oAV557 PCR
Benard et al., 1999
oRP1055 mutagenesis
oAV464 and oAV465 PCR
Gift from Drs. Ana Barbas and Cecilia Arraiano
Digest pAV349
Gift from Drs. Ana Barbas and Cecilia Arraiano
Digest pAV350
oAV459 and oAV460 PCR

Marker
LEU2
LEU2
LEU2
LEU2
LEU2
LEU2
LEU2
LEU2
URA3
LEU2
LEU2
URA3
LEU2
LEU2
LEU2
LEU2
LEU2
LEU2
LEU2
LEU2
URA3
LEU2
LEU2
LEU2
LEU2
LEU2
LEU2
LEU2
LEU2
LEU2
LEU2
LEU2
URA3
LEU2
LEU2
LEU2
LYS2
URA3
URA3
URA3
URA3
LEU2
URA3
URA3
HIS3
HIS3
HIS3
HIS3

pRS415
pAV152
p423GPD
pET15b
p423GPD
pET15b
p423GPD
p423GPD

pRS317
-

Parent plasmid
pRS415
pRS415
pRS415
pRS415
pRS415
pRS415
pRS415
pRS415
pRS416
pRS415
pAV344
pAV361
pAV501
pAV501
pAV501
pRS415
pAV501
pAV501
pAV501
pAV501
pRS416
pAV501
pRS415
pRS415
pRS415
pRS415
pAV454
pAV454
pAV454
pAV454
pAV454
pAV454
pAV318
pRS415
pAV586
pAV586
pGEX4T1
pGEX4T1

Table 2.3: Oligonucleotides used
PCR oligos
oAV185
oAV186
oAV187
oAV188
oAV189
oAV190
oAV271
oAV282
oAV354
oAV356
oAV451
oAV452
oAV459
oAV460
oAV464
oAV465
oAV468
oAV470
oAV472
oAV482
oAV484
oAV541
oAV542
oAV543
oAV544
oAV545
oAV546
oAV547
oAV548
oAV549
oAV565
oAV566
oAV569
oAV570
oAV571
oAV572
oAV573
oAV574
oAV575
oAV578
oAV647
oAV648
oAV662
oAV663
oAV664
oAV678
oAV679
oAV680
oAV681
oAV682
oAV683
oAV684
oAV685
oAV686
oAV687
oAV688
oAV689
oAV690
oAV691
oAV692
oAV693
oAV694
oAV695
oAV696
oAV720
oAV721
oAV722
oAV757
oAV758
oRP1055

Sequence
5' ATATAGAGCTCAAAAACTGCCTACGTACCATTTAAC
5' ATATACTCGAGCACCACCAAAATGTCAATTTTTTTG
5' ATATAACTAGTAACAACATGTCCAATACCACCGTGATTTC
5' ATATAACTAGTTTTGGCCTGTATGATGCAAG
5' ATATAACTAGTTAGATGGAAGATGCTTCAGTATC
5' ATATAACTAGTTTAACGCCTTGTTCTGATTCTGAC
5' ATATAACTAGTTTATTCTCTATTCAAACGATCGTTGGTAAC
5' ATATAACTAGTTTAGGAAGAGGACTCATTATTGTC
5' ATATAACTAGTTTAATTCCTCATTACTTGCCCGAC
5' ATATAACTAGTTTAAATTGTACCGAGGTCTCTCACAAAG
5' GTGTGTGCTACTGCAGTACTTCTTAGAG
5' CGAGCGGCCGCGGTGTGTGGATCCCGAAGATCC
5' ATATAACTAGTTGCGTTATGACTTCTGAAAATCCGGATG
5' ATATACTCGAGTCACCTTTTAAATGACAGATTCTT
5' ATATAACTAGTCCATGGAGTACGTAAACCCTGAAGGTC
5' ATATACTCGAGTTATGCAGCTCGGCGATACTCTAGC
5' ATATAACTAGTTTAAATAGAGTCTCTGATGTCGTCTGCA
5' ATATAACTAGTTTATGATTGAGGTAGCAGTTCCACGATAAC
5' ATATAACTAGTTTACCAGGATCTTCTTTGTATATATACAA
5' GATCGGACATCCCAAGTCTTTCTAGAAGTAGTACCAAGAGTCCGCAAATTGTCG
5' TTGTCCCCCAGATTGTTCTAGATGCAGTGAGAAACAAGTC
5' ATATAACTAGTATGGGTAAGCATTACGTCG
5' GATCAAACGAGTTTTATTTATCATACTTGCATCATACAGGCCAAAACAAC
5' TTCTCTATTCAAACGATCGTTGGTAACAAGAACGACGTTTATGTCATAAG
5' CTTATGACATAAACGTCGTTCTTGTTACCAACGATCGTTTGAATAGAGAAGGTCGACGGATCCCCGGGTT
5' TTTTAACAATAATTCTGCCTTACGCTTGCTAGTAATTGGATCCATCACCG
5' CGGTGATGGATCCAATTACTAGCAAGCGTAAGGCAGAATTATTGTTAAAAGGTCGACGGATCCCCGGGTT
5' AATAGAGTCTCTGATGTCGTCTGCATTTGGTAGTAACTCGATATACTGTA
5' TACAGTATATCGAGTTACTACCAAATGCAGACGACATCAGAGACTCTATTGGTCGACGGATCCCCGGGTT
5' CACCACCAAAATGTCAATTTTTTTGCCATTTTCTAAATAGTTTTCTTCACTTATCGATGAATTCGAGCTCGTT
5' CTCCAGGATGTGTTGATATCAACGATGCCCTACATGCG
5' CGCATGTAGGGCATCGTTGATATCAACACATCCTGGAG
5' CGACAATTTGCGGACTCTTGGTACTACTTCTAGAAAGACTTGGGATGTCCGATC
5' GCATTACGTCGTCTTGGCCACCAACGTGGTGTTAC
5' GTAACACCACGTTGGTGGCCAAGACGACGTAATGC
5' CGATTAATGACAGAAACGCGCGCGCTATAAGGAAAACCTGTCAATGG
5' CCATGACAGGTTTTCCTTATAGCGCGCGCGTTTCTGTCATTAATCG
5' CGTTCTTGTTACCAACGCTCGTTTGAATAGAGAAGC
5' GCTTCTCTATTCAAACGAGCGTTGGTAACAAGAACG
5' GACTTGTTTCTCACTGCATCTAGAACAATCTGGGGGACAA
5' CGCAGAATTCATGTCAGTTCCCGCTATCG
5' ATATACTCGAGTTAAATAGAGTCTCTGATGTCGTCTGCA
5' CGCAGAATTCATGGGTAAGCATTACGTCG
5' ATATAACTAGTAACAACATGCTTGCAGATGGTTTAAGCG
5' ATATAACTAGTAACAACATGTGTCTTTCGAGAAGTTGTA
5' ATATAACTAGTAACAACATGAAGATCGTAAGAGAACACTAT
5' CAAGATCGTAAGAGCACACTACTTAAGATCGGACATC
5' GATGTCCGATCTTAAGTAGTGTGCTCTTACGATCTTG
5' CGTAAGAGAACACGCTTTAAGATCTGACATCCCATGTCTTTC
5' GAAAGACATGGGATGTCAGATCTTAAAGCGTGTTCTCTTACG
5' GTAAGAGAACACTATGCAAGATCTGACATCCCATGTCTTTC
5' GAAAGACATGGGATGTCAGATCTTGCATAGTGTTCTCTTAC
5' GAGAACACTATTTAGCATCGGATATCCCATGTCTTTCG
5' CGAAAGACATGGGATATCCGATGCTAAATAGTGTTCTC
5' CTATTTAAGATCGGCCATCCCATGTCTCTCGAGAAGTTGTACC
5' GGTACAACTTCTCGAGAGACATGGGATGGCCGATCTTAAATAG
5' CTATTTAAGATCGGACGCCCCATGTCTCTCGAGAAGTTGTAC
5' GTACAACTTCTCGAGAGACATGGGGCGTCCGATCTTAAATAG
5' GATCGGACATCCCAAGTCTTTCTAGAAGTTGTACCAAG
5' CTTGGTACAACTTCTAGAAAGACTTGGGATGTCCGATC
5' GATCGGACATCCCATGTCTTTCTAGAAGTAGTACCAAGTGTCCG
5' CGGACACTTGGTACTACTTCTAGAAAGACATGGGATGTCCGATC
5' CATCCCATGTCTTTCTAGAAGTTGTACCAAGAGTCCGCAAATTGTC
5' GACAATTTGCGGACTCTTGGTACAACTTCTAGAAAGACATGGGATG
5' ATATATCTAGAAACAACATGCTTGCAGATGGTTTAAGCG
5' ATATAGGATCCTTAAATAGAGTCTCTGATGTCGTCTGCA
5' ATATAGGATCCTAGATGGAAGATGCTTCAGTATC
5' AATAGAGTCTCTGATGTCGTCTGCATTTGGTAGTAACTCGATATACTGTA
5' TACAGTATATCGAGTTACTACCAAATGCAGACGACATCAGAGACTCTATTGGTCGACGGATCCCCGGGTT
5' TGTCAAATTCAACTAGTGGGTGGCAATGAATG
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Table 2.3: Oligonucleotides used (continued)
Northern oligos
oAV141
oAV224
oAV267
oAV671
oAV783
oAV784
oJA003
oRP993

Sequence
5' AATTGATCTATCGAGGAATTCC
5' GTCTAGCCGCGAGGAAGG
5' CTCTTGCTTCTCTGGAGAGATCGTCAGTC
5' AAAATGGCGTGAGGTAGAGAGAAACCAGCG
5' CGGATAAGAAAGCAACACCTGG
5' GGTTGGCAAAGCAGC
5' TGAGAAGGAAATGACGCT
5' CGAACGACAAGCCTACTCG
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described above. N-terminal truncations were generated similarly, except that the promoter was
PCR amplified and cloned first, with the truncated coding region and 3’ flanking region cloned
second.
Site-directed mutations of Rrp44p were created using the QuikChange II Kit
(Stratagene) and the oligonucleotides listed in Table 2.3. Each oligonucleotide also changes a
restriction site to aid in screening. Following restriction digestion, putative mutations were
verified by sequencing. To combine point mutations in the CR3 region and PIN domain of
Rrp44p with the D551N mutation in the RNB domain, plasmids encoding each single mutation
were digested with SacI and PshAI and ligated together. SacI cuts at the beginning of the
promoter, whereas PshAI cuts at a unique site within the CSD2 domain. To generate the point
mutations of the CR3 region and PIN domain in the 1-324 truncation, the promoter and truncated
coding region were PCR amplified from the full-length point mutations and cloned.
C-terminally TAP-tagged Rrp44 constructs were created using homologous
recombination. To create a gapped plasmid, pAV473 was digested with SpeI, which cuts 3’ of
the Rrp44p promoter. A portion of the coding region of Rrp44p was PCR amplified from
pAV344 so that the 5’-end of the resulting PCR product had at least 50 nucleotides of homology
to the Rrp44p promoter. The TAP tag and HIS3 marker were PCR amplified from a strain
containing Rrp44p-TAP from the yeast TAP-tagged collection (Open Biosystems;
Ghaemmaghami et al., 2003) so that the 5’-end of the resulting PCR product had at least 50
nucleotides of homology to the Rrp44p coding region and that the 3’-end of the resulting PCR
product had at least 50 nucleotides of homology to the 3’ UTR of Rrp44p. The gapped plasmid
and both PCR products were transformed into yeast and subsequently rescued from yeast to
verify the sequence of the plasmid.
Rrp44p GST fusion plasmids were generated by PCR amplifying the RRP44 coding
region from the plasmids described above, digesting the PCR product with EcoRI and XhoI, and
ligating them into pGEX-4T-1 (GE Healthcare).
Yeast growth assays
Complementation growth assays
Complementation growth assays were performed using rrp44 truncations and point
mutations encoded on a LEU2 plasmid. These plasmids were transformed into an rrp44 deletion
strain containing a URA3 plasmid that encoded wild-type RRP44. Transformants were then
grown on SC –LEU –URA + 2% dextrose overnight at 30°C. Cultures were then diluted in the
same selection media to an optical density at 600 nm of 0.8. Next, cells were serially diluted in
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96-well plates by a factor of 5 and spotted onto media containing 5-fluoroorotic acid (5-FOA).
These plates were incubated at 30°C for 2-20 days. 5-FOA selects for cells that have lost the
URA3 plasmid. Therefore, cells that are viable on 5-FOA can lose the URA3 plasmid encoding
wild-type RRP44, which suggests that the rrp44 truncation or point mutant can carry out the
essential function of Rrp44p.
Synthetic lethality growth assays
Synthetic lethality growth assays were performed essentially as described (van Hoof et
al., 2000b). Briefly, plasmids encoding rrp44 truncations and point mutations were transformed
into a dcp1-2, rrp44 deletion strain containing a URA3 plasmid encoding wild-type RRP44.
Transformants were grown in SC –LEU –URA + 2% dextrose overnight at 23°C. Cultures were
diluted in the same selection media to an optical density at 600 nm of 0.8. Next, cells were
serially diluted in 96-well plates by a factor of 5 and spotted onto the same selection media.
Plates were incubated at 23°C (permissive temperature), 30°C, and 37°C (non-permissive
temperature) for 2-5 days. The basis of this assay is that one of the two general mRNA
degradation pathways is required for viability. Cells with a functional 3’ to 5’ decay pathway are
viable at all temperatures, whereas mutants in the 3’ to 5’ degradation pathway are synthetically
lethal with dcp1-2 at the non-permissive temperature.
His3-nonstop growth assays
The his3-nonstop growth assay was performed essentially as described (van Hoof et al.,
2002). Briefly, rrp44 deletion strains containing LEU2 plasmids encoding rrp44 truncations and
point mutations were transformed with a URA3 or LYS2 plasmid encoding a his3-nonstop
reporter. This reporter contains a nonstop mutation at the end of the HIS3 open reading frame.
Transformants were grown in SC –LEU –URA + 2% dextrose or SC –LEU –LYS + 2% dextrose
overnight at 30°C. Cultures were diluted in the same selection media to an optical density at 600
nm of 0.8. Next, cells were serially diluted in 96-well plates and spotted onto media lacking
histidine, SC –HIS –LEU –URA or SC –HIS –LEU –LYS. The plates were incubated at 30°C
for 2-5 days. In cells with a functional nonstop mRNA degradation pathway, the nonstop mRNA
degradation machinery rapidly degrades the his3-nonstop transcript. In contrast, in cells that are
not able to degrade the his3-nonstop transcript, histidine is made, and cells are viable on media
lacking histidine.
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Soluble Cell Lysate Preparation Using Glass Bead Lysis
Cell cultures of optical density at 600 nm of 0.8 were pelleted and resuspended in 250
!L of IP50 buffer [50m! NaCl, 50m! Tris-HCl (pH 7.5), 2m! MgCl2, 0.1% Triton X,
0.00714% "-mercaptoethanol, 0.1! PMSF, with complete EDTA-free protease inhibitors
(Roche)]. 50 !L of glass beads were added to the cell suspension and agitated in a vortex mixer
for 7 minutes at 4°C. Cell lysates were clarified by centrifugation at 4,500 x g for 7 minutes at
4°C.

Tandem Affinity Purification (TAP)
Tandem affinity purifications were performed by adding 10 !L of IgG Sepharose 6 Fast
Flow beads (Amersham Biosciences) to 200 !L of whole-cell lysates. After incubation for 1
hour at 4°C, the supernatant was discarded and the beads were washed two times with 200 !L of
IP50 buffer. The beads were washed two more times with 200 !L of IP1000 buffer [1 ! NaCl,
50 m! Tris-HCl (pH 7.5), 2 m! MgCl2, 0.1% Triton X, 0.00714% "-mercaptoethanol, 0.1 !
PMSF, with complete EDTA-free protease inhibitors (Roche)]. The beads were then
resuspended in 100 !L of IP50 buffer and 33.3 !L of 6X protein sample buffer [350 mM Tris
HCl (pH 6.8), 36% glycerol, 10% SDS, 5% "-mercaptoethanol, 0.012% bromophenol blue] was
added. Bound proteins were eluted from beads by boiling for 3 minutes at 95°C and were
analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
SDS-PAGE and Western Blot analysis
Proteins were separated by SDS-PAGE and transferred to nitrocellulose membranes
(Bio-Rad) for immunodetection essentially as described (Laemmli, 1970; Towbin et al., 1979).
Antibodies were diluted in a 5% solution of non-fat milk in TBST (0.684 M NaCl, 0.1 M Tris
base). Anti-Protein A monoclonal antibody was purchased from Sigma and used at a dilution of
1:1,000,000. Anti-Myc monoclonal antibody was used at a 1:1,000 dilution (kindly provided by
E. Wagner, University of Texas Health Science Center at Houston, Houston, TX). Anti-Pgk1p
monoclonal antibody was purchased from Invitrogen and used at a 1:6,000 dilution.
Plasmid Rescue from Yeast
The plasmid rescue from yeast protocol was adapted from instructions provided by the
S. Fields Laboratory (University of Washington, Seattle, WA) and by using the QIAprep Spin
Miniprep Kit (Qiagen). Briefly, yeast strains were grown in a 5 mL overnight culture of YPD.
Cells were then pelleted and resuspended in 250 !L of Qiagen buffer P1 and 250 !L of acid34

washed glass beads. To disrupt the cell wall, the suspensions were agitated in a vortex mixer for
7 minutes. Next, 250 !L of Qiagen buffer P2 was added and the suspensions were inverted 7
times. To obtain clarified cell lysates, the reactions were centrifuged at maximum speed for 10
minutes. The supernatant was transferred to a QIAprep spin column and spun at maximum speed
for 1 minute. The column was washed once with 750 !L of Qiagen buffer PE by centrifuging the
column at maximum speed for 1 minute. The supernatant was discarded and the column
removed to a clean microcentrifuge tube. Plasmid DNA was eluted by adding 50 !L of sterile
ddH2O, followed by incubated at 37°C for 5 minutes.
Overexpression and Purification of Recombinant Rrp44p
Cell cultures of Rosetta (DE3) E. coli containing a plasmid encoding wild-type RRP44
or rrp44 mutations were grown at 30°C in 2 L of Terrific Broth (TB) [1.2% Tryptone, 2.4%
Yeast Extract, 54.0 mM K2HPO4, 16.2 mM KH2PO4] supplemented with ampicillin (200 µg/ml)
and chloramphenicol (25 µg/ml) to an optical density at 600 nm of 1.2. To induce expression of
rrp44, 0.2 mM of isopropyl "-D-1-thiogalactopyranoside (IPTG) was added to the cultures,
which were then switched to 18°C for overnight incubation. Cell cultures were then pelleted and
resuspended in 30 mL phosphate buffered saline (PBS) [37 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4, 2 mM KH2PO4, 10 mM DTT, and 1 mM phenylmethylsulfonyl fluoride (PMSF); pH
8]. Cell suspensions were then lysed using the French Press. Crude cell extracts were treated
with 5 units of Benzonase (Sigma) for 30 minutes at 0°C and then clarified by a 30 minute
centrifugation at 10,000 x g. Clarified cell lysates were loaded onto a GSTrapTM FF 1 ml column
(GE Healthcare) equilibrated in GST binding buffer [50 mM Tris-HCl (pH 8.5), 10 mM DTT].
Proteins were eluted with a 0-1610 mM glutathione gradient in GST Binding buffer and
fractionated into 2 mL aliquots. The fractions containing purified protein were pooled and loaded
onto a gel filtration column [Superdex 75 10/300 GL or a Superose 12 10/300 GL (GE
Healthcare), depending on the protein size] equilibrated with gel filtration buffer [20 mM TrisHCl, 150 mM NaCl, 5mM MgCl2 and 10 mM DTT buffer (pH 8)]. The eluted proteins were
loaded onto a Vivaspin 500 Centrifugal Concentrator column (Vivaspin) and concentrated by
centrifugation at 4,500 x g at 15°C until approximately 100 !L of concentrated protein remained.
Protein concentration was determined by spectrophotometry using a Nanodrop
spectrophotometer. Glycerol [50% (v/v)] was added to the final fraction, which was stored at 20°C.
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RNase assays
500 nM of Rrp44p GST-fusion recombinant proteins were incubated with 200 nM of 32P
5’-end labeled A30 oligonucleotide in a buffer consisting of 20 mM HEPES (pH 7.5), 150 mM
NaCl, 3 mM MnCl2, 1 mM DTT for the times indicated. Reactions were subject to denaturing
urea-polyacrylamide gel electrophoresis for single nucleotide separation.
Determining the processing of the 5.8S rRNA and the degradation of the 5’ ETS of the prerRNA precursor
Monitoring of 5.8S rRNA processing and 5’ ETS degradation was carried out essentially
as described (Allmang et al., 1999b). Briefly, GAL::rrp44 strains containing LEU2 plasmids
encoding rrp44 truncations and point mutations were grown in SC –LEU + 2% galactose
overnight at 30°C. Cultures were diluted in the same selection media to an optical density at 600
nm of 0.2 and grown to an optical density at 600 nm of 0.8. The medium was replaced with SC –
LEU + 4% glucose to inhibit expression of the endogenous RRP44 allele. At the time points
indicated, 2 mL cell aliquots were pelleted. RNA was isolated and subject to denaturing ureapolyacrylamide gel electrophoresis, followed by Northern blot analysis (see below).
Stability of pgk1pG-nonstop mRNA
To determine the half-life of the pgk1pG-nonstop reporter, yeast strains were grown in
SC –URA + 2% galactose overnight at 30°C. Cultures were diluted in the same selection media
to an optical density at 600 nm of 0.2 and grown to an optical density at 600 nm of 0.8. The
medium was replaced with SC –URA + 4% glucose. At the time points indicated, 2 mL cell
aliquots were pelleted. RNA was isolated and subjected to formaldehyde agarose gel
electrophoresis, followed by Northern blot analysis (see below).
RNA Isolation
RNA isolations were performed essentially as described (Caponigro et al., 1993). Cell
pellets were resuspended in 150 !L of LET [25 mM Tris (pH 8), 100 mM LiCl, 20 mM EDTA],
150 !L of phenol equilibrated with LET, and 250 !L of acid-washed glass beads in a 2 mL tube.
To disrupt the cell wall, cell suspensions were agitated in a vortex mixer for 5 minutes. Next,
250 !L of chloroform and 250 !L of diethyl pyrocarbonate-treated (DEPC) water were added.
To clarify the cell suspensions, the reactions were centrifuged at maximum speed for 2 minutes.
The aqueous phase was transferred to a fresh 2 mL tube containing 400 !L of phenol-chloroform
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equilibrated with LET. Samples were again centrifuged at maximum speed for 2 minutes. The
aqueous phase was transferred to a fresh 2 mL tube containing 400 !L of chloroform. Samples
were again centrifuged at maximum speed for 2 minutes. The aqueous phase was transferred to a
fresh 2 mL tube containing 1 mL 95% EtOH and 40 !L of 3M NaAc. To precipitate the RNA,
samples were incubated at -80°C for at least 30 minutes and then centrifuged at maximum speed
for 30 minutes. RNA pellets were dried in a concentration/drying system and resuspended in 100
!L of DEPC-treated water.
Northern Blot Analysis and Quantitation of Gene Expression
Northern blot analysis was performed essentially as described (Meaux and van Hoof,
2006). Blots were hybridized with 32P 5’-end labeled oligonucleotides specific for the 5.8S
rRNA (oJA003), 5’ ETS (oRP993), pgk1pG-nonstop (oRP141), GAL7 (oAV267), ACT1
(oAV671), the 5’- and 3’-ends of PGK1 and pgk1-SL (oAV784 and oAV783, respectively) and
the RNA subunit of the signal recognition particle (oRP100). The oligonucleotide sequences are
listed in Table 2.3. Signals were detected and quantitated using a STORM PhosphorImager
(Amersham), and corrected for loading by quantitating the RNA subunit of the signal recognition
particle, SCR1, or ACT1.
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Chapter 3: The PIN domain of Rrp44p has endoribonuclease activity
and is essential for exosome function.

NOTE: This Chapter is derived from work that was published in 2009: “The exosome contains domains
with specific endoribonuclease, exoribonuclease and cytoplasmic mRNA decay activities.” Nature
Structural and Molecular Biology. 16 (1): 56 – 62. I am the primary author on this paper and was
involved in preparing the original manuscript. I performed all of the experiments described in this
Chapter with the exception of the biochemical nuclease assays that were performed by our collaborators,
Drs. Ana Barbas and Cecilia Arraiano (Instituto de Tecnologia Química e Biológica [ITQB]; Lisbon,
Portugal). I have been given permission by the publisher of Nature Structural and Molecular Biology, the
Nature Publishing Group, to reproduce any/all of my manuscript in print or electronically for the
purposes of my dissertation.
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INTRODUCTION
Rrp44p is the only catalytic subunit of the core exosome, with its 3’ to 5’
exoribonuclease activity contributed by the RNB domain. Besides the RNB domain, Rrp44p
contains four other domains, three of which are putative RNA binding domains. The fourth
domain, PIN, has not yet been characterized in eukaryotic Rrp44p.
PIN domains are named for their homology with the N-terminus of the bacterial type IV
pilus biosynthetic protein, PilT (Wall and Kaiser, 1999), and are ubiquitous in all three kingdoms
of life. These domains are approximately 100 residues in length and display a sequence
conservation of four acidic residues (Clissold and Ponting, 2000; Makarova et al., 1999). The
acidic residue conservation seen in PIN domains commonly occurs in enzymes that ligate
divalent cations, such as nucleases (Clissold and Ponting, 2000). Although the conserved
residues of the PIN domain are spread across the primary sequence of the protein, the active site
residues come together and are thought to bind Mg2+ or Mn2+. The central channel formed by the
PIN domain is large enough to accommodate ssDNA or RNA, but not dsDNA (Daines et al.,
2007; Fatica et al., 2004).
Bioinformatic analysis of PIN domains predicted a fold similar to the FLAP 5’ to 3’
exonuclease family of proteins, which includes T4 bacteriophage RNase H (Clissold and
Ponting, 2000). Recent structural analysis of archaeal PIN domain-containing proteins, PAE2754
and AF0591, confirmed these predictions, showing a fold similar to the nuclease domain of T4
RNase H. In addition, PAE2754 its conserved acidic residues had a similar spatial arrangement,
suggesting that these residues may also coordinate a metal ion for catalysis. In vitro experiments
confirmed that these enzymes have Mg2+-dependent exonuclease activity on ssDNA, similar to
T4 RNase H (Arcus et al., 2004; Levin et al., 2004).
Importantly, several of the conserved acidic residues of PIN domains are present at the
same structural position in eukaryotic PIN domain-containing proteins, which suggests that these
proteins may also coordinate a divalent cation and exhibit nuclease activity. Recently three
eukaryotic PIN domain-containing proteins, S. cerevisiae Nob1p and Utp24p and H. sapiens
SMG6, were shown to have endoribonuclease activity on ssRNA, with Nob1p and SMG6
dependent on Mn2+ for activity. Importantly, mutations of the third conserved acidic residue in
these proteins abolished PIN domain-mediated endonuclease activity in vitro and in vivo
(Bleichert et al., 2006; Fatica et al., 2004; Glavan et al., 2006). Ribonuclease activity has also
been demonstrated in bacterial PIN domain-containing proteins (Daines et al., 2007). Several of
these proteins are found in toxin-antitoxin systems, where the RNase activity of the PIN domain
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is responsible for degrading the labile antitoxin, resulting in a toxic effect (Anantharaman and
Aravind, 2003; Gerdes et al., 2005).
PIN domain containing-proteins have nuclease activity in all three kingdoms of life,
suggesting that this nuclease activity plays an important cellular role. To determine whether the
PIN domain of S. cerevisiae Rrp44p also has nuclease activity, GST-fusions of Rrp44p were
purified from E. coli and incubated with several RNA substrates. Here, the data indicate that the
PIN domain of yeast Rrp44p has Mn2+-dependent endoribonuclease activity that is not sequence
specific. Additionally, the PIN domain is needed for viability. Data also suggest that while yeast
cells require at least one of the nuclease activities of Rrp44p to survive, either activity is
sufficient for viability. Lastly, the exoribonuclease, but not endoribonuclease, activity of Rrp44p
is required for a functional nuclear exosome.
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RESULTS
The PIN domain of Rrp44p has endoribonuclease activity.
Truncated Rrp44p, which includes the CR3 region and PIN domain (residues 1-235),
was purified as a Glutathione S-transferase (GST) fusion from E. coli. Truncated Rrp44p was
incubated individually with a 32P 5’- and 3’-end labeled A30 oligonucleotide. Exonucleolytic
degradation would yield labeled mononucleotides with only one of the substrates, whereas
truncated Rrp44p showed a similar pattern of labeled oligonucleotides with both substrates
(Schaeffer et al., 2009). This indicates that the PIN domain of Rrp44p acts as an endonuclease.
Truncated Rrp44p was also incubated individually with a 32P 5’-end labeled U30
oligonucleotide and an in vitro transcribed, 32P internally labeled 5’ ETS substrate. Truncated
Rrp44p was active on both, and on an A30 oligonucleotide, indicating that PIN domain
endoribonuclease activity of Rrp44p is not sequence specific (Schaeffer et al., 2009).
Mutation of the third conserved acidic residue, Aspartate 171, abolished the
endoribonuclease activity of Rrp44p (Lebreton et al., 2008; Schaeffer et al., 2009; Schneider et
al., 2009), which has also been shown for other PIN domain-containing proteins (Bleichert et al.,
2006; Fatica et al., 2004; Glavan et al., 2006).
The PIN domain of Rrp44p is needed for viability.
To determine whether the endoribonuclease activity of Rrp44p was needed for cell
survival, C-terminal truncations of RRP44 were generated. These mutants were transformed into
an rrp44 deletion strain that is complemented by full-length, wild-type RRP44 on a plasmid with
a URA3 marker (rrp44# [RRP44, URA3]). Transformants were then spotted onto media
containing 5-fluoroorotic acid (5-FOA) and grown for several days. Growth of the rrp44 mutants
was compared to two controls, empty vector and wild-type RRP44 (Figure 3.1A). In cells that
contain a wild-type URA3 gene, the URA3 gene product (orotine-5’-monophosphate
decarboxylase) converts 5-FOA to 5-fluorouracil, which is toxic to cells (Boeke et al., 1987).
Since 5-FOA is used to select for cells that have lost the wild-type RRP44, URA3 plasmid, only
one mutant copy of rrp44 remains in the cell. Therefore, growth on 5-FOA indicates that mutant
Rrp44p can carry out the protein’s essential function.
A C-terminal truncation that lacks the exoribonucleolytic RNB domain, but contains the
CR3 region and PIN domain (residues 1-235), allowed for slow growth (Figure 3.1A(Schaeffer
et al., 2009). This result is not surprising given that it has been previously shown that a point
mutant that inactivates the catalytic activity of the RNB domain, D551N, also has a slow growth
phenotype (Amblar and Arraiano, 2005; Dziembowski et al., 2007). The slight growth observed
41

upon deletion of the RNB domain suggests that the D551N mutant is not viable only because of
some low-level exonuclease activity in vivo. Instead, growth of the C-terminal truncation that
lacks the RNB domain suggests that exonuclease activity is not crucial for the essential function
of Rrp44p, or the exosome. A C-terminal truncation that lacks a portion of the PIN domain
(residues 1-203) does not support viability (Figure 3.1A; Schaeffer et al., 2009). This lack of
complementation is not due to a lack of expression as both C-terminal truncations are expressed
(Figure 3.1B). This suggests that the PIN domain is required for viability, and thus, the essential
function of Rrp44p.
At least one nuclease activity of Rrp44p is needed for viability.
To determine whether the endonuclease activity of the PIN domain of Rrp44p is needed
for viability, a catalytically inactive endonuclease point mutation (D171A) was generated and
transformed into an rrp44# [RRP44, URA3] strain. Transformants were then spotted onto media
containing 5-FOA and grown for several days. Growth of the D171A mutant was compared to
empty vector, wild-type RRP44 and the catalytically inactive exonuclease point mutant, D551N.
The D171A mutant (Figure 3.2A), or mutants in the three other conserved acidic residues of the
PIN domain (Figure 3.2B), had no obvious growth phenotype. In contrast, the D551N mutant
had a slow growth phenotype (Figure 3.2A; Lebreton et al., 2008; Schaeffer et al., 2009;
Schneider et al., 2009), which has been previously shown in mutants that inactivate Rrp44p
exonuclease activity (Amblar and Arraiano, 2005; Dziembowski et al., 2007). These findings
suggest that neither of the nuclease activities of Rrp44p is required for viability.
To determine whether cells require at least one nuclease activity of Rrp44p to survive,
the double catalytically inactive point mutation (D171A, D551N) was generated and transformed
into an rrp44# [RRP44, URA3] strain. Transformants were then spotted onto media containing
5-FOA and grown for several days. Growth of the D171A, D551N mutant was compared to
empty vector, wild-type RRP44, the D171A mutant, and the D551N mutant. Combining the
viable D171A mutant, or mutants in the other three conserved acidic residues of the PIN domain,
with the D551N mutant resulted in no growth (Figure 3.2A and B; Lebreton et al., 2008;
Schaeffer et al., 2009; Schneider et al., 2009). Similarly, combining the viable PIN mutations
with a viable C-terminal truncation that lacks the exonucleolytic RNB domain, residues 1-324,
also resulted in no growth (Figure 3.2C; Schaeffer et al., 2009). These results suggest that either
nuclease active site is sufficient for viability, however, simultaneous inactivation of both of the
catalytic sites results in a nonfunctional Rrp44p, and thus, no cell growth.
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B.

Figure 3.1: The PIN domain of Rrp44p is needed for viability.
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Figure 3.1: The PIN domain of Rrp44p is needed for viability. A, An rrp44 deletion strain
complemented by full-length RRP44 on a plasmid with a URA3 marker was transformed with
plasmids encoding each of the depicted truncations. Transformants were spotted onto media
containing 5-fluoroorotic acid (5-FOA) and control media (SC –LEU–URA + 2% dextrose), and
grown for several days. Growth of the rrp44 mutants was compared to two control strains, empty
vector and wild-type RRP44. Growth on 5-FOA indicates that truncated Rrp44p can carry out
the essential function of Rrp44p. B, Whole-cell lysates were obtained from strains containing the
C-terminally TAP-tagged Rrp44p truncations described in (A) and were analyzed by Western
blot analysis with antibodies specific to Protein A to detect Rrp44p and to Pgk1p as a loading
control. Expression of the Rrp44p truncated proteins was compared to wild-type Rrp44p.
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Figure 3.2: At least one nuclease activity of Rrp44p is needed for viability.
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C.

Figure 3.2: At least one nuclease activity of Rrp44p is needed for viability.
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Figure 3.2: At least one nuclease activity of Rrp44p is needed for viability. An rrp44
deletion strain complemented by full-length RRP44 on a plasmid with a URA3 marker was
transformed with plasmids encoding the depicted mutations. Transformants were spotted onto
media containing 5-FOA and control media (SC –LEU–URA + 2% dextrose), and grown for
several days. Growth of the rrp44 mutants was compared to two controls, empty vector and
wild-type RRP44. Growth on 5-FOA indicates that mutated Rrp44p can carry out the essential
function of the Rrp44p.

47

The exoribonuclease activity of Rrp44p is needed for both the RNA processing and RNA
degradation activities of the nuclear exosome.
The nuclear exosome processes the 7S rRNA precursor to form the mature 5.8S rRNA
and degrades the 5’ external transcribed spacer (5’ ETS) of the 35S rRNA precursor (Allmang et
al., 1999a; Allmang et al., 1999b; Mitchell et al., 1997; Mitchell et al., 1996). In RNA
processing, an RNA precursor is trimmed to form a mature, stable, small RNA. In RNA
degradation, however, an RNA is cleaved many times to yield nucleotide monophosphates. This
type of cleavage would require an efficient and processive enzyme that is able to degrade an
RNA substrate to completion. Therefore, the endonuclease activity of the PIN domain of Rrp44p
may be sufficient for nuclear exosome-mediated RNA processing, whereas the exonuclease
activity of the RNB may be required for nuclear exosome-mediated RNA decay.
To test this hypothesis, several C-terminal truncations of RRP44 were generated and
transformed into a strain that contains endogenous RRP44 under the control of the galactose
promoter (GAL::rrp44). In the presence of galactose, endogenous RRP44 is actively transcribed,
however, transcription of GAL::rrp44 is shut off in the presence of dextrose. Therefore, to
inhibit expression of endogenous RRP44, these strains were grown in the presence of dextrose.
RNA processing and degradation in the rrp44 truncations was compared to two controls, a strain
containing wild-type RRP44 and an rrp6 deletion strain. Rrp6p is a nuclear exosome cofactor
and is required for nuclear RNA processing and degradation (Briggs et al., 1998). RNA was then
isolated from these strains and subjected to denaturing urea-polyacrylamide gel electrophoresis.
To determine if these strains were defective in RNA processing and/or RNA degradation,
Northern blot analysis was performed using probes specific to the 7S rRNA precursor and to the
5’ ETS, respectively. C-terminal truncations lacking the exonucleolytic RNB domain of Rrp44p
caused the 7S precursor of the 5.8S rRNA to accumulate (Figure 3.3A, above) and caused a 20 to
24 fold increase in the accumulation of the 5’ ETS (Figure 3.3A, middle; Lebreton et al., 2008;
Schaeffer et al., 2009; Schneider et al., 2009). This suggests that the exonucleolytic RNB domain
is needed for efficient nuclear RNA processing and degradation, but does not exclude the
possibility that the endonuclease activity of Rrp44p is also required.
To test whether the endonuclease activity of the PIN domain is also needed for nuclear
RNA processing and/or degradation, plasmids encoding the catalytically inactive endo- and
exonuclease point mutations (D171A and D551N, respectively), as well as the double
catalytically inactive point mutation (D171A, D551N) were transformed into GAL::rrp44. These
strains were grown in the presence of galactose then shifted to media containing dextrose for the
times indicated. Similar to the results obtained with the rrp44 C-terminal truncations, 7S
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processing and 5’ ETS degradation intermediates accumulated in the D551N mutant and in the
D171A, D551N mutant. There were no similar degradation or processing intermediates in the
D171A mutant (Figure 3.B; Schaeffer et al., 2009; Schneider et al., 2009). Thus, both the RNA
processing and degradation functions of the nuclear exosome require the exonuclease activity of
the RNB domain of Rrp44p.
The exonuclease activity of Rrp44p may have some overlapping functions with the nuclear
exosome cofactor, Rrp6p.
Rrp44p exonuclease activity and the nuclear exosome cofactor, Rrp6p, are involved in
maintaining a functional nuclear exosome (Briggs et al., 1998; Dziembowski et al., 2007;
Lebreton et al., 2008; Schaeffer et al., 2009; Schneider et al., 2009). To determine whether the
endo- and/or exonuclease activities of Rrp44p were redundant with Rrp6p in the nucleus, the
D171A and D551N point mutations were combined with an rrp6 deletion. Briefly, plasmids
encoding the D171A and D551N point mutations were transformed into an rrp6 and rrp44
deletion strain to generate the rrp6# D171A and rrp6# D551N strains, respectively. Because
RRP44 is essential, this strain is being complemented by wild-type RRP44 on a plasmid with a
URA3 marker. Transformants were then spotted onto media containing 5-FOA and grown at
three different temperatures (23°C, 30°C, 37°C) for several days. 5-FOA selects for cells that
had lost the wild-type RRP44, URA3 plasmid, therefore, the D171A and D551N point mutations
were the only copies of RRP44 in the cell. Although this particular rrp6 deletion strain can grow
at temperatures up to 37°C, its optimal growth temperature is at 25°C (Schneider et al., 2009).
Additionally, other rrp6 deletion strains are temperature-sensitive (Allmang et al., 1999b).
Growth of the rrp6# D171A and rrp6# D551N strains at all three temperatures was compared to
two controls, an rrp6 and rrp44 deletion strain (rrp6# rrp44#) and an rrp6 deletion strain. The
D551N mutant was synthetically sick with an rrp6 deletion at all three temperatures, with the
most severe growth defect at 37°C, whereas the rrp6# D171A strain had no observable growth
defect (Figure 3.4). This suggests that the exonuclease activity of Rrp44p may have some
overlapping functions with Rrp6p.
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Figure 3.3: The exonuclease activity of Rrp44p is needed for both the RNA processing
and RNA degradation activities of the nuclear exosome.
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C.

Figure 3.3: The exonuclease activity of Rrp44p is needed for both the RNA processing
and RNA degradation activities of the nuclear exosome.
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Figure 3.3: The exonuclease activity of Rrp44p is needed for both the RNA processing and
RNA degradation activities of the nuclear exosome. A, The indicated Rrp44p truncations were
expressed in a GAL::rrp44 strain. RNA was isolated from cultures grown in dextrose (to inhibit
expression of the GAL::rrp44 gene) and analyzed by Northern blot analysis with probes that
hybridize to the 7S precursor of 5.8S rRNA (above), the 5’ ETS of the rRNA (middle) and the
RNA subunit of the signal recognition particle (SCR1; below). The relative levels of the 7S prerRNA and the 5’ ETS were normalized for loading using the SCR1 signal and are indicated
under the above and middle blots. B, rrp44 alleles containing the D171A mutation, the D551N
mutation or the D171A D551N double mutation was introduced into a GAL::rrp44 strain.
Cultures were first grown in media containing galactose and then incubated in media containing
dextrose for the indicated time (in hours). RNA was isolated from these cultures and analyzed by
Northern blot analysis with probes that hybridize to the 5.8S rRNA (above), the 5’ ETS of the
rRNA (middle) and SCR1 (below). In both (A) and (B), RNA processing and RNA degradation
in the rrp44 mutants was compared to two control strains, wild-type RRP44 and an rrp6
deletion. C, A growth analysis of the strains described (B). The strains were grown in selective
glucose media at 30°C to analyze growth.
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Figure 3.4: The exonuclease activity of Rrp44p may have some overlapping functions
with the nuclear exosome cofactor, Rrp6p.
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Figure 3.4: The exonuclease activity of Rrp44p may have some overlapping functions with
the nuclear exosome cofactor, Rrp6p. An rrp44 deletion strain or an rrp6 and rrp44 deletion
strain was transformed with plasmids encoding each of the depicted mutations. Transformants
were spotted onto media containing 5-FOA and grown for several days at the indicated
temperatures. Growth of the rrp6 and rrp44 mutants was compared to two controls, an rrp6 and
rrp44 deletion strain and an rrp6 deletion strain. Growth at 37°C would suggest that the nuclease
activities of Rrp44p are not redundant with Rrp6p.
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DISCUSSION
Implications of two nuclease active sites in the catalytic subunit of the exosome
The data presented in this Chapter were published as the first report of a second nuclease
active site in eukaryotic Rrp44p. Thirteen years after the discovery of the exosome (Mitchell et
al., 1997), this breakthrough finding has revealed that it is possible for the exosome to cleave
RNA internally as well as from the 3’-end.
It was widely accepted that Rrp44p had only 3’ to 5’ exoribonuclease activity. There are
at least two reasons why the catalytically inactive exonuclease mutant, D551N, had no nuclease
activity in vitro. First, the previously reported Rrp44p nuclease assays were performed using
conditions that are favorable for 3’ to 5’ exonuclease activity (Tris buffer supplemented with
Mg2+; Dziembowski et al., 2007; Liu et al., 2006; Lorentzen et al., 2008). When a C-terminal
Rrp44p truncation that lacks the exonucleolytic RNB domain is tested in this buffer combination,
there is no observable endonuclease activity (Schaeffer et al., 2009). Second, robust
endonuclease activity was observed using truncated Rrp44p proteins, with much less activity
seen with full-length Rrp44p (Schaeffer et al., 2009). This may suggest that the C-terminal
domains of Rrp44p regulate the activity of the PIN domain. Nonetheless, the endonuclease
activity of truncated Rrp44p, under conditions that are favorable for PIN domain activity
(HEPES buffer supplemented with Mn2+), is similar to the exonuclease activity of full-length
Rrp44p under conditions that are amenable to RNB domain activity (Schaeffer et al., 2009).
Therefore, although endonuclease activity had not been previously identified, it is robust and
physiologically relevant under certain conditions and/or on RNA substrates that have not yet
been determined.
The presence of two nuclease active sites in Rrp44p may indicate that the endo- and
exonucleolytic domains act on different RNA substrates. Under this hypothesis, the
endonucleolytic PIN domain may act on previously uncharacterized substrates, meaning that
there may be more exosome substrates than previously thought. Additionally, the Rrp44p
endonuclease may be responsible for an endonucleolytic cleavage event in an RNA processing
and/or RNA degradation pathway where the endonuclease has not yet been identified.
Alternatively, the presence of two catalytic sites may increase the overall efficiency of RNA
processing and/or RNA degradation. Under this hypothesis, the endo- and exonuclease activities
of Rrp44p do not have separate substrates, but rather can act together on most or all exosome
substrates.
Combining RNases into a single RNA degradation machine is not unique in nature. In
the E. coli degradosome, the RNase E endoribonuclease is combined with the 3’ to 5’
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exoribonuclease activity of PNPase (Carpousis et al., 1994; Py et al., 1994). In metazoan
processing bodies (P-bodies), the Argonaute endoribonuclease is combined with several
exoribonucleolytic deadenylation factors and the 5’ to 3’ exoribonuclease activity of Xrn1p
(Andrei et al., 2005; Bashkirov et al., 1997; Cougot et al., 2004; Ingelfinger et al., 2002; Liu et
al., 2005; Zheng et al., 2008). Because this combination has evolved multiple times
independently, it likely offers a fundamental advantage to the cell.
The nuclease activities of Rrp44p may be functionally redundant.
The results shown in this Chapter also indicate that while cells require at least one
nuclease activity of Rrp44p to survive, either is sufficient. This suggests that the Rrp44p
endonuclease is active and is important in vivo. Additionally, this suggests that these nuclease
activities are redundant for the essential function of Rrp44p. Such functional redundancy is not
an unprecedented theme for RNases, and is similar to what is found in Rrp44p and Rrp6p in
yeast (Dziembowski et al., 2007), the 5’ to 3’ exoribonuclease, Xrn1p, and the exosome in yeast
(Anderson and Parker, 1998; Johnson and Kolodner, 1995), and several exoribonucleases in E.
coli (Andrade et al., 2009; Deutscher and Li, 2001).
Although either nuclease activity is sufficient for viability, a C-terminal truncation
lacking a portion of the endonucleolytic PIN domain cannot support growth. This result may
indicate that the PIN domain, in addition to having nuclease activity, may also serve as a
platform for crucial protein-protein interactions. The C-terminal region of the PIN domain
(residues 203-235) may be needed for interaction with the core exosome and/or for interactions
with a previously unidentified exosome cofactor. In support of this, it has been recently shown
that the PIN domain of Rrp44p is important for exosome interaction (Schneider et al., 2009).
Alternatively, this region may be needed to make critical contacts with an RNA substrate.
Rrp44p exoribonuclease activity and the nuclear exosome cofactor, Rrp6p, are needed for
a functional nuclear exosome.
Lastly, the data presented here indicate that the exonuclease activity of Rrp44p is needed
for a functional nuclear exosome, namely the RNA processing of the 7S precursor to form the
mature 5.8S rRNA and the degradation of the 5’ ETS. However, it was recently published that
the endonuclease activity of Rrp44p is needed for 5’ ETS degradation (Lebreton et al., 2008).
This observation may be explained by the use of a different parental strain (W303) from what
was used in this work (BY4741). Additionally, another study, in which the BY4741 strain was
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used, confirmed the results presented here (Schneider et al., 2009). Therefore, the Rrp44p
endonuclease may behave differently in different strain backgrounds.
The results shown here indicate that the exonuclease activities of Rrp44p and Rrp6p may
have some overlapping functions. It is important to note that while the D551N mutant was
synthetically sick with an rrp6 deletion in this study, a previous study found that abolishing the
exonuclease activity of Rrp44p in an rrp6 deletion strain did not support viability. This
observation can be explained by the use of a different parental strain (W303) from what was
used in this work (BY4741). In support of the work presented here, another study, in which the
BY4741 strain was used, confirmed the results shown here- the rrp6! D551N strain had a slow
growth phenotype when compared to a wild-type strain, an rrp6 deletion, and the D551N mutant
(Schneider et al., 2009). Therefore, the Rrp44p and Rrp6p exonucleases seem to behave
differently in different strain backgrounds. Accordingly, recent data suggest that the functional
interactions between Rrp44p and Rrp6p are important for only certain Rrp6p substrates
(Callahan and Butler, 2008).
The involvement of the Rrp44p endonuclease in other nuclear RNA processing and
degradation reactions has not yet been tested. The possibility exists that the endonuclease
activity of Rrp44p is needed for the processing of snRNA and/or snoRNA precursors. The
Rrp44p endonuclease may also be involved in one of the multiple nuclear RNA surveillance
pathways needed to degrade abnormally processed rRNA, tRNA, snRNA, snoRNA, and/or
mRNA (see Chapter 7).
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Chapter 4: The exoribonuclease activity of Rrp44p is required for
exosome-mediated mRNA decay.
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INTRODUCTION
The eukaryotic exosome is a ten subunit complex that is involved in multiple RNA
processing and RNA degradation reactions in both the nucleus and cytoplasm. The cytoplasmic
exosome is strictly involved in mRNA degradation, where it degrades two types of transcripts. In
one pathway, the exosome degrades normal transcripts to allow the cell to rapidly change mRNA
levels, and ultimately protein levels, in response to a particular signal (Anderson and Parker,
1998). In mRNA surveillance, the exosome degrades aberrant transcripts in order to maintain the
fidelity of gene expression. These types of aberrant mRNAs include host transcripts that lack
termination codons (Frischmeyer et al., 2002; van Hoof et al., 2002) or poly(A) tails (Meaux and
van Hoof, 2006), host transcripts that stall translation elongation (Doma and Parker, 2006) or
contain premature termination codons (Gatfield and Izaurralde, 2004; Mitchell and Tollervey,
2003; Takahashi et al., 2003), and viral mRNAs (Guo et al., 2007).
In eukaryotes, normal transcripts are degraded by one of two pathways (Figure 1.2). In
both cases, deadenylation, or removal of the poly(A) tail is the initiating and rate-limiting step
(Muhlrad and Parker, 1992; Shyu et al., 1991). Degradation of the poly(A) tail triggers 5’ to 3’
mRNA decay in yeast. In this pathway, the 5’ cap is removed by the decapping complex, Dcp1p
and Dcp2, which then allows the 5’ to 3’ exoribonuclease, Xrn1p, to degrade the transcript from
the 5’-end (Decker and Parker, 1993; Hsu and Stevens, 1993; Muhlrad et al., 1994). Following
deadenylation, mRNA can also be degraded from the 3’-end, a process catalyzed by the exosome
(Anderson and Parker, 1998; Mukherjee et al., 2002; Rodgers et al., 2002). Inactivation of both
mRNA decay pathways results in loss of viability, underscoring the importance of mRNA
turnover (Anderson and Parker, 1998).
In cytoplasmic mRNA surveillance pathways, the exosome degrades aberrant
transcripts. One example of an mRNA surveillance pathway is the degradation of mRNAs that
lack termination codons, termed nonstop transcripts, in the nonstop mRNA degradation pathway
(Figure 1.3; Frischmeyer et al., 2002; van Hoof et al., 2002). Nonstop transcripts can arise from
mistakes in gene expression, including premature polyadenylation, due to inaccurate 3’-end
formation or through the use of a cryptic polyadenylation site (Bucheli et al., 2007). In the
current nonstop decay model, the translating ribosome reads through the poly(A) tail and stalls at
the 3’-end. The cytoplasmic exosome cofactor, Ski7p, is then believed to recognize the ribosome
with an empty A-site and recruit the exosome to rapidly exonucleolytically degrade the transcript
from the 3’-end (van Hoof et al., 2002).
Transcripts that stall translation elongation, perhaps due to secondary structure, are also
degraded by the cytoplasmic exosome in an RNA surveillance pathway termed no-go decay
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(Figure 1.4 and Figure 4.6). In the current model of no-go decay, a ribosome that stalls during
translation elongation is recognized by two paralogs of translation release factors, Hbs1p and
Dom34p. The transcript is then endonucleolytically cleaved near the stalled ribosome, releasing
a 5’- and 3’-degradation fragment. The 5’-fragment is degraded by the cytoplasmic exosome,
whereas the 3’-degradation fragment is degraded by the 5’ to 3’ exoribonuclease, Xrn1p, in the
5’ to 3’ mRNA degradation pathway (Doma and Parker, 2006). The endoribonuclease
responsible for the initial cleavage event, and freeing of the ribosome, has not yet been
identified.
The exosome subunit believed to be involved in these cytoplasmic mRNA degradation
reactions is Rrp44p, as it is the only catalytically active subunit (Dziembowski et al., 2007).
Specifically, the exonuclease activity of Rrp44p may be involved in general 3’ to 5’ mRNA
degradation, nonstop mRNA decay, and in the degradation of the 5’-fragment in no-go decay.
Additionally, the endonuclease activity of Rrp44p may be needed for the initial cleavage event in
no-go decay. To determine whether the nuclease activities of Rrp44p are involved in these
cytoplasmic mRNA degradation reactions, strains containing C-terminal truncations and
catalytically inactive point mutations of Rrp44p were generated. The degradation of several
representative reporter transcripts was then analyzed in these mutants. Here, the data indicate
that the exonucleolytic RNB domain is required for exosome-mediated 3’ to 5’ mRNA decay.
Interestingly, the data also suggest that neither the endo- or exonuclease activities of Rrp44p are
needed for the degradation of nonstop transcripts and that the endonuclease activity of Rrp44p is
not required for endonucleolytic cleavage in no-go decay. Additionally, the results suggest that
the endonuclease activity of Rrp44p is not redundant with Ski7p in nonstop decay.
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RESULTS
The exonuclease activity of Rrp44p is needed for exosome-mediated 3’ to 5’ mRNA decay.
To determine whether the endo- and/or exonuclease activities of Rrp44p were needed for
general 3’ to 5’ decay, a synthetic lethality growth assay was performed (van Hoof et al., 2000b).
The basis of this assay is that at least one of the two mRNA decay pathways is required for
viability. Therefore, mutants in the 3’ to 5’ decay pathway are synthetically lethal with mutants
in the 5’ to 3’ decay pathway (Anderson and Parker, 1998). Briefly, plasmids encoding the
individual catalytically inactive Rrp44p nuclease point mutations, D171A and D551N, were
transformed into an rrp44 deletion strain that contains a temperature-sensitive allele of dcp1
(dcp1-2), generating the dcp1-2 D171A and dcp1-2 D551N strains. Dcp1p is a subunit of the
decapping complex needed for 5’ to 3’ mRNA decay (Coller and Parker, 2004). These strains
also contain a plasmid encoding wild-type RRP44 and URA3 marker. Transformants were then
spotted onto media containing 5-FOA to select for cells that had lost the wild-type RRP44, URA3
plasmid. Therefore, the D171A and D551N point mutations were the only copies of RRP44 in
the cell. The dcp1-2 D171A and dcp1-2 D551N strains were then spotted onto selection media
and grown at three different temperatures (23°C, 30°C, 37°C) for several days. Growth of these
strains at the non-permissive temperature for dcp1-2 (37°C) was compared to two control strains.
The first control was a ski7 deletion strain that also contained the dcp1-2 allele (dcp1-2 ski7#).
Ski7p is a cytoplasmic exosome cofactor that is required for general 3’ to 5’ decay (Araki et al.,
2001; van Hoof et al., 2000b). The second control strain contained only the dcp1-2 mutant.
While the dcp1-2 D171A strain had no detectable growth phenotype, the D551N mutant was
synthetically lethal with dcp1-2 at the non-permissive temperature (Figure 4.1A). In support of
this finding, it has also been shown that deletion of Xrn1p, the 5’ to 3’ exoribonuclease, is also
synthetically lethal with the D551N mutant (Schneider et al., 2009). Combined, these data
suggest that the exonuclease activity, but not endonuclease activity, of Rrp44p is needed for
exosome-mediated 3’ to 5’ mRNA decay.
To further test the importance of Rrp44p exonuclease activity in general 3’ to 5’ mRNA
decay, the stability of an endogenous mRNA, GAL7, was measured. GAL7 is a galactose
metabolism gene and is expressed in media containing galactose. The degradation of the GAL7
mRNA reporter was measured in the dcp1-2 D171A and dcp1-2 D551N strains. GAL7 stability
in these strains was compared to two control strains, dcp1-2 and dcp1-2 ski7#. Briefly, these
strains were grown in liquid media containing galactose at the permissive temperature for dcp1-2
(23°C) and then shifted to the non-permissive temperature (37°C) for one hour. The strains were
then grown in media containing dextrose to shut off transcription of GAL7. RNA was isolated
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from these strains and subject to agarose formaldehyde gel electrophoresis. Northern blot
analysis was then performed using probes specific to GAL7, and SCR1 as a loading control. In
the dcp1-2 strain, GAL7 was unstable since the 3’ to 5’ decay pathway was still functional.
Conversely, in the dcp1-2 ski7! strain, GAL7 was more than 4-times more stable, as neither the
5’ to 3’ or 3’ to 5’ mRNA decay pathway was functional. GAL7 was unstable in the dcp1-2
D171A strain, however, GAL7 was 2-times more stable in the dcp1-2 D551N strain as compared
to the dcp1-2 strain (Figure 4.1B and C). Although the exonuclease mutant stabilizes GAL7,
there is some residual mRNA decay of the reporter in the dcp1-2 D551N strain. This may be
explained by incomplete inactivation of the dcp1-2 allele, residual activity of the D551N mutant,
or the presence of an exonuclease that is redundant with Rrp44p. Overall, these results suggest
that, similar to the data obtained in the synthetic lethality growth assay, the exonuclease activity
of Rrp44p is needed for the general 3’ to 5’ decay activity of the cytoplasmic exosome.
Neither of the nuclease activities of Rrp44p are required to degrade nonstop transcripts.
To determine whether the exonuclease activity of Rrp44p is required to degrade nonstop
mRNAs, the stability of a representative nonstop transcript was measured in a strain that lacks
the exonucleolytic RNB domain of Rrp44p. Briefly, the GAL::pgk1pG-nonstop reporter was
transformed into an rrp44 deletion strain that is complemented with a C-terminal truncation of
Rrp44p that lacks the RNB domain.
This reporter contains a nonstop mutation in the PGK1 (3-phosphoglycerate kinase)
open reading frame and is a known substrate of the nonstop decay pathway (van Hoof et al.,
2002). Because this reporter is under the control of the galactose promoter, the pgk1pG-nonstop
transcript is expressed in media containing galactose, however, transcription is rapidly shut off in
media containing dextrose. This reporter also has a poly-guanine tract (pG) in order to
differentiate between the stability of the reporter and the endogenous transcript.
The stability of the nonstop transcript in the rrp44 deletion strain that lacks the RNB
domain was compared to two control strains, a strain containing wild-type Rrp44p and a ski7
deletion strain. These strains were grown in liquid media containing galactose and then shifted to
media containing dextrose to shut off transcription of the GAL::pgk1pG-nonstop reporter. RNA
was isolated from these strains and subject to agarose formaldehyde gel electrophoresis.
Northern blot analysis was then performed using probes specific to pgk1pG, and to SCR1 as a
loading control. In the wild-type strain, GAL::pgk1pG-nonstop was unstable since the nonstop
mRNA decay pathway was still functional. Conversely, when the nonstop decay pathway was
inactivated in the ski7 deletion strain, the nonstop transcript was 7-times more stable. In the
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Figure 4.1: The exonuclease activity of Rrp44p is needed for exosome-mediated 3’ to 5’
mRNA degradation.
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Figure 4.1: The exonuclease activity of Rrp44p is needed for exosome-mediated 3’ to 5’
mRNA degradation. A, An rrp44 deletion strain containing a plasmid encoding wild-type
RRP44 and a URA3 marker, as well as a temperature-sensitive allele of dcp1 (dcp1-2), was
transformed with plasmids encoding the depicted mutations. Transformants were spotted onto
media containing 5-FOA and grown for several days at the indicated temperatures. Growth of
the dcp1-2 rrp44 mutants was compared to two control strains, a ski7 deletion strain that also
contains the dcp1-2 allele (dcp1-2 ski7!) and a strain containing only the dcp1-2 mutant. Growth
on 5-FOA at 37°C, the non-permissive temperature of the dcp1-2 allele, indicates that mutated
Rrp44p can carry out exosome-mediated 3’ to 5’ mRNA degradation. B, RNA was isolated from
each strain described in (A) and analyzed by Northern blot analysis with probes that hybridize to
GAL7 and SCR1. The half-life GAL7 was normalized for loading using the SCR1 signal and are
as indicated (in minutes). C, A graphical representation of the half-life of the GAL7 transcript.
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strain that lacked the RNB domain of Rrp44p, GAL::pgk1pG-nonstop was as unstable as it was
in the wild-type strain (Figure 4.2A and B), which suggests that exonucleolytic RNB domain of
Rrp44p is not needed for the degradation of nonstop transcripts.
In order to determine whether the endonuclease activity of the PIN domain is needed for
nonstop decay, the his3-nonstop growth assay was performed. Briefly, another representative
nonstop reporter, his3-nonstop, was transformed into rrp44 deletion strains that were
individually complemented with the D171A and D551N mutants. The his3-nonstop growth assay
is counter-intuitive in that in strains that have defects in nonstop decay, the his3-nonstop reporter
is stable, which allows cells to grow on media lacking histidine. In contrast, cells that have a
functional nonstop decay pathway rapidly degrade the his3-nonstop transcript, resulting in a lack
of growth on media lacking histidine (van Hoof et al., 2002). The growth of the catalytically
inactive point mutants on media lacking histidine was compared to two controls, a wild-type
strain and a ski7 deletion strain. Similar to the wild-type strain, both of the catalytically inactive
point mutants were viable on media lacking histidine (Figure 4.3A). These results suggest that
neither of the nuclease activities of Rrp44p are involved in degrading nonstop transcripts.
The his3-nonstop growth assay is an indirect measure of whether the nonstop decay
pathway is functional. A more direct way to test for a functional nonstop decay pathway is to
measure the stability of a representative nonstop mRNA. Therefore, the stability of the
GAL::pgk1pG-nonstop transcript was measured in strains containing the catalytically inactive
point mutants of Rrp44p. The stability of the nonstop transcript in the rrp44 point mutants was
compared to two controls, a strain containing wild-type Rrp44p and a ski7 deletion strain. These
strains were grown in liquid media containing galactose and then shifted to media containing
dextrose to shut off transcription of the GAL::pgk1pG-nonstop reporter. RNA was isolated from
these strains and subject to agarose formaldehyde gel electrophoresis. Northern blot analysis was
then performed using probes specific to pgk1pG, and to ACT1 as a loading control. Similar to
what was observed in the his3-nonstop growth assay, the GAL::pgk1pG-nonstop transcript was
as unstable in both of the catalytically inactive point mutants as it was in the wild-type strain
(Figure 4.3B and C). Combined, these results indicate that neither of the nuclease activities of
Rrp44p are needed for the degradation of nonstop transcripts.
The endonuclease activity of Rrp44p is not redundant with Ski7p in nonstop mRNA
degradation.
In the current model of nonstop mRNA degradation, the C-terminus of Ski7p recognizes
the ribosome with an empty A-site and recruits the exosome to rapidly degrade the nonstop
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Figure 4.2: The exonuclease activity of Rrp44p is not needed for nonstop mRNA
degradation.
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Figure 4.2: The exonuclease activity of Rrp44p is not needed for nonstop mRNA
degradation. A, An rrp44 deletion strain complemented by a plasmid encoding a C-terminal
truncation of Rrp44p that lacks the exonucleolytic RNB domain was transformed with the
GAL::pgk1pG-nonstop reporter. The stability of the transcript in the rrp44 mutant strain was
compared to two control strains, wild-type RRP44 and a ski7 deletion. Cultures were first grown
in media containing galactose and then incubated in media containing dextrose (to inhibit
transcription of the GAL::pgk1pG-nonstop reporter) for the indicated time (in minutes). RNA
was isolated from these strains and analyzed by Northern blot analysis with probes that hybridize
to PGK1 and SCR1. The half-life of the GAL::pgk1pG-nonstop transcript was normalized for
loading using the SCR1 signal and are as indicated (in minutes). B, A graphical representation of
the half-life of the GAL::pgk1pG-nonstop transcript.
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Figure 4.3: Neither of the nuclease activities of Rrp44p are needed to degrade nonstop
transcripts.
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Figure 4.3: Neither of the nuclease activities of Rrp44p are needed to degrade nonstop
transcripts. A, An rrp44 deletion strain containing the D171A mutant or the D551N mutant was
transformed with a his3-nonstop reporter. Transformants were spotted onto media containing, or
lacking, histidine and grown for several days. Growth of the rrp44 mutants was compared to two
control strains, wild-type RRP44 and a ski7 deletion. Growth on media lacking histidine
indicates that the nonstop mRNA degradation machinery is not functional. B, An rrp44 deletion
strain complemented by a plasmid encoding the D171A mutation or the D551N mutation was
transformed with the GAL::pgk1pG-nonstop reporter. The stability of the transcript in the rrp44
mutant strains was compared to two control strains, wild-type RRP44 and a ski7 deletion.
Cultures were first grown in media containing galactose and then incubated in media containing
dextrose (to inhibit transcription of the GAL::pgk1pG-nonstop reporter) for the indicated time (in
minutes). RNA was isolated from these strains and analyzed by Northern blot analysis with
probes that hybridize to PGK1 and ACT1. The half-life of the GAL::pgk1pG-nonstop transcript
was normalized for loading using the ACT1 signal and are as indicated. C, A graphical
representation of the half-life of the GAL::pgk1pG-nonstop transcript.
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transcript from the 3’-end (Figure 1.3; van Hoof et al., 2002). One unexpected issue with this
model is that the 3’-end of the mRNA should be inaccessible to the exosome because it is
presumably buried inside of the ribosome. One solution to this problem may be that Ski7p
triggers ribosome disassembly. The C-terminus of Ski7p is similar to eRF3, and eRF1 and eRF3
are thought to trigger ribosome disassembly at termination codons. Therefore, the C-terminus of
Ski7p may be needed to remove the stalled ribosome to allow the nonstop transcript to be
degraded. Consistent with this idea, a C-terminal truncation of Ski7p that lacks the region
homologous to eRF3 partially inhibits nonstop decay (van Hoof et al., 2002). This partial
inhibition suggests that ribosome disassembly by Ski7p is one way, although not the only way, a
stalled ribosome can be removed from a nonstop transcript. A second solution may be that the
Rrp44p endonuclease cleaves the transcript near the ribosome, allowing for the 3’-end of the
mRNA to be accessible. A third solution is a combination of the two, where either the Cterminus of Ski7p or the endonuclease activity of Rrp44p remove the ribosome (Figure 4.4). This
third model predicts that a strain containing a C-terminal truncation of Ski7p and the
catalytically inactive endonuclease point mutant of Rrp44p, D171A, would completely block
nonstop decay.
To test whether the C-terminus of Ski7p and the endonuclease activity of Rrp44p were
redundant in nonstop mRNA decay, a his3-nonstop growth assay was performed. In this assay, a
representative nonstop reporter, his3-nonstop, was transformed into a strain containing a Cterminal truncation of Ski7p (as the only copy of Ski7p) and the D171A mutant of Rrp44p (as
the only copy of Rrp44p). This reporter contains a nonstop mutation in the HIS3 open reading
frame and is a known substrate of the nonstop decay pathway. The basis for this assay is that in a
strain that is defective in nonstop mRNA decay, the his3-nonstop reporter will be stable, thus
allowing cells to synthesize histidine and grow on media lacking histidine. In contrast, in a wildtype strain, where the nonstop decay machinery is functional, the reporter will be rapidly
degraded and cells will be inviable on media lacking histidine (van Hoof et al., 2002). Growth of
the strain containing a C-terminal truncation of Ski7p and the D171A mutant of Rrp44p on
media lacking histidine was compared to several controls, a wild-type strain, a ski7 deletion
strain, a strain lacking the C-terminus of Ski7p, and a strain containing only the D171A mutant
of Rrp44p. Since the C-terminus of Ski7p is involved in nonstop decay, the strain lacking the Cterminus of Ski7p was able to grow on media lacking histidine. Because the N-terminus of Ski7p
is needed for general 3’ to 5’ mRNA decay, the ski7 deletion strain grew even better on media
lacking histidine, indicating a stronger defect in nonstop mRNA decay. The strain containing a
C-terminal truncation of Ski7p and the D171A mutant had the same growth phenotype on media
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Figure 4.4: Schematic representation of ribosome disassembly in nonstop mRNA
degradation.
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Figure 4.4: Schematic representation of ribosome disassembly in nonstop mRNA
degradation. In the first model, the stalled ribosome is removed, and subsequently
disassembled, by Ski7p. In the second model, endonucleolytic cleavage by Rrp44p removes the
ribosome. In the third model, ribosome disassembly is mediated by both Ski7p and the
endonuclease activity of Rrp44p, with either being sufficient.
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lacking histidine as the strain containing a C-terminal truncation of Ski7p (Figure 4.5). This
suggests that the endonuclease activity of Rrp44p is not redundant with the C-terminus of Ski7p
for ribosome disassembly in nonstop decay.
The Rrp44p endonuclease in not responsible for endonucleolytic cleavage in no-go decay.
To determine whether the endonuclease activity of Rrp44p is involved in the no-go
decay pathway, the steady-state level of a representative no-go decay transcript was measured in
strains that lack Rrp44p endonuclease activity. Because the endonucleolytic 5’- and 3’-cleavage
fragments can only be detected in strains that lack a functional cytoplasmic exosome and 5’ to 3’
mRNA degradation pathway, respectively, a plasmid encoding the catalytically inactive
endonuclease point mutant, D171A, was transformed into two different strains, a ski7 and rrp44
deletion strain and an xrn1 and rrp44 deletion strain to generate the ski7# D171A and xrn1#
D171A strains, respectively. These strains also contain a plasmid that encodes wild-type RRP44
and a URA3 marker. Transformants were then spotted onto media containing 5-FOA and grown
for several days to obtain cells that could lose the wild-type RRP44, URA3 plasmid. Thus, the
ski7! D171A and xrn1! D171A strains contained only one copy of Rrp44p. These strains were
then transformed with the GAL::pgk1-SL reporter, and as a control, a plasmid encoding wildtype GAL::PGK1. The GAL::pgk1-SL reporter contains a stem loop in the pgk1 (3phosphoglycerate kinase) open reading frame, which creates a stable secondary structure that is
known to stall translation elongation (Figure 4.6A; Doma and Parker, 2006).
As a control, degradation of the pgk1-SL transcript was analyzed in three control strains,
each complemented by a plasmid encoding wild-type RRP44: an rrp44 deletion strain (Wildtype), a ski7 and rrp44 deletion strain (ski7!), and an xrn1 and rrp44 deletion strain (xrn1!).
Cultures of these strains were grown in media containing galactose and then RNA was isolated
and subjected to agarose formaldehyde gel electrophoresis. Northern blot analysis was then
performed using probes specific to the 5’-end of the pgk1 open reading frame, the 3’-end of the
pgk1 open reading frame just downstream of the stem loop, and to SCR1 as a loading control. If
the Rrp44p endonuclease is responsible for endonucleolytic cleavage of the pgk1-SL transcript,
the 5’- and 3’-degradation fragments should not be detectable in the ski7! D171A and xrn1!
D171A strains, respectively. The data presented here, however, show that the 5’-fragment is
present at the same levels in the ski7! D171A strain as in the ski7! control strain (Figure 4.6B).
Similarly, the 3’-fragment is present in both the xrn1! and xrn1! D171A strains (Figure 4.6C).
The 3’-degradation fragment is also present in the wild-type strain (Figure 4.6C). This
may suggest that the stem-loop structure can block Xrn1p. It is not yet known whether this
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Figure 4.5: The endonuclease activity of Rrp44p is not redundant with Ski7p in nonstop
mRNA degradation.
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Figure 4.5: The endonuclease activity of Rrp44p is not redundant with Ski7p in nonstop
mRNA degradation. A strain containing a C-terminal truncation of Ski7p and the D171A point
mutant of Rrp44p was transformed with the his3-nonstop reporter. Transformants were spotted
onto media containing, or lacking, histidine and grown for several days. Growth of the ski7 and
rrp44 mutants was compared to several controls, a wild-type strain, a strain containing the
D171A mutant, a strain lacking the C-terminus of Ski7p, and a ski7 deletion strain. Growth on
media lacking histidine indicates that the nonstop mRNA degradation machinery is not
functional.
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Figure 4.6: The Rrp44p endonuclease is not responsible for endonucleolytic cleavage
in no-go decay.
76

B.

C.

Figure 4.6: The Rrp44p endonuclease is not responsible for endonucleolytic cleavage
in no-go decay.
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Figure 4.6: The Rrp44p endonuclease is not responsible for endonucleolytic cleavage in nogo decay. A, In the current model of no-go decay, a translating ribosome stalls during translation
elongation, possibly due to secondary structure in the transcript. The stalled ribosome is then
thought to be recognized by the eRF3 and eRF1 paralogs, Hbs1p and Dom34p, respectively. The
transcript is then endonucleolytically cleaved, possibly by the Rrp44p endonuclease, which
releases the stalled ribosome and generates a 5’- and 3’-degradation fragment. The 5’- and 3’degradation fragments are degraded by the cytoplasmic exosome and the 5’ to 3’
exoribonuclease, Xrn1p, respectively. B and C, A ski7! (B) and xrn1! (C) strain containing the
rrp44 D171A mutant were transformed with the GAL::PGK1 and GAL::pgk1-SL reporters. The
degradation of the GAL::PGK1 and GAL::pgk1-SL transcripts in these strains were compared to
three control strains, wild-type, a ski7! strain (B), and an xrn1! strain (C). RNA was isolated
from cultures grown in galactose and analyzed by Northern blot analysis with probes that
hybridize to the regions 5’- (B) or 3’- (C) of the stem-loop stall site, as illustrated (A).
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degradation fragment arises by decapping followed by 5’ to 3’ degradation by Xrn1p, or by
endonucleolytic cleavage. Despite the presence of this fragment in the wild-type strain, the 3’
degradation fragment detected in the xrn1! strain must be produced by endonucleolytic
cleavage, which suggests that at least some of the 3’-degradation fragment detected in the wildtype strain is produced by endonucleolytic cleavage.
The presence of the 5’- and 3’-degradation fragments in the ski7! D171A and xrn1!
D171A strains suggest that the endonuclease activity of Rrp44p is not needed for the initial
endonucleolytic cleavage event in no-go decay. These results, however, do not exclude the
possibility that the exonuclease activity of Rrp44p is responsible for complete degradation of the
5’-degradation fragment.

79

DISCUSSION
The data presented in this Chapter analyze the roles of the nuclease activities of Rrp44p
in the cytoplasmic exosome. Here, the exonuclease activity of Rrp44p is shown to be responsible
for exosome-mediated 3’ to 5’ mRNA decay. This finding is supported by a previous study that
showed that the D551N mutant of Rrp44p is synthetically lethal with a deletion of Xrn1p, the
exoribonuclease involved in the 5’ to 3’ mRNA decay pathway (Schneider et al., 2009).
Therefore, these data indicate that mRNA turnover is an essential process that is mediated by at
least two key exoribonucleases, and that the endonuclease activity of Rrp44p contributes little to
the degradation of normal transcripts.
The data presented here also show that the nuclease activities of Rrp44p are not needed
for nonstop mRNA decay and that the endonuclease activity of Rrp44p is not needed for no-go
decay.
Implications for nonstop mRNA degradation
The data shown here indicate that neither the endo- or exonuclease activities of Rrp44p
are involved in degrading nonstop transcripts. This observation could be explained by one of
three possibilities. First, the Rrp44p nucleases may be redundant in nonstop decay. This idea is
difficult to test, however, because the double catalytically inactive point mutant (D171A,
D551N) is not viable. Therefore, alternative means must be used to test whether nonstop
transcripts are degraded when both the endo- and exonuclease activities of Rrp44p are abolished
(see Chapter 7).
A second explanation is that nonstop decay is independent of the known catalytic
activities of the cytoplasmic exosome. Under this hypothesis, a different nuclease would be
responsible for the degradation of nonstop transcripts.
Lastly, a small fraction of the nuclear-localized exosome cofactor, Rrp6p, may associate
with the cytoplasmic exosome to degrade nonstop transcripts. In this case, a small amount of
Rrp6p activity may be enough for a functional nonstop mRNA decay pathway. In support of this,
the human homolog of Rrp6p has been shown to localize to the nucleus and the cytoplasm in
human cell lines (Lejeune et al., 2003). Additionally, Rrp6p has been shown to interact with the
cytoplasmic exosome cofactor, Ski7p (Collins et al., 2007; Peng et al., 2003). In this explanation,
however, the 3’-end of the nonstop transcript would still be buried in the ribosome. In this
model, an unknown endonuclease may cleave the nonstop transcript near the ribosome, allowing
the 3’-end to be accessible to Rrp6p.

80

The finding that the endonuclease activity of Rrp44p is not redundant with the Cterminus of Ski7p for ribosome disassembly suggests that either Ski7p functions alone or that
another protein functions with Ski7p to free stalled ribosomes from a nonstop transcript. Because
a C-terminal truncation of Ski7p only partially inhibits nonstop decay (van Hoof et al., 2002), it
is more likely that another protein or endoribonuclease work with Ski7p in ribosome
disassembly.
As will be discussed in the next Chapter, a different mutation in Rrp44p does stabilize
nonstop reporter transcripts (see Figure 5.7). Thus, Rrp44p is required for nonstop mRNA
degradation, and the most likely explanation is that the endo- and exonuclease activities of
Rrp44p are redundant for nonstop decay (see Chapter 7).
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Chapter 5: The CR3 region, a putative zinc binding site of Rrp44p, is
important for exosome activity.

NOTE: I performed all of the experiments described in this Chapter with the exception of the biochemical
nuclease assay that was performed by our collaborators, Filipa Reis and Dr. Cecilia Arraiano (Instituto
de Tecnologia Química e Biológica [ITQB]; Lisbon, Portugal) – as denoted in the figure legend
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INTRODUCTION
Rrp44p is the catalytic subunit of the exosome and has two nuclease active sites. The
PIN domain of Rrp44p has endonuclease activity and the RNB domain has 3’ to 5’ exonuclease
activity. In addition to these two domains, a CR3 region is in the N-terminus and three putative
RNA binding domains are spread throughout the protein. The CR3 region consists of three
conserved cysteine residues (C47, C52, and C55) and is present in most eukaryotic homologs of
Rrp44p that have a PIN domain. Currently, no information exists on the CR3 region in Rrp44p
or in any other protein. Although it has been proposed that this region is important for proteinprotein interactions (Ponting et al., 2000), no data exist to support this.
Recently the crystal structure of Rrp44p was published, however, the first 33 residues of
the protein were not included (Bonneau et al., 2009). Therefore, it is not yet known whether the
CR3 region consists of more than the three cysteine residues or if this region has a unique fold.
For this reason, the three cysteine residues will be referred to as only the CR3 region. Further
examination of the crystal structure of Rrp44p shows that two of the three cysteines are modeled
to form a disulfide bond (C52 and C55; Figure 5.1A and B; Bonneau et al., 2009). However,
because of the low resolution of the structure (3 Angstroms), the electron density is not defined
enough to determine which residues, if any, form a disulfide bond. Another striking feature of
the structure is that the three cysteines of the CR3 region are in close proximity to histidine 184
(H184; Figure 5.1A and B). This spatial organization is consistent with the coordination of a zinc
ion, which may be needed, directly or indirectly, for protein stabilization, interaction with the
exosome, and/or for Rrp44p nuclease activity. Indeed preliminary evidence suggests that Rrp44p
endonuclease activity is stimulated by the addition of zinc (Filipa Reis and Dr. Cecilia Arraiano,
personal communication). Interestingly, H184 is present in all eukaryotic homologs of Rrp44p
that have a CR3 region.
Several studies have shown multiple interactions between Rrp44p and the exosome. In
the first report, yeast two-hybrid data suggested an interaction between the CR3 region and the
PIN domain of human Rrp44p with human Rrp43p, a subunit of the PH ring in the exosome
(Lehner and Sanderson, 2004). In another study, a cryo-EM structure of the yeast exosome
predicted that the CR3 region and the PIN domain of Rrp44p interact with Rrp41p, another
subunit of the PH ring. This study also predicted major contacts between the cold shock domains
(CSDs) of Rrp44p, and to a lesser extent the RNB domain, with Rrp45p, another PH ring subunit
(Wang et al., 2007). Lastly, the most recent study suggests that the PIN domain of Rrp44p
mediates interaction with the core exosome (Schneider et al., 2009). It is not yet known whether
this region consists of only the PIN domain or includes both the CR3 region and PIN domain.
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Figure 5.1: The three cysteines of the CR3 region and histidine 184 (H184) of Rrp44p
have the proper geometry for the coordination of a zinc atom.
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Figure 5.1: The three cysteines of the CR3 region and histidine 184 (H184) of Rrp44p have
the proper geometry for the coordination of a zinc atom. A, Side view of the S. cerevisiae
Rrp44p structure (Bonneau et al., 2009). The N- and C-termini are shown in red. The three
cysteines of the CR3 region (C47, C52, C55) and H184 are shown in yellow. A disulfide bond is
shown between C52 and C55 of the CR3 region. The zoomed-in view shows only the Nterminus of Rrp44p and better depicts the spatial organization between the three cysteines of the
CR3 region and H184. B, The electron density of the N-terminus of Rrp44p is shown in blue
mesh. The three cysteines of the CR3 region and H184 are shown in yellow. The disulfide bond
between C52 and C55 is shown in orange and the nitrogen atoms of H184 are shown in blue
(Bonneau et al., 2009). This figure was created by Sean Johnson (Utah State University, Utah).
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Combined these studies suggest that the CR3 region and PIN domain of Rrp44p are important
for exosome interaction. More importantly, these studies suggest that multiple regions of Rrp44p
are needed for Rrp44p to interact with the exosome.
To determine the role(s) of the CR3 region of Rrp44p in the exosome, a triple CR3
mutant was generated, in which the three cysteine residues of the CR3 region were mutated. This
triple CR3 mutant was then used to assay the interaction between Rrp44p and the exosome as
well as exosome function. The data presented here are the first report of a CR3 region being
needed for the formation of a complex in vivo and for enzymatic activity in vitro. Specifically,
the data suggest that the CR3 region is needed for optimal cell growth and is needed for Rrp44p
to interact with the exosome. The data presented here also show that the CR3 region is needed
for Rrp44p endonuclease activity and for a functional cytoplasmic exosome. Importantly, these
results also indicate that the modeled disulfide bond between the second and third cysteine
residue of the CR3 region is not needed for exosome function.
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RESULTS
Mutating the three conserved cysteine residues of Rrp44p results in a slow growth
phenotype.
To determine whether the CR3 region was needed for cell survival, a triple CR3 mutant
was generated, where the three cysteine residues were mutated to serine (C47S, C52S, C55S).
The CR3 mutant was then transformed into an rrp44# [RRP44, URA3] strain. Transformants
were spotted onto media containing 5-FOA and grown for several days. Growth of the CR3
mutant was compared to two controls, empty vector and wild-type RRP44. As compared to wildtype, the triple CR3 mutant allowed for only slow growth (Figure 5.2A). This suggests that the
CR3 region is needed for optimal growth, however, this phenotype could be due to decreased
expression of the triple CR3 mutant protein (Figure 5.3).
The CR3 region is necessary, but may not be sufficient, for Rrp44p to interact with the
exosome.
To determine whether the CR3 region of Rrp44p mediated interaction with the exosome,
wild-type Rrp44p and the triple CR3 mutant were C-terminally TAP-tagged. Wild-type and
mutant Rrp44p were purified using IgG sepharose beads specific to the Protein A portion of the
TAP tag. Proteins bound to Rrp44p were eluted and analyzed using sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE). Whole cell lysates were obtained from the
Rrp44p strains and were compared to the bound fraction. The interaction of wild-type Rrp44p
and the CR3 mutant with the exosome was compared to empty vector. Unlike wild-type Rrp44p,
the triple CR3 mutant was unable to interact with the exosome, suggesting that this region is
necessary for exosome interaction (Figure 5.3). Because the CR3 region alone was not tested for
exosome interaction, it is not yet known whether this region is sufficient for Rrp44p to associate
with exosome. Additionally, previous studies indicate that other regions of Rrp44p are also
needed for exosome interaction (Lehner and Sanderson, 2004; Schneider et al., 2009; Wang et
al., 2007).
The CR3 region is needed for efficient Rrp44p endonuclease activity in vivo and in vitro.
To determine whether the CR3 region was needed for the endonuclease activity of
Rrp44p, the triple CR3 mutant was tested in three different assays. First, the triple CR3 mutant
combined with the catalytically inactive exonuclease point mutant, D551N, was tested for
complementation of an rrp44 deletion strain. Briefly, a plasmid containing the triple CR3 and
D551N mutations was transformed into an rrp44# [RRP44, URA3] strain. Transformants were
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Figure 5.2: Mutating the three conserved cysteine residues of Rrp44p results in a slow
growth phenotype.
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Figure 5.2: Mutating the three conserved cysteine residues of Rrp44p results in a slow
growth phenotype. An rrp44 deletion strain complemented by full-length RRP44 on a plasmid
with a URA3 marker was transformed with plasmid encoding the triple CR3 mutation.
Transformants were spotted onto media containing 5-FOA and control media (SC –LEU–URA +
2% dextrose), and grown for several days. Growth of the triple CR3 mutant was compared to
two controls, empty vector and wild-type RRP44. Growth on 5-FOA indicates that the CR3
region is not needed for the essential function of Rrp44p.
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Figure 5.3: The CR3 region of Rrp44p is needed for interaction with the exosome.
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Figure 5.3: The CR3 region of Rrp44p is needed for interaction with the exosome. The Cterminal TAP-tagged triple CR3 mutant was purified using IgG sepharose beads. Prior to
purification, whole-cell lysates were isolated (left). Purified proteins were eluted by boiling the
beads (right). Interaction of the triple CR3 mutant with the exosome was compared to two
controls, wild-type Rrp44p and empty vector. Whole-cell lysates and purified proteins were
analyzed by Western blot analysis with antibodies specific to Protein A (above) to detect
Rrp44p, Rrp4p (middle) to detect interaction with the exosome, and Pgk1p (below) as a loading
control. The asterisk in the middle blot indicates a nonspecific protein.
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spotted onto media containing 5-FOA and grown for several days. Growth of the CR3, D551N
strain was compared to two controls, empty vector and wild-type RRP44. If the CR3 region was
needed for Rrp44p endonuclease activity, the CR3 mutant should be synthetically lethal with
D551N because cells lacking both the endo- and exonuclease activities of Rrp44p are not viable
(Lebreton et al., 2008; Schaeffer et al., 2009; Schneider et al., 2009). Indeed, the CR3, D551N
mutant did not support viability (Figure 5.4A). This suggests that the CR3 region may be needed
for the endonuclease activity of Rrp44p.
To further test the genetic interaction between the CR3 region and the endonucleolytic
PIN domain of Rrp44p, the triple CR3 mutation was generated in a C-terminal truncation of
Rrp44p that lacks the exonucleolytic RNB domain. This truncation was also tested for
complementation of an rrp44# [RRP44, URA3] strain. Again, if the CR3 region was needed for
Rrp44p endonuclease activity, the CR3 mutant should be synthetically lethal with a truncation
lacking the exoribonucleolytic domain because cells lacking both the endo- and exonuclease
activities of Rrp44p are not viable (Lebreton et al., 2008; Schaeffer et al., 2009; Schneider et al.,
2009). Similar to the results obtained with the CR3, D551N mutant, the CR3 truncation lacking
exonuclease activity did not support viability (Figure 5.4B). This further suggests that the CR3
region is needed for Rrp44p endonuclease activity.
To more directly test the importance of the CR3 region in PIN domain nuclease activity,
two mutant, truncated Rrp44p proteins were tested for endonuclease activity in vitro. In the first
mutant, the CR3 mutation was again combined with a C-terminal truncation of Rrp44p that
lacked the exonucleolytic RNB domain (residues 1-235). In the second truncation, both the CR3
region and the RNB domain were removed, leaving only the PIN domain (residues 84-235).
Both of the Rrp44p truncated proteins were purified as GST fusions from E. coli and incubated
individually with a 32P 5’-end labeled A30 oligonucleotide. Degradation of the RNA substrate in
the Rrp44p mutants was compared to two controls, a reaction that did not contain any protein
(control) and a C-terminal truncated Rrp44p that lacked the RNB domain but had an intact CR3
region and PIN domain (residues 1-235; Wild-type). The efficiency of endonucleolytic cleavage
was reduced in both of the Rrp44p mutants, with a more severe defect seen in the Rrp44p
truncation that lacked the CR3 region and RNB domain (Figure 5.4C). Combined, these results
indicate that the CR3 region of Rrp44p is needed for efficient endonuclease activity.
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Figure 5.4: The CR3 region of Rrp44p is needed for endonuclease activity in vivo and
in vitro.
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Figure 5.4: The CR3 region of Rrp44p is needed for endonuclease activity in vivo and
in vitro.
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Figure 5.4: The CR3 region of Rrp44p is needed for endonuclease activity in vivo and in
vitro. A and B, An rrp44 deletion strain complemented by full-length RRP44 on a plasmid with
a URA3 marker was transformed with plasmids encoding each of the depicted mutations or
truncations. Transformants were spotted onto media containing 5-FOA and control media (SC –
LEU–URA + 2% dextrose), and grown for several days. Growth of the rrp44 mutants was
compared to two controls, empty vector and wild-type Rrp44p. Growth on 5-FOA would suggest
that the CR3 region is not needed for Rrp44p endonuclease activity. C, The depicted Rrp44p
mutants were purified as GST-fusion recombinant proteins from E. coli and incubated with a 5’end labeled A30 oligonucleotide for the time indicated (in minutes). Reactions were subjected to
denaturing urea-polyacrylamide gel electrophoresis for single nucleotide separation. This
experiment was performed by F. Reis in the laboratory of Dr. Cecilia Arraiano.
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The CR3 region of Rrp44p genetically interacts with the nuclease activities of the exosome.
The CR3 region genetically interacts with the exonucleolytic RNB domain of Rrp44p.
To determine whether the CR3 region was needed for Rrp44p exonuclease activity, the
triple CR3 mutant was tested in three different assays. First, a plasmid containing the triple CR3
mutation and the catalytically inactive endonuclease point mutation, D171A, was tested for
complementation of an rrp44# [RRP44, URA3] strain. Growth of the CR3, D171A mutant strain
was compared to two controls, empty vector and wild-type RRP44. If the CR3 region was
needed for Rrp44p exonuclease activity, the triple CR3 mutant should be synthetically lethal
with D171A because cells lacking both the endo- and exonuclease activities of Rrp44p are not
viable (Lebreton et al., 2008; Schaeffer et al., 2009; Schneider et al., 2009). Indeed, the CR3,
D171A mutant did not support viability (Figure 5.5A). This suggests that the CR3 region
genetically interacts with the exonucleolytic RNB domain of Rrp44p, and that the CR3 region
may also be needed for exonuclease activity.
To further test the functional interaction between the CR3 region and the RNB domain, a
synthetic lethality growth assay was performed using the triple CR3 mutant. Briefly, a plasmid
encoding the triple CR3 point mutation was transformed into an rrp44 deletion strain that
contains a temperature-sensitive allele of dcp1 (dcp1-2) and a plasmid encoding wild-type
RRP44 and a URA3 marker, generating the dcp1-2 CR3 mutant strain. Dcp1p is a subunit of the
decapping complex needed for 5’ to 3’ mRNA decay (Coller and Parker, 2004). The basis of this
assay is that at least one of the two mRNA decay pathways is required for viability (Anderson
and Parker, 1998). Therefore, if the CR3 region of Rrp44p is needed for 3’ to 5’ decay pathway,
the triple CR3 mutant should be synthetically lethal with dcp1-2. The dcp1-2 CR3 strain was
then spotted onto media containing 5-FOA and grown at three different temperatures (23°C,
30°C, 37°C) for several days. Growth of this strain at the non-permissive temperature for dcp1-2
(37°C) was compared to two control strains. The first control was a ski7 deletion strain that also
contained the dcp1-2 allele (dcp1-2 ski7#). Ski7p is a cytoplasmic exosome cofactor that is
required for general 3’ to 5’ decay (Araki et al., 2001; van Hoof et al., 2000b). The second
control strain contained only the dcp1-2 mutant. The triple CR3 point mutant was synthetically
lethal with dcp1-2 at the non-permissive temperature (Figure 5.5B), again indicating a genetic
interaction between the CR3 region and RNB domain of Rrp44p.
Because the synthetic lethality growth assay used above is only an indirect measure of 3’
to 5’ mRNA degradation, the stability of an endogenous mRNA, GAL7, was measured in the
dcp1-2 CR3 mutant strain. GAL7 is a galactose metabolism gene and is expressed in media

96

containing galactose. GAL7 stability in the dcp1-2 CR3 mutant strain was compared to two
control strains, a strain containing the dcp1-2 mutant and the dcp1-2 ski7# strain. Briefly, these
strains were grown in liquid media containing galactose at the permissive temperature for dcp1-2
(23°C) and then shifted to the non-permissive temperature (37°C) for one hour. The strains were
then grown in media containing dextrose to shut off transcription of GAL7. RNA was isolated
from these strains and subject to agarose formaldehyde gel electrophoresis. Northern blot
analysis was then performed using probes specific to GAL7, and SCR1 as a loading control. In
the dcp1-2 strain, GAL7 was unstable since the 3’ to 5’ decay pathway was still functional.
Conversely, in the dcp1-2 ski7! strain, GAL7 was more than 4-times more stable, as neither the
5’ to 3’ or 3’ to 5’ mRNA decay pathway was functional. Similar to the dcp1-2 ski7! control
strain, GAL7 was more than 4-times more stable in the dcp1-2 CR3 strain than the dcp1-2 strain
alone. (Figure 5.5C and D). Since the exonuclease activity of Rrp44p is known to degrade
mRNAs, these results suggest that the CR3 region of Rrp44p may be needed for the exonuclease
activity of Rrp44p.
The CR3 region genetically interacts with the nuclear exosome cofactor, Rrp6p.
The catalytically inactive mutant of Rrp44p, D551N, is synthetically sick upon deletion
of Rrp6p, a nuclear exosome cofactor. This indicates that the RNB domain of Rrp44p genetically
interacts with Rrp6p. To determine whether the CR3 region of Rrp44p also genetically interacts
with Rrp6p, a plasmid encoding the triple CR3 mutation was transformed into an rrp44 and rrp6
deletion strain, generating the rrp6# CR3 mutant. This strain also contains a plasmid encoding
wild-type RRP44 and a URA3 marker. Transformants were then spotted onto media containing
5-FOA and grown at three different temperatures (23°C, 30°C, 37°C) for several days. Although
this particular rrp6 deletion strain can grow at temperatures up to 37°C, its optimal growth
temperature is at 25°C (Schneider et al., 2009). Additionally, other rrp6 deletion strains are
temperature-sensitive (Allmang et al., 1999b). Growth of the rrp6# CR3 strain at all three
temperatures was compared to two controls, an rrp6 and rrp44 deletion strain and an rrp6
deletion strain. If the CR3 region genetically interacts with Rrp6p, the triple CR3 mutant should
be synthetically sick or synthetically lethal with an rrp6 deletion. Indeed, the triple CR3 mutant
was synthetically sick with an rrp6 deletion at lower temperatures, and synthetically lethal with
an rrp6 deletion at 37°C (Figure 5.6). Combined, these results indicate that the CR3 region
genetically interacts with the exonucleolytic RNB domain of Rrp44p and with Rrp6p.
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Figure 5.5: The CR3 region of Rrp44p genetically interacts with the exonucleolytic
RNB domain of Rrp44p.
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Figure 5.5: The CR3 region of Rrp44p genetically interacts with the exonucleolytic
RNB domain of Rrp44p.
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Figure 5.5: The CR3 region of Rrp44p genetically interacts with the exonucleolytic RNB
domain of Rrp44p. A, An rrp44 deletion strain complemented by full-length RRP44 on a
plasmid with a URA3 marker was transformed with plasmids encoding each of the depicted
mutations. Transformants were spotted onto media containing 5-FOA and control media (SC –
LEU–URA + 2% dextrose), and grown for several days. Growth of the rrp44 mutants was
compared to two controls, empty vector and wild-type RRP44. Growth on 5-FOA would suggest
that the CR3 region is not needed for Rrp44p exonuclease activity. B, An rrp44 deletion strain
containing a plasmid encoding wild-type RRP44 and a URA3 marker, as well as a temperaturesensitive allele of dcp1 (dcp1-2), was transformed with a plasmid encoding the triple CR3
mutation. Transformants were spotted onto media containing 5-FOA and grown for several days
at the indicated temperatures. Growth of the dcp1-2 rrp44 triple CR3 mutant was compared to
two control strains, a ski7 deletion strain that also contains the dcp1-2 allele (dcp1-2 ski7!) and a
strain containing only the dcp1-2 mutant. Growth on 5-FOA at 37°C, the non-permissive
temperature of the dcp1-2 allele, would suggest that the CR3 region of Rrp44p does not
genetically interact with the exonucleolytic RNB domain.
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Figure 5.6: The CR3 region of Rrp44p genetically interacts with the nuclear exosome
cofactor, Rrp6p.
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Figure 5.6: The CR3 region of Rrp44p genetically interacts with the nuclear exosome
cofactor, Rrp6p. An rrp44 deletion strain or an rrp6 and rrp44 deletion strain was transformed
with a plasmid encoding the triple CR3 mutation. Transformants were spotted onto media
containing 5-FOA and grown for several days at the indicated temperatures. Growth of the rrp6
and rrp44 mutants was compared to two controls, an rrp6 and rrp44 deletion strain and an rrp44
deletion strain. Growth at 37°C would suggest that the CR3 region of Rrp44p does not
genetically interact with Rrp6p.
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The CR3 region of Rrp44p is important in nonstop mRNA degradation.
The data presented in Chapter 4 indicate that neither the endo- or exonuclease activities
of Rrp44p are needed for a functional nonstop mRNA degradation pathway. The CR3 region has
already been shown to be needed for both of the Rrp44p nuclease activities. Therefore, if these
nucleases are redundant in nonstop decay, then the triple CR3 mutant should be unable to
degrade nonstop transcripts. In order to test the effects of the triple CR3 mutant in nonstop
decay, a his3-nonstop growth assay was performed. In this assay, the his3-nonstop reporter was
transformed into an rrp44! strain that was complemented by the triple CR3 mutant. The basis
for this assay is that the his3-nonstop reporter is stable in a strain that is defective in nonstop
mRNA decay, thus allowing cells to make histidine and grow on media lacking histidine (van
Hoof et al., 2002). The growth of the triple CR3 mutant on media lacking histidine was
compared to two controls, a wild-type strain and a ski7 deletion strain. In addition to being
required for general 3’ to 5’ mRNA decay, Ski7p is needed for the degradation of nonstop
transcripts (Frischmeyer et al., 2002). Similar to the ski7 deletion strain, the triple CR3 mutant
did not support growth on media lacking histidine (Figure 5.7A). These results suggest that the
CR3 region is needed for a functional nonstop mRNA decay pathway.
Because the his3-nonstop growth assay is an indirect measure of whether the nonstop
decay pathway is functional, a more direct assay was used. Specifically, the stability of the
GAL::pgk1pG-nonstop transcript was measured in a strain containing the triple CR3 mutant of
Rrp44p. The stability of the nonstop transcript in this strain was compared to two controls, a
strain containing wild-type Rrp44p and a ski7 deletion strain. These strains were grown in liquid
media containing galactose and then shifted to media containing dextrose to shut off
transcription of the GAL::pgk1pG-nonstop reporter. RNA was isolated from these strains and
subject to agarose formaldehyde gel electrophoresis. Northern blot analysis was then performed
using probes specific to pgk1pG, and to ACT1 as a loading control. The GAL::pgk1pG-nonstop
transcript was as stable in the triple CR3 mutant as it was in the ski7 deletion strain (Figure 5.7B
and C). Combined, these results indicate that the CR3 region of Rrp44p is needed for the
degradation of nonstop transcripts.
The disulfide bond of the CR3 region is not needed for optimal cell growth.
A disulfide bond is modeled to form between the second and third residues of the CR3
region (Bonneau et al., 2009). To determine if this disulfide bond is needed for optimal cell
growth, the three individual cysteine residues of the CR3 region were mutated to serine. The
individual cysteine mutants were then transformed into an rrp44# [RRP44, URA3] strain.
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Figure 5.7: The CR3 region of Rrp44p is needed for nonstop mRNA degradation.
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Figure 5.7: The CR3 region of Rrp44p is needed for nonstop mRNA degradation. A, An
rrp44 deletion strain complemented by a plasmid encoding the triple CR3 mutant was
transformed with the his3-nonstop reporter. Transformants were spotted onto media containing,
or lacking, histidine and grown for several days. Growth of the triple CR3 mutant was compared
to two control strains, wild-type RRP44 and a ski7 deletion. Growth on media lacking histidine
indicates that the nonstop mRNA degradation machinery is not functional. B, An rrp44 deletion
strain complemented by a plasmid encoding the triple CR3 mutant was transformed with the
GAL::pgk1pG-nonstop reporter. The stability of the transcript in the triple CR3 mutant was
compared to two control strains, wild-type RRP44 and a ski7 deletion. Cultures were first grown
in media containing galactose and then incubated in media containing dextrose (to inhibit
transcription of the GAL::pgk1pG-nonstop reporter) for the indicated time (in minutes). RNA
was isolated from these strains and analyzed by Northern blot analysis with probes that hybridize
to PGK1 and ACT1. The half-life of the GAL::pgk1pG-nonstop transcript was normalized for
loading using the ACT1 signal and are as indicated (in minutes). C, A graphical representation of
the half-life of the GAL::pgk1pG-nonstop transcript.

105

Transformants were spotted onto media containing 5-FOA and grown for several days. Growth
of the individual cysteine mutants was compared to three controls, empty vector, wild-type
RRP44, and the triple CR3 mutant. As compared to wild-type and the triple CR3 mutant, the
individual cysteine mutants had an intermediate growth phenotype- their growth was not as
robust as wild-type but was not as slow as the triple CR3 mutant. In particular, the C55S mutant
had a growth phenotype similar to wild-type Rrp44p (Figure 5.8). This suggests that the disulfide
bond modeled between C52 and C55 of the CR3 region is not needed for optimal growth. These
results do not exclude the possibility that the disulfide bond exists between C47 and C52 of the
CR3 region.
The disulfide bond of the CR3 region is not important in nonstop mRNA degradation.
Because the CR3 region is needed for nonstop mRNA decay, the role of the disulfide
bond between the second and third cysteine residues of the CR3 region was tested in this mRNA
surveillance pathway. Briefly, the his3-nonstop reporter was transformed into rrp44 deletion
strains that were complemented by the individual cysteine mutants. In this assay, cells with a
non-functional nonstop mRNA degradation pathway are viable on media lacking histidine,
whereas wild-type cells are inviable on media lacking histidine because they are able to rapidly
degrade the his3-nonstop transcript. The growth of the individual cysteine mutants on media
lacking histidine was compared to three controls, a wild-type strain, a ski7 deletion strain, and
the triple CR3 mutant. In contrast to the triple CR3 mutant, the individual cysteine mutants were
viable on media lacking histidine (Figure 5.9). This suggests that the nonstop decay defect of the
triple CR3 mutant is not due to the lack of a disulfide bond between the second and third
cysteine residues of the CR3 region and that nonstop decay does not require a disulfide bond in
the CR3 region of Rrp44p.
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Figure 5.8: The disulfide bond of the CR3 region is not needed for optimal cell growth.
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Figure 5.8: The disulfide bond of the CR3 region is not needed for optimal cell growth. An
rrp44 deletion strain complemented by full-length RRP44 on a plasmid with a URA3 marker was
transformed with plasmids encoding each of the depicted mutations. Transformants were spotted
onto media containing 5-FOA and control media (SC –LEU–URA + 2% dextrose), and grown
for several days. Growth of the rrp44 mutants was compared to two controls, empty vector and
wild-type RRP44. Growth on 5-FOA indicates that mutated Rrp44p can carry out the essential
function of Rrp44p.
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Figure 5.9: The disulfide bond of CR3 region is not needed for nonstop mRNA
degradation.
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Figure 5.9: The disulfide bond of the CR3 region is not needed for nonstop mRNA
degradation. rrp44 deletions strain complemented by plasmids encoding the depicted mutations
were transformed with the his3-nonstop reporter. Transformants were spotted onto media
containing, or lacking, histidine and grown for several days. Growth of the rrp44 mutants was
compared to three control strains, wild-type RRP44, a ski7 deletion, and the triple CR3 mutant.
Growth on media lacking histidine indicates that the nonstop mRNA degradation machinery is
not functional.
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DISCUSSION
The CR3 region may be a putative zinc binding domain.
The spatial organization of the three cysteines of the CR3 region and histidine 184
(H184; Figure 5.1A and B) suggests that these residues may coordinate a zinc ion. Therefore, the
defects seen in the triple CR3 mutant may be explained by the lack of this coordination. The
presence of a zinc ion may be directly or indirectly required for Rrp44p protein
expression/stabilization, Rrp44p nuclease activity, and/or may be needed for Rrp44p to interact
with the exosome. Specifically, there are several ways in which this coordination may impact the
interaction between Rrp44p and the exosome and/or exosome function, none of which are
mutually exclusive.
One possibility is that the lack of coordination may decrease the expression or
stabilization of the Rrp44p protein, which in turn reduces cell growth and may decrease the
interaction between Rrp44p and the exosome. Specifically, the coordination of a zinc ion may be
needed for the correct folding of the CR3 region, and thus Rrp44p. Under this hypothesis, the
lack of a functional exosome may be a secondary consequence of Rrp44p protein misfolding.
Another possibility is that the lack of a zinc ion may interfere with Rrp44p endo- and/or
exonuclease activity. If the coordination of zinc is important for both of these nuclease activities,
this may explain why the triple CR3 mutant has a slow growth phenotype. Additionally, if these
nuclease activities are redundant in nonstop mRNA decay, this could also explain the nonstop
decay defect observed in the triple CR3 mutant. In support of this, preliminary evidence suggests
that Rrp44p endonuclease activity is stimulated by the addition of zinc (Filipa Reis and Dr.
Cecilia Arraiano, personal communication). For a more detailed explanation as to how the
coordination of zinc may influence the CR3 region of Rrp44p, and thus the exosome, see
Chapter 7.
Interestingly, the data presented here also show that the disulfide bond modeled between
the second and third residues of the CR3 region is not required for optimal cell growth or for
nonstop mRNA degradation. Because of the low resolution of the latest crystal structure of
Rrp44p, the electron density is not defined enough to determine which residues, if any, of the
CR3 region form a disulfide bond. Therefore, the results shown here, combined with the low
resolution of the crystal structure, indicate that the disulfide bond of the CR3 region is not
biologically important and suggests that it may not be present in the N-terminus of Rrp44p. In
addition, a stable disulfide bond is unlikely to form in the reducing environment of the nucleus
or cytoplasm.
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The CR3 region is one of many regions of Rrp44p that is needed for exosome interaction.
The observation that the CR3 region mediates interaction between Rrp44p and the
exosome is not surprising given that this interaction was predicted in human Rrp44p (Lehner and
Sanderson, 2004) and by a cryo-EM structure of the yeast exosome (Wang et al., 2007). In the
most recent study to show an interaction between Rrp44p and the core exosome, the authors
concluded that the PIN domain of Rrp44p is needed for exosome interaction. In the study,
however, it is not clear whether the region of Rrp44p that interacts with the exosome consists of
only the PIN domain or the CR3 region and PIN domain. Additionally, the interaction detected
when just the PIN domain was used (residues 86-203) was much weaker than in full-length
Rrp44p (Schneider et al., 2009), which suggests that more than just the PIN domain is needed for
Rrp44p to interact with the exosome. Additionally, the lack of interaction seen when a deletion
of the PIN domain was used (a deletion of residues 86-203), could be explained by a transient
interaction of mutant Rrp44p with the exosome or it may be an artifact of the
immunoprecipitation conditions that were used. This latter possibility is likely since the
interaction between Rrp44p and the exosome is salt-sensitive (Allmang et al., 1999b).
Since Rrp44p only loosely associates with the exosome (Allmang et al., 1999b),
interaction of the CR3 mutant with the core exosome was tested under low and high salt
conditions (50 mM and 1 M NaCl, respectively). The inability of the CR3 mutant to interact with
the exosome, even under low salt conditions, further supports the importance of this region in
mediating interaction with the exosome.
The data presented here, combined with the three previous studies on Rrp44p-exosome
interaction, suggest that the CR3 region of Rrp44p is just one region of the protein that is needed
to interact with the exosome. Specifically, five of the six domains of Rrp44p have been
implicated in exosome interaction (Lehner and Sanderson, 2004; Schneider et al., 2009; Wang et
al., 2007).
The functional interaction between the CR3 region and the PIN domain of Rrp44p
The observation that the triple CR3 mutant was synthetically lethal with the D551N
mutant and with a C-terminal truncation of Rrp44p that lacked the RNB domain, suggests that
the CR3 region is needed for the endonuclease activity of Rrp44p. One possible reason for this is
that the CR3 region may be needed for the 5’-end dependency exhibited by the PIN domain. It
has been previously shown that the Rrp44p endonuclease more efficiently degrades an RNA
substrate that contains a 5’ monophosphate than a 5’ hydroxyl (Schaeffer et al., 2009). Indeed
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preliminary evidence suggests that the CR3 region is important in differentiating between the 5’ends of RNA substrates (Filipa Reis and Dr. Cecilia Arraiano, personal communication).
Another possibility is that the CR3 region is indirectly needed for Rrp44p endonuclease
activity. Specifically, the coordination of a zinc ion between the CR3 region and H184 may be
needed for a functional endonuclease active site. In the triple CR3 mutant, the CR3 region may
be folded in such a way that precludes coordination of zinc, which may, therefore, decrease the
endonuclease activity of Rrp44p. In support of this, H184 is on the same alpha-helix as D171,
the active site residue of the endonucleolytic PIN domain.
The finding that the triple CR3 mutant is synthetically lethal with the D551N mutant and
with a C-terminal truncation of Rrp44p may also be explained by a lack of protein expression,
since the CR3 mutant is expressed at lower levels than wild-type Rrp44p. To determine whether
the lack of growth is an artifact of expression, the CR3, D551N mutant and the triple CR3
mutant combined with a C-terminal truncation that lacks the RNB domain will be C-terminally
TAP-tagged and expression of the mutant proteins will be analyzed. Regardless of whether these
CR3 mutant proteins are expressed, the CR3 region is needed for efficient endonucleolytic
cleavage in vitro. Additionally, the genetic interaction between the CR3 region and PIN domain
is supported by the close proximity of the three cysteine residues and the active site of the PIN
domain in the crystal structure (Bonneau et al., 2009).
The functional interaction between the CR3 region and the RNB domain of Rrp44p
The observation that the triple CR3 mutant was synthetically lethal with the D171A
mutant suggests that the CR3 region is needed for exonuclease activity of Rrp44p. Although the
CR3 region and the active site of the RNB domain are not in close proximity in the crystal
structure, the CR3 region may be needed to interact with cytoplasmic exosome cofactors that are
required for 3’ to 5’ mRNA degradation (see Chapter 7). Another possible explanation is that the
CR3, D171A mutant is not expressed. A potential decrease in expression, coupled with a loss of
exosome interaction, may explain the lack of complementation by the CR3, D171A mutant.
The CR3 region has a novel role in nonstop mRNA degradation.
The defect in nonstop decay seen in the triple CR3 mutant can be explained by several
possibilities. In the first two explanations, it is assumed that the endo- and exonuclease activities
of Rrp44p are redundant in nonstop decay. If this were the case, the nonstop decay defect is not
surprising given that the CR3 region seems to be important for both of the nuclease activities of
Rrp44p. Therefore, if the Rrp44p nuclease active sites have decreased nuclease activities in a
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triple CR3 mutant, nonstop transcripts would be stabilized. Alternatively, it may be that the
reduced expression of the triple CR3 mutant causes a reduction in the nuclease activities of
Rrp44p, again resulting in the inability of Rrp44p to degrade nonstop transcripts (see Chapter 7).
If the nuclease activities of Rrp44p are not redundant in nonstop mRNA decay another
unidentified nuclease is responsible for the degradation of nonstop transcripts. It may be that the
CR3 region of Rrp44p is needed to recruit this nuclease. Under this hypothesis, if the triple CR3
mutant cannot recruit the nonstop decay nuclease, nonstop transcripts would be stabilized.
One more possibility, that does not require that the nuclease activities of Rrp44p be
redundant in nonstop decay, is that the CR3 region of Rrp44p may interact with the nonstop
mRNA decay machinery. In this model, abolishing this interaction would inactivate the nonstop
decay pathway prior to mRNA degradation (see Chapter 7).
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Chapter 6: The far N-terminus of Rrp44p is important for exosome
function.
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INTRODUCTION
The eukaryotic exosome is involved in the 3’-end processing and 3’-end degradation of
various RNAs in the nucleus and the cytoplasm. The nuclear exosome processes RNA precursors
to form small, stable, mature RNAs, including the 5.8S rRNA (Mitchell et al., 1997; Mitchell et
al., 1996). The nuclear exosome also degrades RNA, specifically the 5’ external transcribed
spacer (5’ ETS) of the 35S rRNA precursor (Allmang et al., 1999a). In contrast to the nuclear
exosome, the cytoplasmic exosome is solely involved in mRNA degradation. Here, the exosome
degrades normal and aberrant transcripts as a means of regulating and maintaining the fidelity of
gene expression, respectively. Specifically, the cytoplasmic exosome is involved in degrading
nonstop transcripts, or mRNAs that lack termination codons (Frischmeyer et al., 2002; van Hoof
et al., 2002). Several studies suggest that the essential function of Rrp44p, and the exosome, is in
the nucleus because none of the known cytoplasmic exosome functions are required for viability.
Although the exosome contains 10 subunits, only one subunit, Rrp44p, is catalytically
active (Dziembowski et al., 2007; Liu et al., 2006; Mamolen and Andrulis, 2009). Rrp44p
consists of six putative domains, two of which have nuclease activity. The N-terminal PIN
domain has endoribonuclease activity (Lebreton et al., 2008; Schaeffer et al., 2009; Schneider et
al., 2009) and the C-terminal RNB domain has 3’ to 5’ exoribonuclease activity (Dziembowski
et al., 2007). Three of the six domains are putative RNA binding domains and are spread
throughout the protein. Lastly, the CR3 region, which may not fit the classical definition of a
domain, lies in the N-terminus of Rrp44p and seems to be important for most, if not all, of the
known functions of the exosome (see Chapter 5). Previous studies on Rrp44p have focused only
on the protein’s endo- and exonuclease activities. Therefore, the far N-terminus of Rrp44p,
specifically residues 1-46, has not yet been characterized. Recently, the crystal structure of
Rrp44p was published, however, the structure lacked the first 33 residues (Bonneau et al., 2009).
Bioinformatic analysis suggests that the far N-terminus of Rrp44p contains a linker region that
consists of residues 34 to 46, with six of these residues highly conserved in eukaryotic Rrp44p
homologs (Figure 6.1A). Importantly, four of these highly conserved residues have been
implicated in exosome interaction (Bonneau et al., 2009).
Because the exosome is present in both the nucleus and the cytoplasm, at least one
subunit requires a nuclear localization signal (NLS). Of the ten subunits, only Rrp44p has a
putative NLS, in fact, it has four putative NLSs spread throughout the protein. It is not yet
known which, if any, of these NLSs are required for Rrp44p, or any of the other exosome
subunits, to localize to the nucleus. In support of the importance of the NLSs in Rrp44p,
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Drosophila Rrp44p requires a C-terminal NLS for nuclear localization (Graham et al., 2009). It
may be that the four putative NLSs of yeast Rrp44p are redundant for localization.
To determine the function of the far N-terminus of Rrp44p, specifically residues 1-46,
and whether this region is needed for the essential function of Rrp44p, several N-terminal
truncations and point mutations were generated and assayed for exosome function in vivo. The
data here show that the far N-terminus of Rrp44p, specifically a linker region consisting of
conserved residues, including residues 34 to 46, is needed for viability. In addition, at least the
first 33 residues of the far N-terminus are needed for Rrp44p to interact with the exosome.
Combining N-terminal mutants with catalytically inactive nuclease mutants of Rrp44p suggests
that the N-terminus is not needed for the endo- or exonuclease activities of Rrp44p. Lastly, the
data presented here suggest at least one of the putative NLSs of Rrp44p is required for viability.
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RESULTS
A conserved stretch of residues in the far N-terminus of Rrp44p is needed for viability.
To determine whether the far N-terminus of Rrp44p, specifically residues 1-46, is
needed for cell survival, plasmids encoding N-terminal truncations were generated and
transformed into an rrp44# [RRP44, URA3] strain. Transformants were then spotted onto media
containing 5-FOA and grown for several days. Growth of the rrp44 truncations was compared to
two controls, empty vector and wild-type RRP44. N-terminal truncations that lack up to the first
33 residues of Rrp44p had no obvious growth phenotype, with the smallest complementing
truncation encoding residues 34-1001. In contrast, N-terminal truncations that lack the first 46
residues (47-1001), or more, did not support viability (Figure 6.1B). This lack of
complementation is not due to a lack of protein expression, as both the 34-1001 and 47-1001
truncations are expressed at levels similar to wild-type (Figure 6.2). This suggests that the linker
region, or residues 34 to 46, of Rrp44p is required for cell survival.
To determine whether the lack of complementation seen in 47-1001 truncation can be
attributed to the lack of one of the conserved residues of the linker region, plasmids encoding
point mutations in six of the most conserved residues were generated and tested for
complementation of an rrp44# [RRP44, URA3] strain. Transformants were then spotted onto
media containing 5-FOA and grown for several days. Growth of the Rrp44p point mutants was
compared to two controls, empty vector and wild-type RRP44. Similar to wild-type, the point
mutants had no obvious growth defects (Figure 6.1C). Therefore, although residues 34 to 46 of
the linker region are needed for viability, point mutants in the most conserved residues of this
region have no effect on cell growth.
The N-terminus of Rrp44p is necessary, but may not be sufficient, for Rrp44p to interact
with the exosome.
One explanation for why the linker region, or residues 34 to 46, is needed for viability is
that this region is needed for Rrp44p to interact with the core exosome. Indeed, four of the most
highly conserved residues of this region have been implicated in exosome interaction (Bonneau
et al., 2009). To test whether this region mediates interaction with the exosome in vivo, wild-type
Rrp44p and the N-terminal truncations of Rrp44p, 34-1001 and 47-1001, were C-terminally
TAP-tagged. Wild-type and the truncated Rrp44p proteins were purified using IgG sepharose
beads specific to the protein A portion of the TAP tag. Proteins bound to the Rrp44p proteins
were eluted and analyzed using SDS-PAGE. Whole cell lysates from the wild-type and truncated
Rrp44p strains were compared to the bound fractions from these strains. The interaction of the
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Figure 6.1: Residues 34 to 46 of Rrp44p are needed for viability.
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Figure 6.1: Residues 34 to 46 of Rrp44p are needed for viability.
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Figure 6.1: Residues 34 to 46 of Rrp44p are needed for viability. A, A schematic
representation of the N-terminus (residues 18 to 55) of Rrp44p. Conservation is indicated by the
height of each amino acid. B, An rrp44 deletion strain complemented by full-length RRP44 on a
plasmid with a URA3 marker was transformed with plasmids encoding each of the depicted
truncations. Transformants were spotted onto media containing 5-FOA and control media (SC –
LEU–URA + 2% dextrose), and grown for several days. Growth of the rrp44 truncations was
compared to two controls, empty vector and wild-type RRP44. Growth on 5-FOA indicates that
truncated Rrp44p can carry out the essential function of Rrp44p. C, An rrp44 deletion strain
complemented by full-length RRP44 on a plasmid with a URA3 marker was transformed with
plasmids encoding each of the depicted mutations. Transformants were spotted onto media
containing 5-FOA and control media (SC –LEU–URA + 2% dextrose), and grown for several
days. Growth of the rrp44 mutants was compared to two controls, empty vector and wild-type
RRP44. Growth on 5-FOA indicates that mutated Rrp44p can carry out the essential function of
Rrp44p.
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wild-type and truncated Rrp44p proteins with the exosome was compared to empty vector. In
contrast to wild-type, both of the N-terminal truncated Rrp44p proteins were unable to interact
with the exosome suggesting that at least the first 33 residues of Rrp44p residues are needed for
exosome interaction (Figure 6.2). Because this region alone was not tested for exosome
interaction, it is not yet known whether this region is sufficient for Rrp44p to interact with the
exosome. Additionally, previous studies indicate that other regions of Rrp44p are also needed for
exosome interaction (Lehner and Sanderson, 2004; Schneider et al., 2009; Wang et al., 2007).
The results presented so far indicate that deletion of the first 33 residues disrupts exosome
interaction, but not exosome function.
Several residues in the N-terminus of Rrp44p are needed for an essential function that also
requires the C-terminus of Rrp44p.
To determine whether the N-terminus of Rrp44p is needed for the protein’s
endonuclease activity, an N-terminal truncation and N-terminal point mutants were tested for
whether they were synthetically lethal with mutants of Rrp44p that lack exonuclease activity. If
the N-terminus of Rrp44p is needed for endonuclease activity, the combination of N-terminal
truncations/point mutants with a mutant lacking exonuclease activity should not complement an
rrp44# [RRP44, URA3] strain because cells lacking both the endo- and exonuclease activities of
Rrp44p are not viable (Lebreton et al., 2008; Schaeffer et al., 2009; Schneider et al., 2009).
To determine whether the first 33 residues of the far N-terminus of Rrp44p are needed
for the protein’s endonuclease activity, the catalytically inactive exonuclease point mutant,
D551N, was generated in the 34-1001 truncation (D551N 34-1001) and tested for
complementation of an rrp44# [RRP44, URA3] strain. Growth of the D551N 34-1001 mutant
strain was compared to four controls, empty vector, wild-type RRP44, the 34-1001 truncation,
and the D551N mutant. The D551N 34-1001 mutant did have a slight growth defect when
compared to a strain containing the 34-1001 truncation and a strain containing the D551N
mutant, however, deletion of the first 33 residues was not synthetically lethal with the D551N
mutant (Figure 6.3A). This suggests that the first 33 residues of Rrp44p are not needed for the
protein’s endonuclease activity.
To determine whether any of the six conserved residues of the linker region in the far Nterminus of Rrp44p (E38, Y40, L41, R42, D44, and I45), are needed for endonuclease activity,
point mutations in these residues were generated in a C-terminal Rrp44p truncation that lacks
exonuclease activity. These truncations were then tested for complementation of an rrp44#
[RRP44, URA3] strain. Growth of the rrp44 mutant truncations was compared to two controls,
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Figure 6.2: The N-terminus of Rrp44p is needed for interaction with the exosome.
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Figure 6.2: The N-terminus of Rrp44p is needed for interaction with the exosome. Cterminal TAP-tagged Rrp44p mutants were purified using IgG sepharose beads. Prior to
purification, whole-cell lysates were isolated (left). Purified proteins were eluted by boiling the
beads (right). Interaction of the Rrp44p truncated proteins with the exosome was compared to
two controls, wild-type Rrp44p and empty vector. Whole-cell lysates and purified proteins were
analyzed by Western blot analysis with antibodies specific to Protein A (above) to detect
Rrp44p, Rrp4p (middle) to detect interaction with the exosome, and Pgk1p (below) as a loading
control. The asterisk in the middle blot indicates a nonspecific protein.
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empty vector and wild-type RRP44. Three of the six point mutants (Y40A, L41A, and R42A)
were synthetically lethal with a truncation lacking exonuclease activity, whereas the other three
point mutants exhibited no growth defect when combined with a C-terminal truncation of
Rrp44p (Figure 6.3B and C). This suggests that some of the six conserved residues of the linker
region in the far N-terminus of Rrp44p may be needed for PIN domain endonuclease activity.
To further test the genetic interaction between these three conserved residues and the
endonucleolytic PIN domain, the Y40A, L41A, and R42A mutants were combined, individually,
with the D551N mutant and tested for complementation of an rrp44# [RRP44, URA3] strain. In
contrast to the results obtained when these point mutants were generated in a truncation lacking
the exonucleolytic RNB domain, the Y40A, L41A, and R42A mutants were not synthetically
lethal with the D551N mutant (Figure 6.3C). These results suggest that the three conserved
residues of the linker region in the far N-terminus of Rrp44p are likely not required for the
endonuclease activity of the protein but rather for an essential function of Rrp44p that also
requires the C-terminus of the protein (see Discussion)
The first 33 residues of Rrp44p do not genetically interact with the exonuclease activities of
the exosome.
The first 33 residues are not needed for exosome-mediated 3’ to 5’ mRNA degradation.
To determine whether the first 33 residues of Rrp44p are needed for the protein’s
exonuclease activity, the N-terminal truncation, 34-1001, was tested in two different assays.
First, the catalytically inactive endonuclease point mutant, D171A, was generated in the 34-1001
truncation (D171A 34-1001) and tested for complementation of an rrp44# [RRP44, URA3]
strain. Growth of the D171A 34-1001 mutant was compared to two controls, empty vector and
wild-type RRP44. If the first 33 residues are needed for the exonuclease activity of Rrp44p, a
truncation lacking these residues should be synthetically lethal with D171A because cells lacking
both the endo- and exonuclease activities of Rrp44p are not viable (Lebreton et al., 2008;
Schaeffer et al., 2009; Schneider et al., 2009). Similar to wild-type Rrp44p, the D171A 34-1001
mutant had no obvious growth defect (Figure 6.4A), suggesting that the first 33 residues of
Rrp44p are not needed for the exonuclease activity of the protein’s RNB domain.
To further test the functional interaction between the first 33 residues of Rrp44p and the
RNB domain, a synthetic lethality growth assay was performed. Briefly, a plasmid encoding
residues 34-1001 was transformed into an rrp44 deletion strain that also contained a
temperature-sensitive allele of dcp1 (dcp1-2) and a plasmid encoding wild-type RRP44 and a
URA3 marker, generating the dcp1-2 34-1001 strain. Dcp1p is a subunit of the decapping
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Figure 6.3: Several residues in the N-terminus of Rrp44p are needed for an essential
function that also requires the C-terminus of Rrp44p.
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Figure 6.3: Several residues in the N-terminus of Rrp44p are needed for an essential
function that also requires the C-terminus of Rrp44p.
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Figure 6.3: Several residues in the N-terminus of Rrp44p are needed for an essential
function that also requires the C-terminus of Rrp44p. An rrp44 deletion strain complemented
by full-length RRP44 on a plasmid with a URA3 marker was transformed with plasmids
encoding each of the depicted mutations. Transformants were spotted onto media containing 5FOA and control media (SC –LEU–URA + 2% dextrose), and grown for several days. Growth of
the rrp44 mutants was compared to empty vector and wild-type RRP44. Growth on 5-FOA
would suggest that mutated Rrp44p can carry out the essential function of Rrp44p.
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complex needed for 5’ to 3’ mRNA decay (Coller and Parker, 2004). The basis of this assay is
that at least one of the two mRNA decay pathways is required for viability (Anderson and
Parker, 1998). Therefore, if the first 33 residues of Rrp44p are needed for a functional 3’ to 5’
decay pathway, a truncation lacking these residues should be synthetically lethal with the dcp1-2
mutant. The dcp1-2 34-1001 strain was then spotted onto media containing 5-FOA and grown at
three different temperatures (23°C, 30°C, 37°C) for several days. Growth of the strain at the nonpermissive temperature for dcp1-2 (37°C) was compared to two control strains. The first control
was a ski7 deletion strain that also contained the dcp1-2 allele. Ski7p is a cytoplasmic exosome
cofactor that is required for general 3’ to 5’ decay (Araki et al., 2001; van Hoof et al., 2000b).
The second control strain contained only the dcp1-2 mutant. The N-terminal truncation was not
synthetically lethal with dcp1-2 at the non-permissive temperature (Figure 6.4B), again
indicating that these residues are not needed for Rrp44p exonuclease activity.
The first 33 residues of Rrp44p do not genetically interact with the nuclear exosome cofactor,
Rrp6p.
The catalytically inactive exonuclease mutant of Rrp44p, D551N, is synthetically sick
upon deletion of Rrp6p, a nuclear exosome cofactor. This indicates that the RNB domain of
Rrp44p genetically interacts with Rrp6p. To determine whether the first 33 residues of Rrp44p
also genetically interact with Rrp6p, a plasmid encoding residues 34-1001 was transformed into
an rrp44 and rrp6 deletion strain, generating the rrp6# 34-1001 mutant. This strain also contains
a plasmid encoding wild-type RRP44 and a URA3 marker. Transformants were then spotted onto
media containing 5-FOA and grown at three different temperatures (23°C, 30°C, 37°C) for
several days. Although this particular rrp6 deletion strain can grow at temperatures up to 37°C,
its optimal growth temperature is at 25°C (Schneider et al., 2009). Additionally, other rrp6
deletion strains are temperature-sensitive (Allmang et al., 1999b). Growth of the rrp6# 34-1001
strain at all three temperatures was compared to two controls, an rrp6 and rrp44 deletion strain
and rrp6 deletion strain. The 34-1001 truncation was not synthetically sick or lethal with an rrp6
deletion at any of the three temperatures (Figure 6.5). These results suggest that the first 33
residues of Rrp44p do not genetically interact with Rrp6p.
The first 33 residues of Rrp44p are not needed for nonstop mRNA degradation.
Thus far, the data presented here indicate that neither the endo- or exonuclease activities
of Rrp44p are needed for a functional nonstop mRNA degradation pathway, however, the CR3
region is needed for the degradation of nonstop transcripts. To determine whether the first 33
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Figure 6.4: The first 33 residues of Rrp44p are not needed for exosome-mediated 3’ to
5’ mRNA degradation.
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Figure 6.4: The first 33 residues of Rrp44p are not needed for exosome-mediated 3’ to 5’
mRNA degradation. A, An rrp44 deletion strain complemented by full-length RRP44 on a
plasmid with a URA3 marker was transformed with plasmids encoding each of the depicted
mutations. Transformants were spotted onto media containing 5-FOA and control media (SC –
LEU–URA + 2% dextrose), and grown for several days. Growth of the rrp44 mutants was
compared to two controls, empty vector and wild-type RRP44. Growth on 5-FOA indicates that
mutated Rrp44p can carry exosome-mediated 3’ to 5’ mRNA degradation. B, An rrp44 deletion
strain containing a plasmid encoding wild-type RRP44 and a URA3 marker, as well as a
temperature-sensitive allele of dcp1 (dcp1-2), was transformed with a plasmid encoding residues
34 to 1001. Transformants were spotted onto media containing 5-FOA and grown for several
days at the indicated temperatures. Growth of the dcp1-2 rrp44 34-1001 mutant was compared to
two control strains, a ski7 deletion strain that also contains the dcp1-2 allele (dcp1-2 ski7!) and a
strain containing only the dcp1-2 mutant. Growth on 5-FOA at 37°C, the non-permissive
temperature of the dcp1-2 allele, indicates that the first 33 residues of Rrp44p are not needed for
exosome-mediated 3’ to 5’ mRNA degradation.
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Figure 6.5: The first 33 residues of Rrp44p do not genetically interact with the nuclear
exosome cofactor, Rrp6p.
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Figure 6.5: The first 33 residues of Rrp44p do not genetically interact with the nuclear
exosome cofactor, Rrp6p. An rrp44 deletion strain or an rrp6 and rrp44 deletion strain was
transformed with a plasmid encoding residues 34 to 1001. Transformants were spotted onto
media containing 5-FOA and grown for several days at the indicated temperatures. Growth of
the rrp6 34-1001 mutant was compared to two controls, an rrp6 and rrp44 deletion strain and an
rrp44 deletion strain. Growth at 37°C indicates that the first 33 residues of Rrp44p do not
genetically interact with Rrp6p.
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residues of Rrp44p are also needed for nonstop decay, a his3-nonstop growth assay was
performed. In this assay, the his3-nonstop reporter was transformed into an rrp44 deletion strain
that was complemented by the 34-1001 truncation. The basis for this assay is that the his3nonstop reporter is stable in a strain that is defective in nonstop mRNA decay, thus allowing
cells to make histidine and grow on media lacking histidine (van Hoof et al., 2002). The growth
of the 34-1001 truncation on media lacking histidine was compared to two controls, a wild-type
strain and a ski7 deletion strain. Similar to the wild-type strain, the 34-1001 truncation did not
support viability on media lacking histidine (Figure 6.6). These results suggest that the first 33
residues of Rrp44p are not needed for a functional nonstop mRNA decay pathway.
The first 33 residues of Rrp44p are not required for the RNA processing or RNA
degradation activities of the nuclear exosome.
The nuclear exosome processes the 7S rRNA precursor to form the mature 5.8S rRNA
and degrades the 5’ external transcribed spacer (5’ ETS) of the 35S rRNA precursor (Allmang et
al., 1999a; Allmang et al., 1999b; Mitchell et al., 1997; Mitchell et al., 1996). To test whether the
first 33 residues of Rrp44p are needed for these nuclear RNA processing and/or degradation
reactions, RNA was isolated from an rrp44 deletion strain that was complemented with the 341001 truncation. RNA was also isolated from three controls, a strain containing an rrp6 deletion,
a strain containing wild-type RRP44, and a strain containing the D551N mutant. Rrp6p, a
nuclear exosome cofactor, is required for nuclear RNA processing and degradation (Briggs et al.,
1998). The RNA from these strains was then subject to denaturing urea-polyacrylamide gel
electrophoresis. To determine if these strains were defective in RNA processing and/or
degradation, Northern blot analysis was performed using probes specific to the 7S rRNA
precursor and to the 5’ ETS, respectively. Intermediates of 5.8S rRNA processing and 5’ ETS
degradation accumulate in an rrp6 deletion strain and in the D551N mutant, since Rrp6p and the
exonuclease activity of Rrp44p have been shown to be required for a functional nuclear
exosome. In contrast to these strains, the 5.8S rRNA and the 5’ ETS were efficiently processed
and degraded, respectively, in the strain containing the 34-1001 truncation (Figure 6.7). This
suggests that the first 33 residues of Rrp44p are not needed for the RNA processing and
degradation functions of the nuclear exosome.
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Figure 6.6: The first 33 residues of Rrp44p are not needed for nonstop mRNA
degradation.
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Figure 6.6: The first 33 residues of Rrp44p are not needed for nonstop mRNA degradation.
An rrp44 deletion strain complemented by a plasmid encoding residues 34 to 1001 was
transformed with the his3-nonstop reporter. Transformants were spotted onto media containing,
or lacking, histidine and grown for several days. Growth of rrp44 truncation was compared to
two controls strains, a ski7 deletion and wild-type RRP44. Growth on media lacking histidine
indicates that the nonstop mRNA degradation machinery is not functional.
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Figure 6.7: first 33 residues of Rrp44p are not needed for the RNA processing or RNA
degradation activities of the nuclear exosome.
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Figure 6.7: The first 33 residues of Rrp44p are not needed for the RNA processing or RNA
degradation activities of the nuclear exosome. The indicated rrp44 mutants were expressed in
an rrp44 deletion strain. RNA was isolated and analyzed by Northern blot analysis with probes
that hybridize to the 7S precursor of 5.8S rRNA (above), the 5’ ETS of the rRNA (middle) and
the RNA subunit of the signal recognition particle (SCR1; below). RNA processing and RNA
degradation in the rrp44 mutants was compared to two control strains, an rrp6 deletion and wildtype RRP44. The relative levels of the 7S pre-rRNA and the 5’ ETS were normalized for loading
using the SCR1 signal.
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At least one of the putative nuclear localization signals (NLSs) of Rrp44p is needed for
viability.
The exosomes’ presence in the nucleus suggests that at least one exosome subunit has an
NLS. Indeed, Rrp44p has four putative NLSs spread throughout the protein. The first NLS is in
the far N-terminus of Rrp44p, while the second and third are in the cold shock domains (CSD1
and CSD2, respectively). The fourth putative NLS is in the C-terminal S1 domain, one of the
three putative RNA binding domains (Figure 6.8A). To determine whether these NLSs are
required for viability, an N- and C-terminal truncation of Rrp44p were generated. Specifically,
the N-terminal truncation, 13-1001, lacks the first putative NLS and the C-terminal truncation, 1235, lacks the second, third, and fourth putative NLS. These truncations were transformed into
an rrp44# [RRP44, URA3] strain. Transformants were then spotted onto media containing 5FOA and grown for several days. Growth of the rrp44 truncations was compared to two controls,
empty vector and wild-type RRP44. The 13-1001 truncation had no obvious growth defect,
whereas the 1-235 truncation had a slow growth phenotype (Figure 6.8B). The slow growth of
the 1-235 truncation has been previously reported (see Chapter 3; Schaeffer et al., 2009) and is
likely due to a lack of Rrp44p exonuclease activity. These results suggest that none of the
putative NLSs of Rrp44p are required for viability, but does not exclude the possibility that these
NLSs are redundant.
To determine whether cells require at least one putative NLS to survive, an N- and Cterminal truncation, 13-235, was generated and tested for complementation of an rrp44#
[RRP44, URA3] strain. Growth of the 13-235 truncation was compared to four controls, empty
vector, wild-type RRP44, the 13-1001 truncation, and the 1-235 truncation. The 13-235
truncation resulted in no growth (Figure 6.8B), however, this lack of complementation was not
due to a lack of protein expression, as the 13-235 truncation was expressed at levels higher than
wild-type Rrp44 (Figure 6.8C). These results suggest that any of the putative NLSs of Rrp44p
are sufficient for viability, however, the absence of all putative NLSs results in a nonfunctional
Rrp44p, and thus, no cell growth.
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Figure 6.8: At least one of the putative localization signals (NLSs) of Rrp44p is needed
for viability.
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Figure 6.8: At least one of the putative localization signals (NLSs) of Rrp44p is needed for
viability. A, A schematic representation of the putative NLSs of Rrp44p. B, An rrp44 deletion
strain complemented by full-length RRP44 on a plasmid with a URA3 marker was transformed
with plasmids encoding each of the depicted truncations. Transformants were spotted onto media
containing 5-FOA and control media (SC –LEU –URA + 2% dextrose), and grown for several
days. Growth of the rrp44 truncations was compared to two controls, empty vector and wild-type
RRP44. Growth on 5-FOA indicates that truncated Rrp44p can carry out the essential function of
Rrp44p. C, Whole-cell lysate was obtained from a strain containing the C-terminally TAPtagged 13-235 Rrp44p truncation described in (A) and was analyzed by Western blot analysis
with antibodies specific to Protein A to detect Rrp44p and to Pgk1p as a loading control.
Expression of the Rrp44p truncated protein was compared to wild-type Rrp44p.
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DISCUSSION
Residues 34 to 46 are needed for the essential function of Rrp44p.
The results shown in this Chapter indicate that while the first 33 residues of Rrp44p are
not essential, conserved residues 34 to 46 of the linker region are required for viability. Further
analysis showed that although deletion of the linker results in a lack of cell growth, mutating six
of the most conserved residues of this region had no effect on cell viability. These differences in
growth may be because the residues of the linker region participate in redundant protein-protein
interactions that are required for viability. In support of this, the N-terminus of Rrp44p is needed
for interaction with the exosome (see Chapter 5; Lehner and Sanderson, 2004; Schneider et al.,
2009; Wang et al., 2007).
An alternate explanation for why the 47-1001 truncation fails to support viability is that
this truncated protein may be non-functional. Although this N-terminal truncation is expressed,
there is a possibility that the protein is misfolded, and thus, causes a decrease in protein function.
The N-terminus is one of many regions of Rrp44p that are needed for exosome interaction.
Since both the 34-1001 and 47-1001 truncations do not interact with the exosome, the
data presented here can be interpreted in one of two ways. It may be that only the first 33
residues of Rrp44p are needed to bind the core exosome. Alternatively, this region and the linker
region (residues 1 to 46) may be required for exosome interaction (see Chapter 7). In support of
this, four of the most conserved residues of the linker region have been implicated in exosome
interaction (Bonneau et al., 2009).
Because Rrp44p loosely associates with the exosome (Allmang et al., 1999b), interaction
of the N-terminal truncations of Rrp44p with the exosome was tested under low and high salt
conditions (50 mM and 1 M, respectively). The inability of both truncations to interact with the
exosome, even under low salt conditions, suggests that at least the first 33 residues of Rrp44p are
necessary for exosome association.
The observation that the 34-1001 truncation has no obvious growth defect, but is unable
to interact with the exosome, may mean that association of Rrp44p with the exosome is not
required for viability. In support of this, Rrp44p does not co-purify with exosomes in humans,
Arabidopsis, or trypanosomes (Allmang et al., 1999b; Chekanova et al., 2002; Estevez et al.,
2001). Additionally, human Rrp44p can complement a yeast rrp44 mutant (Shiomi et al., 1998).
Alternatively, the interaction between Rrp44p and the exosome may be essential, with multiple
regions of Rrp44p redundant in exosome interaction. In support of this, it has been previously
shown that, in addition to the N-terminus of Rrp44p, the CR3 region (Lehner and Sanderson,
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2004; Schneider et al., 2009), nuclease domains, and CSDs (Wang et al., 2007) of Rrp44p are
needed for exosome interaction. Therefore, it seems that the N-terminus is just one of many
regions/domains that mediates the interaction between Rrp44p and the exosome.
The functional interaction between the N-terminus and the nuclease domains of Rrp44p
The first 33 residues, and at least three of the six conserved residues of the linker region
(E38, D44, and I45), are not needed for endonuclease activity. Mutations of the other three linker
residues (Y40, L41, and R42), however, are synthetically lethal with a C-terminal truncation that
lacks the exonucleolytic RNB domain of Rrp44p but not with the D551N mutant that abolishes
Rrp44p exonuclease activity. A mutant that is synthetically lethal with an Rrp44p mutant that
lacks exonuclease activity may be in a residue or region that is needed for endonuclease activity.
This genetic interaction can occur because cells require at least one nuclease activity of Rrp44p
to survive. Therefore, although the results of these growth assays differ, it is possible that Y40,
L41, and R42 are needed for the endonuclease activity of Rrp44p (see Chapter 7).
Another explanation as to why the Y40A, L41A, and R42A mutants are synthetically
lethal with a C-terminal truncation that lacks the RNB domain is that these linker residues and
the RNB domain make redundant contacts with the core exosome or exosome cofactor. If the
interaction between Rrp44p and the exosome/exosome cofactor is required for viability,
mutating these linker residues alone, or in combination with D551N, would still allow Rrp44p to
associate with the exosome/exosome cofactor and, therefore, would not affect viability. In
contrast, mutating these residues in a truncation that lacks the RNB domain may mean that
Rrp44p is no longer able to interact with the exosome/exosome cofactor, resulting in a synthetic
lethal phenotype (see Chapter 7).
While the functional interaction between the N-terminus of Rrp44p and the
endonucleolytic PIN domain is still unclear, the data presented in this Chapter indicate that the
first 33 residues of Rrp44p are not needed for exonuclease activity. Specifically, two different
growth assays show that there is no genetic interaction between these residues and the RNB
domain of Rrp44p.
The essential function of Rrp44p is likely to be in the nucleus.
Although the essential function of Rrp44p and the exosome is not yet known, the finding
that Rrp44p requires at least one putative NLS for viability suggests that the essential function of
Rrp44p is in the nucleus. Despite the lack of growth in a strain containing a truncation that lacks
all four putative NLSs, 13-235, the data presented here do not exclude the possibility that this
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truncated protein can still localize to the nucleus. Even if this truncated protein does localize to
the nucleus, it would still be unclear why this truncation is unable to support cell growth.
In support of the essential function of Rrp44p being in the nucleus, none of the known
cytoplasmic exosome functions are essential. The data presented here do not exclude the
possibility, however, that an unidentified cytoplasmic exosome function is required for viability.
In contrast to the known functions of cytoplasmic exosome, the end products of RNA processing
by the nuclear exosome are required for viability, specifically the formation of the 5.8S rRNA.
Several studies, however, suggest that 5.8S rRNA processing is not the essential function of
Rrp44p, namely because when Rrp44p is depleted or the exonuclease activity of Rrp44p is
abolished, 5.8S rRNA is still produced. Likewise, depleting Rrp44p results in defects in snRNA,
snoRNA, and tRNA processing, however, there these mature RNAs are always produced
(Allmang et al., 1999a; Allmang et al., 1999b; de la Cruz et al., 1998; Dziembowski et al., 2007;
LaCava et al., 2005; Lebreton et al., 2008; Mitchell et al., 1997; Mitchell et al., 1996; Schaeffer
et al., 2009; Schneider et al., 2009; van Hoof et al., 2000a). This suggests that there are
redundant pathways to process these RNAs.
The nuclear exosome is also involved in the degradation of aberrantly processed RNAs,
including rRNA, sn/snoRNA, tRNA and mRNA. It is possible that the essential function of
Rrp44p is the degradation of aberrant RNAs in the nucleus. In support of this, the degradation of
these RNAs requires the TRAMP complex, a nuclear cofactor complex that is also required for
cell viability (Castano et al., 1996; Inoue et al., 2000; Liang et al., 1996).
Because the nuclear RNAs targeted for processing and degradation by Rrp44p are
crucial in many aspects of gene expression, including splicing and translation, there are likely
redundant pathways to ensure these nuclear RNAs are efficiently processed and rapidly
degraded, when needed. Because Rrp44p is needed for the processing and degradation of a
variety of nuclear RNAs, the essential function of Rrp44p may be a combination of nuclear RNA
processing reactions and/or the degradation of multiple RNAs, instead of just one specific RNA
substrate. For a more detailed discussion of the essential function of Rrp44p, see Chapter 7.
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Chapter 7: Conclusions and Perspectives
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SUMMARY AND FUTURE DIRECTIONS
The endoribonucleolytic PIN domain of Rrp44p is required for cell survival.
The N-terminus of Rrp44p contains a PIN domain, which prior to this study, had not
been characterized in eukaryotic Rrp44p. PIN domain-containing proteins in other organisms
have nuclease activity. Specifically, these enzymes coordinate a divalent cation and catalyze the
cleavage of DNA or ssRNA (Arcus et al., 2004; Bleichert et al., 2006; Daines et al., 2007; Fatica
et al., 2004; Glavan et al., 2006; Levin et al., 2004). Because Rrp44p has the conserved acidic
residues of the PIN domain active site, it was hypothesized that the PIN domain of Rrp44p may
have nuclease activity. Through a collaboration with Dr. Cecilia Arraiano’s laboratory (Instituto
de Tecnologia Química e Biológica [ITQB]; Lisbon, Portugal), the data presented here show that
the PIN domain of Rrp44p has endoribonuclease activity. It is likely that this second nuclease
active site was not previously identified because it is detectable under different conditions than
the exoribonuclease activity of Rrp44p. Despite three separate studies that have identified the
endonuclease activity of Rrp44p (Lebreton et al., 2008; Schaeffer et al., 2009; Schneider et al.,
2009), the substrates of the PIN domain have not yet been identified. The endo- and exonuclease
activities of Rrp44p either act on separate substrates or on some of the same substrates.
Additionally, the endonuclease activity may prefer RNA substrates that have not yet been
identified as exosome substrates.
Although the catalytic activity of the PIN domain is not required for viability, the Cterminus of the PIN domain, specifically residues 203 to 235, is needed for cell survival. This
may be because this region is needed for interaction with the core exosome, an exosome
cofactor, and/or an RNA substrate. In support of this, the PIN domain of Rrp44p has been shown
to mediate interaction with the exosome (Schneider et al., 2009).
The exonuclease activity of Rrp44p is needed for a functional nuclear and cytoplasmic
exosome.
When it was discovered in 2007, the catalytically active RNB domain of Rrp44p was
shown to be responsible for the 3’ to 5’ exonuclease activity of the exosome (Dziembowski et
al., 2007). In support of this, the data presented here also show that the exonuclease activity of
Rrp44p is needed for exosome-mediated 3’ to 5’ mRNA degradation. Because of the importance
of this nuclease activity in general mRNA turnover, these findings reveal that Rrp44p is a key
post-transcriptional regulator of eukaryotic gene expression.
In addition to the important role the exonuclease activity of Rrp44p plays in the
cytoplasm, the results presented here also indicate that the exonuclease activity is needed for
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metabolism of the yeast 35S rRNA precursor in the nucleus. Specifically, the catalytic activity of
the RNB domain of Rrp44p is needed for the degradation of the 5’ ETS and for the processing of
the 7S pre-rRNA to form the mature 5.8S rRNA species. Importantly, other studies corroborate
these findings (Dziembowski et al., 2007; Lebreton et al., 2008; Schneider et al., 2009). In
further support of a role for the exonuclease activity of Rrp44p in the nucleus, the catalytic RNB
domain of Rrp44p genetically interacts with the nuclear exosome cofactor, Rrp6p. Rrp6p also
possesses exoribonuclease activity and is needed for many of the RNA processing and
degradation reactions that occur in the nucleus (Allmang et al., 1999a; Briggs et al., 1998;
Butler, 2002; Fatica et al., 2000; van Hoof et al., 2000a). The genetic interaction between these
two nucleases suggests that they may have overlapping functions, however, a recent study
suggests that the physical interaction between Rrp44p and Rrp6p is needed for the metabolism of
only a few Rrp6p substrates (Callahan and Butler, 2008).
Determining the RNA substrates of the endo- and exonuclease activities of Rrp44p
It is not yet known whether the endo- and exonuclease activities of Rrp44p are involved
in the other RNA processing and degradation reactions of the exosome. Specifically, the nuclear
exosome is involved in processing RNA precursors to form small, stable, mature RNA species,
as well as in the degradation of improperly processed forms of these, and other, RNAs. In
contrast, the cytoplasmic exosome is strictly involved in mRNA degradation, where it is
involved in general mRNA decay to rid the cell of transcripts that are no longer needed, and in
mRNA surveillance, where it degrades aberrant transcripts that can have potentially deleterious
effects on the cell. Future studies of Rrp44p should focus on the involvement of its nuclease
activities in these cellular RNA processing and degradation reactions.
Determining the cytoplasmic RNA substrates of Rrp44p
In addition to its role in general mRNA turnover, the cytoplasmic exosome is involved
in RNA surveillance pathways, in which it rapidly degrades aberrant transcripts. An example of
this is the nonsense-mediated decay (NMD) pathway. Here, transcripts that contain premature
termination codons (PTCs) are targeted for degradation by the cytoplasmic exosome (Mitchell
and Tollervey, 2003; Takahashi et al., 2003). To determine whether the nuclease activities of
Rrp44p are involved in this RNA surveillance pathway, the stability of a representative PTCcontaining transcript should be measured in strains containing the catalytically inactive nuclease
point mutants. Briefly, the GAL::pgk1pG-PTC reporter should be transformed into rrp44
deletion strains that are complemented by the D171A and D551N mutants. The GAL::pgk1pG147

PTC reporter contains a premature termination codon in the open reading frame of 3phosphoglycerate kinase (PGK1) and a polyguanine (pG) tract to distinguish between the
reporter and the endogenous transcript (Takahashi et al., 2003). Because this reporter is under
the control of the galactose promoter, the GAL::pgk1pG-PTC transcript is expressed in media
containing galactose, however, its transcription is rapidly shut off in media containing dextrose.
Therefore, to determine the stability of the transcript, strains initially grown in galactose should
be shifted to media containing dextrose. As a control, the stability of the GAL::pgk1pG-PTC
transcript in these strains should be compared to the stability of the reporter in two control
strains, a wild-type strain and a strain with a defective cytoplasmic exosome. RNA should then
be isolated from these strains at various times and subjected to agarose formaldehyde gel
electrophoresis, followed by Northern blot analysis. To determine whether strains containing the
catalytically inactive nuclease point mutants are defective in NMD, blots should be hybridized
with a probe specific to pgk1pg, and SCR1 as a loading control. Stabilization of the
GAL::pgk1pG-PTC transcript in strains containing the D171A and/or D551N mutants would
suggest that the endo- and/or exonuclease activities of Rrp44p are needed for NMD.
The cytoplasmic exosome also has an antiviral function, whereby the exosome is
thought to degrade unadenylated viral RNA, including the L-A virus and the M satellite RNA. M
satellite RNA encodes a protein toxin, which is secreted from cells, and ultimately kills
surrounding uninfected cells. The antiviral activity of the exosome was initially discovered in a
screen for “superkiller” mutants, or mutants that are able to more efficiently kill surrounding
cells (Toh and Wickner, 1980). This screen identified the SKI genes, several of which encode
exosome subunits and cytoplasmic exosome cofactors, including Ski7p and the Ski complex.
Because the Ski proteins are involved in mRNA degradation, it is thought that the exosomes
antiviral activity stems from its ability to degrade viral RNAs (Brown et al., 2000; Meaux and
van Hoof, 2006).
To test whether the nuclease activities of Rrp44p are needed for viral RNA degradation,
and thus the antiviral activity of the exosome, a killer assay should be performed (Figure 7.1;
Schaeffer et al., 2008). In this assay, infected, toxin-producing cells that contain the D171A or
D551N mutant should be spotted on a lawn of uninfected cells. As a control, (i) an uninfected
strain, (ii) a wild-type, toxin-producing strain, and (iii) a ski7 deletion strain should also be
spotted on the lawn of uninfected cells. The premise of this assay is that infected cells secrete the
killer toxin that then kills the surrounding uninfected cells, thus creating a halo, or zone of
clearance. In this assay, the uninfected control strain would not create a halo. In contrast, the ski7
deletion strain, a known “superkiller” strain, would produce a halo larger than the wild-type,
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Figure 7.1: Schematic representation of the yeast killer assay.
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Figure 7.1: Schematic representation of the yeast killer assay. The involvement of the
nuclease activities of Rrp44p in viral RNA degradation should be analyzed using the killer assay.
First, a lawn of uninfected cells should be plated. Next, tester strains, including (i) an uninfected
strain (ii) a wild-type, infected strain (iii) a ski7 deletion strain and (iv) infected strains
containing the catalytically inactive rrp44 nuclease mutants (rrp44*; rrp44 D171A or rrp44
D551N) should be spotted on the lawn of uninfected cells. Infected cells secrete a killer toxin
that then kills the surrounding uninfected cells, thus creating a halo, or zone of clearance. The
ski7 deletion strain, a known “superkiller” strain, produces a halo larger than the wild-type,
infected strain.
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infected strain. If the halo produced by the strain containing the D171A and/or D551N mutants is
similar to the ski7" strain, this would suggest that the endo- and/or exonuclease activities of
Rrp44p are required for viral RNA degradation and may, therefore, be needed for the antiviral
function of the exosome.
Determining the nuclear RNA substrates of Rrp44p
The exonuclease activity of Rrp44p is required for 5.8S rRNA processing and for the
degradation of the 5’ ETS, whereas the endonuclease activity does not seem to be required for
the metabolism of the 35S rRNA precursor. The data presented here, however, do not exclude
the possibility that the nuclease activities of Rrp44p are needed for the other RNA processing
and degradation reactions of the nuclear exosome (Table 7.1). In addition to processing and
degrading the 35S rRNA precursor, the nuclear exosome processes and degrades snRNAs and
three different types of snoRNAs, including those that are independently transcribed, snoRNAs
that are intron-derived, and polycistronic snoRNAs (Allmang et al., 1999a; Allmang et al.,
1999b; de la Cruz et al., 1998; Mitchell et al., 1997; van Hoof et al., 2000a). The nuclear
exosome is also involved in RNA surveillance, whereby it rapidly degrades aberrantly processed
forms of these RNAs (Egecioglu et al., 2006; LaCava et al., 2005). The exosome also maintains
the fidelity of gene expression by degrading unspliced mRNAs (Bousquet-Antonelli et al., 2000)
and cryptic unstable transcripts (CUTs), which are the result of transcription of intergenic
regions (Davis and Ares, 2006).
To determine if the nuclease activities of Rrp44p are needed for these nuclear RNA
processing and degradation reactions, RNA should be isolated from a strain containing the
D171A mutant and a strain containing the D551N mutant. As a control, RNA should also be
isolated from a wild-type strain and a strain with a defective nuclear exosome. The RNA from
these strains should be subjected to denaturing urea-polyacrylamide gel electrophoresis,
followed by Northern blot analysis. To determine if the Rrp44p nuclease activities are needed for
the processing and/or degradation of snRNAs, snoRNAs, unspliced mRNA, and/or CUTs, blots
should be hybridized with probes specific to known nuclear exosome substrates including: (i)
three snRNAs, U1, U4, and U5 (ii) at least one of each of the different types of snoRNAs,
including snR33, U18, and U14 (iii) the intron of a typically spliced mRNA, such as RP51A and
(iv) a CUT, such as SGR1. The presence of RNA processing and/or degradation intermediates in
strains containing the D171A and/or D551N mutants would suggest that the endo- and/or
exonuclease activities of Rrp44p are needed for these nuclear RNA metabolism reactions.
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Degradation

Unspliced mRNAs

rna14 encodes CFI, a factor needed for 3'-end mRNA cleavage and polyadenylation

¥

RP51A encodes a ribosomal protein of the small (40S) subunit

˚HSP104 encodes a heat shock protein and is a known susbtrate of CF1

ˆSGR1 is a non-coding, promoter-associated transcript

‡

*trm6 encodes m1A methyltransferase, which is needed for proper tRNAiMet modification

Degradation

mRNAs with improperly processed 3'-ends

Degradation

Cryptic Unstable Transcripts (CUTs)

rrp44 D171A
rrp44 D551N

rrp44 D551N, rna14.1‡

RP51A¥

HSP104˚

SGR1ˆ

rrp44 D171A
rrp44 D551N
rrp44 D171A, rna14.1‡

tRNAiMet

-snR33 (ITsnoRNA)
-U18 (I-DsnoRNA)
-U14 (PsnoRNA)

rrp44 D171A, trm6-504*
rrp44 D551N, trm6-504*

Processing; degradation of rrp44 D171A
aberrant snoRNAs
rrp44 D551N
Degradation

-Independently transcribed snoRNAs (ITsnoRNAs)
-Intron-dervied snoRNAs (I-DsnoRNAs)
-Polycistronic snoRNAs (PsnoRNAs)

U1, U4, U5

Strain to test role of Rrp44p
Northern blot analysis
endonuclease in RNA
with a probe specific to:
metabolism

Processing; degradation of rrp44 D171A
aberrant snRNAs
rrp44 D551N

Role of the exosome in RNA
metabolism

Hypomodified initiator tRNAMet

snoRNAs

snRNAs

Nuclear exosome substrate

Table 7.1: Strains and probes needed to test the role of the Rrp44p nucleases in nuclear RNA metabolism

In addition to degrading improperly processed snRNAs, and snoRNAs, the nuclear
exosome also degrades improperly modified tRNAs, including the initiator tRNAiMet (Table 7.1).
This hypomodified tRNA accumulates in cells that have a defective m1A methyltransferase,
which results in a lack methylation of adenosine at position 58 of the T$C loop (Kadaba et al.,
2004; Kadaba et al., 2006). To test whether the endo- and/or exonuclease activities of Rrp44p are
needed to degrade these transcripts, the D171A and D551N mutants should be separately
combined with a temperature-sensitive mutant of the m1A methyltransferase, trm6-504. RNA
should be isolated from a wild-type strain, a strain containing only the trm6-504 mutant, a strain
containing the D171A trm6-504 double mutant, and a strain containing the D551N trm6-504
double mutant. The RNA from these strains should be subjected to denaturing ureapolyacrylamide gel electrophoresis, followed by Northern blot analysis with a probe specific to
the initiator tRMAiMet. The presence of hypomodified tRNAiMet in strains containing the D171A
and/or D551N mutants would suggest that the endo- and/or exonuclease activities of Rrp44p are
needed for the degradation of improperly modified tRNAs.
Lastly, the nuclear exosome is involved in degrading mRNAs that have defects in 3’-end
processing (Table 7.1; Libri et al., 2002; Torchet et al., 2002). These types of transcripts
accumulate in cells that are defective in transcription termination, mRNA cleavage, or
polyadenylation. To test whether the nucleases activities of Rrp44p are needed to degrade these
transcripts, the D171A and the D551N mutants should be separately combined with a
temperature-sensitive mutant of rna14.1, which encodes an mRNA cleavage and
polyadenylation factor, CFI (Minvielle-Sebastia et al., 1994; Minvielle-Sebastia et al., 1991). A
strain containing only the rna14.1 mutant does not accumulate 3’-extended transcripts due to the
rapid degradation of these aberrant mRNAs by the nuclear exosome. In contrast, a strain
containing rna14.1 and an exosome mutant, does accumulate these transcripts (Torchet et al.,
2002). To determine whether the endo- and/or exonuclease activities of Rrp44p degrade these
aberrant mRNAs, RNA should be isolated from a strain containing only the rna14.1 mutant, a
strain that contains the rna14.1 mutant that also lacks a functional nuclear exosome, a strain
containing the D171A rna14.1 double mutant, and a strain containing the D551N rna14.1 double
mutant. The RNA from these strains should be subjected to denaturing urea-polyacrylamide gel
electrophoresis, followed by Northern blot analysis. Specifically, blots should be hybridized with
a probe specific to HSP104, a transcript known to be processed at its 3’-end by CFI (Libri et al.,
2002). The presence of 3’-extended HSP104 species in strains containing the D171A and/or
D551N mutants would suggest that the endo- and/or exonuclease activities of Rrp44p are needed
for the degradation of mRNAs that have defects in 3’-end processing.
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Global approaches to determining the RNA substrates of Rrp44p
The approaches described above should be useful in determining if the nuclease
activities of Rrp44p are needed to degrade specific RNA substrates, however, these approaches
are limited to only known nuclear exosome substrates. Therefore, two more global approaches
should be taken to determine the substrates of nuclease activities of Rrp44p. First, a tiling
microarray should be performed on a wild-type strain, a strain containing the D171A mutant, and
a strain containing the D551N mutant. Comparing the results from the catalytically inactive
nuclease mutants to the wild-type strain will yield RNA substrates that are upregulated in the
nuclease mutants, and are therefore, degraded by the Rrp44p endo- and/or exonuclease.
Another approach to detect the RNA substrates of the Rrp44p nucleases is to examine
the genetic interactions that occur in a wild-type strain but do not occur in strains containing the
D171A or D551N mutants. To do this, a heterozygote diploid-based synthetic lethality analysis
with microarrays (dSLAM) should be performed (Figure 7.2; Pan et al., 2007). Specifically, the
D171A and D551N mutants should be introduced, individually, into a population of
approximately 6000 heterozygous diploid Yeast Knockout (YKO) mutants. The heterozygote
diploid double mutants should then be sporulated and the resultant haploid double mutants
should be studied for synthetic lethality by microarray analysis. Briefly, the unique 20 nucleotide
sequences flanking the deletion cassette of the YKO mutants, termed “molecular barcodes”,
should be PCR amplified with a Cy3-labeled primer from the haploid double mutants
(Experiment) and a Cy5-labeled primer from the haploid single knockout mutants (Control).
Both PCR products should be hybridized to a microarray chip containing each of the “molecular
barcodes”. A synthetic lethal interaction should be observed by high Control-to-Experiment Cy5
hybridization signal intensity (Pan et al., 2004).
The CR3 region of Rrp44p may be a putative zinc binding domain.
The N-terminus of Rrp44p contains a CR3 region that contains three conserved cysteine
residues (C47, C52, and C55). Despite extensive functional analyses of Rrp44p over the past
three years, no information exists on the CR3 region in Rrp44p or in any other protein. Further
complicating the study of this region is the lack of structural data on the N-terminus of Rrp44p.
Although there are two published crystal structures of the catalytic subunit, neither contain the
N-terminus in its entirety. Because of the lack of functional and structural data on this region, it
is still not known how the CR3 region functions in Rrp44p, or the exosome, whether this region
adopts a unique fold, or if this region consists of more than three cysteine residues.
Despite the lack of the entire N-terminus, the latest crystal structure of Rrp44p (Bonneau
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Figure 7.2: Schematic representation of the heterozygote diploid-based synthetic
lethality analysis with microarrays (dSLAM) technique.
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Figure 7.2: Schematic representation of the heterozygote diploid-based synthetic lethality
analysis with microarrays (dSLAM) technique. The genetic interactions of the Rrp44p
nucleases should be analyzed using dSLAM. Specifically, a plasmid encoding the catalytically
inactive nuclease point mutations of RRP44 (rrp44*; rrp44 D171A or rrp44 D551N) should be
transformed into a population of approximately 6000 heterozygous diploid Yeast Knockout
(YKO) mutants. The heterozygote diploid double mutants should then be sporulated and
haploids should be selected. To determine whether the double mutants are synthetically lethal,
the unique 20-nucleotide sequences flanking the deletion cassette of the YKO mutants, termed
“molecular barcodes”, should be PCR amplified. In the double mutants, a Cy3-labeled primer
should be used for amplification whereas a Cy5-labeled primer should be used to PCR amplify
the “molecular barcodes” in the single mutants. Both PCR products should be hybridized to a
microarray chip containing each of the “molecular barcodes”. A synthetic lethal interaction
should be observed by high Cy5 hybridization signal intensity.
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et al., 2009) provided at least two interesting findings. First, the second and third residues of the
CR3 region are modeled to form a disulfide bond, however, the data presented here suggest that
the disulfide bond is not required for the function of Rrp44p, or the exosome. In addition, the
electron density of the crystal structure of Rrp44p is not defined enough to determine whether
the residues of the CR3 region form a disulfide bond with each other or with other residues of
Rrp44p. The second interesting observation of the Rrp44p crystal structure is that the three
cysteine residues of the CR3 region are in close proximity to histidine 184 (H184). This spatial
organization is consistent with coordination of a zinc ion, however, no metal ion was present in
the crystal structure. The lack of a metal ion may be an artifact of the protein purification
conditions that were used, and does not exclude the possibility that the CR3 region and H184
coordinate a metal. To determine whether Rrp44p coordinates a zinc ion, a GST-fusion of fulllength Rrp44p should be expressed and purified from E. coli. The purified protein sample should
then be subjected to atomic absorption spectroscopy, a technique used to determine the
concentration of a particular metal element in a sample (Sperling and Welz, 1999). Briefly, this
technique transforms a liquid protein sample into an atomic gas and then analyzes the free atoms
of the protein sample. As an internal control, this technique should detect the presence of Mn2+,
which is coordinated by the PIN domain active site, and Mg2+, which is coordinated by the RNB
domain active site. If these metals are not detected, the GST-fusion of Rrp44p should be purified
using different purification conditions to ensure that the lack of metals is not due to the protein
purification conditions.
The coordination of a zinc ion may be needed, directly or indirectly, for Rrp44p protein
stabilization, interaction with the exosome, and/or for Rrp44p nuclease activity. Indeed,
preliminary evidence suggests that endonuclease activity of Rrp44p is stimulated by the addition
of zinc (Filipa Reis and Dr. Cecilia Arraiano, personal communication). In addition, mutation of
the three cysteine residues of the CR3 region results in growth defects and defects in exosome
interaction and function. However, the requirement for the CR3 region in exosome interaction
may be indirect. If the coordination of a zinc atom between the CR3 region and H184 is needed
for proper folding, the CR3 region in the triple CR3 mutant may not be folded correctly, which
could also cause the upstream linker region to misfold. Since this region contains residues that
contact the exosome (Y40, L41, R42, and D44), this misfolding could disrupt exosome
interaction. Therefore, further studies are needed to determine whether the CR3 region is directly
involved in exosome interaction or if the lack of interaction seen in the triple CR3 mutant is a
secondary consequence of protein misfolding.
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Several experiments, including in vivo genetic analysis and in vitro biochemical nuclease
assays, also suggest that the CR3 region is needed for the nuclease activities of Rrp44p.
Therefore, the overall conclusion is that the defects seen in the triple CR3 mutant may be
explained by the lack of coordination of a zinc ion.
The CR3 region of Rrp44p may be needed for 3’ to 5’ mRNA degradation because this
region may interact with a protein involved in 3’ to 5’ mRNA decay.
The observation that mutating the three cysteine residues of the CR3 region is
synthetically lethal with the D171A mutant and a mutant that inactivates the 5’ to 3’ mRNA
degradation pathway, suggests that the CR3 region is needed for exonuclease activity of Rrp44p.
Although the CR3 region and the active site of the RNB domain are not in close proximity in the
crystal structure, the CR3 region may be needed to interact with cytoplasmic exosome cofactors
that are required for 3’ to 5’ mRNA degradation, including Ski7p and the Ski complex. It has
been previously reported that Ski7p interacts with the exosome (Araki et al., 2001), however, an
interaction between the exosome and the Ski complex has not yet been shown. To determine
whether the CR3 region of Rrp44p interacts with these cofactors, Rrp44p and the cytoplasmic
exosome cofactors should be C-terminally tagged. Specifically, Ski7p and members of the Ski
complex, Ski2p, Ski3p, and Ski8p, should be C-terminally Myc-tagged, whereas wild-type
Rrp44p and the triple CR3 mutant should be C-terminally TAP-tagged. Wild-type Rrp44p, the
triple CR3 mutant, and a strain containing an empty vector should be purified. Proteins bound to
Rrp44p should be eluted, subjected to SDS-PAGE, and Western blot analysis should be
performed. Specifically, interactions between Rrp44p, Ski7p, and the Ski complex should be
detected using antibodies specific to the Myc tag.
Targeted co-purification of proteins bound to Rrp44p followed by Western blot analysis
is one way to detect interactions between Rrp44p and the cytoplasmic exosome cofactors,
however, a limitation of this technique is that the individual proteins must be tagged. Therefore,
a more global approach should be taken to determine what proteins bind to the CR3 region of
Rrp44p. Specifically, C-terminally TAP-tagged wild-type Rrp44p and the triple CR3 mutant
should be purified and subjected to SDS-PAGE. The SDS gel should then be stained with
Coomassie Brilliant Blue. Any proteins that bind to wild-type Rrp44p, but not to the triple CR3
mutant, should be extracted and analyzed by mass spectrometry.
Another possible explanation for why the triple CR3 mutant is synthetically lethal with
the D171A mutant is that the CR3, D171A mutant protein is not expressed. A potential decrease
in expression, coupled with a loss of exosome interaction due to the triple CR3 mutation, may
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explain the lack of complementation by the CR3, D171A mutant. To determine whether the lack
of growth is an artifact of expression, the CR3, D171A mutant should be C-terminally TAPtagged and protein expression should be analyzed using SDS-PAGE and Western blot analysis.
Nonstop mRNA degradation requires Rrp44p.
A functional nonstop mRNA degradation pathway may not require the nuclease activities of
Rrp44p.
The data presented here suggest that the nuclease activities of Rrp44p are not needed for
the degradation of nonstop transcripts. These findings can be explained by one of three
possibilities. First, the nucleases may be redundant in nonstop decay. One method used to
determine whether the nuclease activities of Rrp44p are redundant in this mRNA surveillance
pathway was to measure the stability of a representative nonstop reporter in a strain that
abolishes both of the nuclease activities of Rrp44p. Specifically, the GAL::pgk1pG-nonstop
reporter was transformed into an rrp44 deletion strain that was complemented by a plasmid
encoding a temperature-sensitive allele of rrp44 (rrp44ts). This strain also contained a plasmid
encoding the D171A or D551N point mutation of Rrp44p. These strains were initially grown at
the permissive temperature (23°C) then shifted to the non-permissive temperature (37°C) for ten
hours to inactivate the rrp44ts allele. However, Northern blot analysis revealed that
GAL::pgk1pG-nonstop transcript was still unstable after the ten hour shift to the non-permissive
temperature, indicating that this time course was not sufficient to inactivate the rrp44ts allele.
Therefore, alternative means must be used to test whether nonstop transcripts are degraded when
both the endo- and exonuclease activities of Rrp44p are abolished.
Another way to test the redundancy of the Rrp44p nucleases in nonstop decay is to test
whether the double catalytically inactive D171A, D551N mutant can rescue the nonstop mRNA
decay defect of the triple CR3 mutant using the his3-nonstop growth assay. Briefly, an rrp44
deletion strain that is complemented by a plasmid encoding the triple CR3 mutation (rrp44"
C47S, C52S, C55S) will be transformed with a plasmid encoding the double D171A, D551N
point mutation. As a control, the rrp44" C47S, C52S, C55S strain will also be transformed with
plasmids encoding wild-type RRP44, the D171A mutation alone, the D551N mutation alone, and
an empty vector. The resulting strains will then be transformed with the his3-nonstop reporter,
which contains a nonstop mutation in the HIS3 open reading frame. The basis for this assay is
that the his3-nonstop transcript will be stable in a strain that is defective in nonstop mRNA
degradation, and will, therefore, be viable on media lacking histidine. Conversely, in a strain
with a functional nonstop decay pathway the his3-nonstop transcript will be rapidly degraded,
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resulting in a lack of viability on media lacking histidine. Since, independently, the nuclease
activities of Rrp44p are not required for nonstop decay, wild-type Rrp44p, the D171A mutant,
and the D551N mutant should rescue the nonstop decay defects caused by the triple CR3 mutant,
which will result in a lack of growth of these strains on media lacking histidine. In contrast, if the
nuclease activities of Rrp44p are redundant in nonstop decay, the double catalytically inactive
mutant should not be able to rescue the triple CR3 mutant, and should, therefore, be viable on
media lacking histidine.
A second explanation for why the endo- and exonuclease activities of Rrp44p are not
needed to degrade nonstop transcripts is that nonstop decay is independent of the known
catalytic activities of the cytoplasmic exosome. Under this hypothesis, a different cellular
nuclease would be responsible for the degradation of nonstop transcripts. Interestingly, a recent
genome-wide screen to identify factors involved in nonstop decay did not identify any additional
nucleases (Wilson et al., 2007).
Lastly, abolishing the nuclease activities of Rrp44p may not have an effect on nonstop
decay because Rrp6p, a known nuclear exosome cofactor, may be required for the degradation of
nonstop transcripts. Although Rrp6p is presumed to be present only in the nucleus, a small
fraction of the protein may associate with the cytoplasmic exosome. In this case, a small amount
of Rrp6p activity may be sufficient for the degradation of nonstop transcripts. In support of this,
the human homolog of Rrp6p localizes to the nucleus and the cytoplasm in human cell lines
(Lejeune et al., 2003). Additionally, Rrp6p has been shown to interact with Ski7p, a cytoplasmic
exosome cofactor required for general 3’ to 5’ mRNA degradation and nonstop mRNA decay
(Collins et al., 2007; Peng et al., 2003). To determine whether Rrp6p is involved in nonstop
decay, the stability of a representative nonstop transcript, GAL::pgk1pG-nonstop, should be
measured in an rrp6 deletion strain. As a control, the nonstop reporter should also be
transformed into a wild-type strain and a ski7 deletion strain. The aforementioned strains should
be grown in liquid media containing galactose to induce expression of the reporter and then
switched to media containing dextrose to shut off reporter transcription. RNA should then be
isolated from the strains and subject to agarose formaldehyde gel electrophoresis. Northern blot
analysis should then be performed using probes specific to pgk1pG, and SCR1 as a loading
control. If the GAL::pgk1pG-nonstop transcript has a similar half-life in the rrp6 deletion strain
as it does in the ski7 deletion strain, Rrp6p may be involved in nonstop decay, which would
suggest that it is not excluded from the cytoplasm.
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The CR3 region of Rrp44p is needed for a functional nonstop mRNA decay pathway.
Nonstop transcripts are not efficiently degraded in the triple CR3 mutant, which suggests
that the CR3 region is needed for nonstop decay. This result can be interpreted in one of two
ways. In the first interpretation, the nuclease activities of Rrp44p are redundant in nonstop
decay. In the second interpretation, the nuclease activities of Rrp44p are not required for nonstop
decay, meaning that a nuclease activity that is independent of the exosome is responsible for the
degradation of nonstop transcripts.
If the nuclease activities of Rrp44p are redundant in nonstop decay, the nonstop decay
defects observed in the triple CR3 mutant may be because the triple CR3 mutant protein is
expressed at lower levels than wild-type Rrp44p. Under this hypothesis, decreased expression of
Rrp44p could result in decreased nuclease activity, which would result in the stabilization of
nonstop transcripts. If the nuclease activities of Rrp44p are found to be redundant in nonstop
decay, the stability of a representative nonstop transcript should be analyzed in a strain that
overexpresses the triple CR3 mutant. Briefly, an rrp44 deletion strain that is complemented by a
plasmid that overexpresses the triple CR3 mutant should be transformed with the GAL::pgk1pGnonstop transcript. As a control, the GAL::pgk1pG-nonstop reporter should also be transformed
into a wild-type strain and in a ski7 deletion strain. RNA should be isolated from these strains
and subjected to agarose formaldehyde gel electrophoresis. The stability of the GAL::pgk1pGnonstop transcript should be analyzed in these strains by performing Northern blot analysis.
Specifically, blots should be hybridized with probes that are specific to pgk1pG, and SCR1 as a
loading control. If the decreased expression of the triple CR3 mutant is responsible for a nonfunctional nonstop decay pathway, the GAL::pgk1pG-nonstop transcript should be rapidly
degraded in a strain that overexpresses the triple CR3 mutant. Alternatively, stabilization of the
nonstop reporter in the strain that overexpresses the triple CR3 mutant would suggest that the
CR3 region is truly needed for nonstop decay. If the nuclease activities of Rrp44p are redundant
in nonstop decay, the latter result would not be surprising given that the CR3 region seems to be
needed for the nuclease activities of Rrp44p.
The CR3 mutant could have defects in nonstop decay even if the nuclease activities of
Rrp44p are not redundant for the degradation of nonstop transcripts. If the nuclease activities are
not redundant, another nuclease is responsible for degrading nonstop transcripts. It may be that
the CR3 region of Rrp44p interacts with this nuclease, and that this interaction is required for
nonstop decay. This hypothesis could be tested by determining whether any cellular nucleases
associate with wild-type Rrp44p but not with the triple CR3 mutant.
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Lastly, regardless of whether the nuclease activities of Rrp44p are redundant in nonstop
decay, the nonstop decay defects observed in the triple CR3 mutant may be because the CR3
region of Rrp44p is needed interact with the nonstop mRNA degradation machinery.
Specifically, the CR3 region could be tested for its interaction with the cytoplasmic exosome
cofactors, Ski7p and the Ski complex (see above).
The far N-terminus of Rrp44p is needed for viability and is only one of several regions of
Rrp44p that is required for interaction with the exosome.
The N-terminus of Rrp44p consists of the far N-terminus, which includes residues 1 to
46, a CR3 region, and a PIN domain. The structure and function of the far N-terminus is not yet
known. This region, however, does contain a linker region of conserved residues, specifically,
residues 34 to 46. The results presented here indicate that this linker region is important for
viability and that at least the first 33 residues of the far N-terminus of Rrp44p are needed for
exosome interaction. What is not yet known is which residues of the linker region are needed for
viability and whether the rest of the far N-terminus of Rrp44p mediates interaction with the
exosome.
Determining which residues of the far N-terminus of Rrp44p are needed for viability
The data presented here indicate that the linker region, which consists of the highly
conserved residues 34 to 46, is needed for viability. Interestingly, individually mutating six of
the most conserved residues of this region has no effect on cell growth. This discrepancy may be
because the residues of the linker region make redundant protein-protein interactions that are
required for viability. For example, the linker region may be needed to interact with the exosome
(Bonneau et al., 2009) and/or with an exosome cofactor. If this interaction is required for
viability, mutation of one residue would not affect cell growth, however, deletion of the entire
region would be lethal. In support of this, the data presented here and in other studies indicate
that the N-terminus is needed for interaction with the exosome (Bonneau et al., 2009; Lehner and
Sanderson, 2004; Schneider et al., 2009; Wang et al., 2007). To test whether these residues are
redundant for viability, several combinations of linker mutants would have to be generated and
tested for complementation of an rrp44# [RRP44, URA3] strain. The generation of these mutants
would be laborious given that there are six highly conserved residues, with a large number of
combinations that could be tested.
This experiment would determine whether the linker residues are redundant for viability,
but would not establish whether these residues are redundant for an essential protein-protein
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interaction. To test this would be difficult, given that a vital protein-protein interaction would
have to be identified and combinations of linker mutants would have to be tested for the lack of
this protein-protein interaction. Although the results presented here, along with several other
studies, seem to indicate that multiple regions of Rrp44p are needed for association with the
exosome, no one study has identified whether these regions are truly redundant for exosome
interaction. Additionally, it is not yet known whether the interaction between Rrp44p and the
yeast exosome is required for viability.
Determining which regions of the N-terminus of Rrp44p are needed for exosome interaction
The data shown here indicate that the first 33 residues of Rrp44p are needed for
exosome interaction, however, the data do not exclude the possibility that the entire far Nterminus of Rrp44p is needed for association with the exosome. Specifically, the linker region,
residues 34 to 46, may function with the first 33 residues to mediate the interaction between
Rrp44p and the exosome.
Therefore, to determine if the linker region of Rrp44p is also required for exosome
interaction, an exosome subunit, Rrp43p, should be C-terminally Myc-tagged. In addition, wildtype Rrp44p, the 34-1001 and 47-1001 truncations, and a truncation that lacks the conserved
stretch of linker residues, residues 34 to 46, should be C-terminally TAP-tagged and then
purified. Proteins bound to wild-type and truncated Rrp44p should be eluted and subjected to
SDS-PAGE and Western blot analysis. Specifically, the interactions between Rrp44p and the
exosome, namely Rrp43p, should be observed through the use of an antibody specific to the Myc
tag. If only the first 33 residues of Rrp44p are required for exosome interaction, wild-type
Rrp44p and a truncation lacking residues 34 to 46 would interact with the exosome. In contrast,
if the entire far N-terminus, which includes residues 1 to 46, is required to interact with the
exosome, an interaction between only wild-type Rrp44p and the exosome would be observed. If
the residues of this region make redundant contacts with the exosome, and the interaction
between Rrp44p and the exosome is essential, this result would explain why deletion of the first
46 residues of Rrp44p does not support viability.
Although the first 33 residues of the far N-terminus of Rrp44p are necessary for
association with the exosome, this region does not appear to be sufficient for exosome
interaction. Specifically, the data presented here and in other studies, indicate that the entire Nterminus of Rrp44p, including the uncharacterized far N-terminus, CR3 region, and PIN domain,
are required for exosome interaction (Schneider et al., 2009). In addition, a cryo-EM structure of
the yeast exosome suggests that the RNB domain of Rrp44p also makes contacts with the
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exosome (Wang et al., 2007). Therefore, the N-terminus is likely one of many regions of Rrp44p
that are needed for exosome interaction.
Determining the function of the three conserved residues of the far N-terminus of Rrp44p
Point mutations of three of the conserved residues of the far N-terminus (Y40A, L41A,
and R42A) are synthetically lethal with a C-terminal truncation of Rrp44p that lacks the
exonucleolytic RNB domain. Because at least one nuclease activity of Rrp44p is required for cell
viability, this finding suggests that these residues may be needed for the endonuclease activity of
Rrp44p. However, these three point mutants are not synthetically lethal with the D551N mutant,
which suggests that these residues are not needed for PIN domain nuclease activity. To
differentiate between these possibilities, the Y40A, L41A, and R42A point mutants, as well as
wild-type Rrp44p, should be expressed and purified as GST-fusions from E. coli. The purified
Rrp44p proteins should then be in incubated with a 32P 5’-end labeled A30 oligonucleotide. RNA
aliquots should be isolated at certain times and subjected to denaturing urea-polyacrylamide gel
electrophoresis for single nucleotide separation. A PhosphorImager screen should then be used
to detect endonucleolytic cleavage of the A30 substrate.
The synthetic lethality observed when these three point mutations where generated in a
C-terminal truncation of Rrp44p that lacks the RNB domain could also be because these three
linker residues and the RNB domain make redundant contacts with the exosome and/or exosome
cofactors. If the interaction between Rrp44p and the exosome/exosome cofactor are required for
viability, mutating the linker residues alone, or in combination with D551N, would still allow for
Rrp44p to make these vital protein-protein interactions, and would thus not affect viability. In
contrast, mutating these conserved residues in a truncation that lacks the RNB domain may mean
that Rrp44p is no longer able to participate these essential protein-protein interactions, resulting
in a synthetic lethal phenotype. To determine whether these regions of Rrp44p are redundant for
protein-protein interactions, the following proteins should be C-terminally TAP-tagged and
purified: wild-type Rrp44p, the individual linker point mutants, the D551N mutant, and a mutant
version of Rrp44p that combines a linker mutant with the D551N mutant. The purified proteins
should be subject to SDS-PAGE, followed by staining of the SDS gel with Coomassie Brilliant
Blue. Any proteins that bind to the individual linker mutants and the D551N mutant, but not to
the combination mutant, should be extracted and analyzed by mass spectrometry.
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Determining the essential function of Rrp44p
Thirteen years after the discovery of the exosome (Mitchell et al., 1997), its essential
function(s) is not yet known. In addition, it is not clear why the ten subunits of the exosome are
all required for viability. The essential function of Rrp44p is likely nuclear because none of the
known cytoplasmic functions of the exosome are required for viability and removing the putative
NLSs of Rrp44p results in a lack of cell growth. The data presented here, however, do not
exclude the possibility that the Rrp44p truncation that lacks the putative NLSs (13-235) can still
localize to the nucleus. To address this, the cellular localization of this truncated protein will be
determined by GFP-tagging residues 13-235. In addition to being nuclear, the essential function
of Rrp44p requires its nuclease activities, as abolishing both the endo- and exonuclease activities
of Rrp44p results in a lack of cell growth.
Although it is possible that the essential function of the exosome is distinct from that of
Rrp44p, the findings presented here suggest that the essential function of the exosome mirrors
that of Rrp44p. Specifically, Rrp44p is the only catalytic subunit of the exosome, with two
separate nuclease active sites. Since the exosome has only been shown to be involved in RNA
metabolism, the essential function of the exosome most likely requires the nuclease activity of
Rrp44p. Additionally, the likely nuclear essential function of the exosome would have to rely on
the nuclear localization of Rrp44p since Rrp44p is the only subunit that contains a putative NLS.
The data presented here suggest that the essential function of Rrp44p and the exosome is
nuclear, however, the nuclear exosome is involved in numerous RNA processing reactions.
Because the products of these processing reactions are required for cell survival, it is impossible
to know which of the processing reactions is/are needed for viability. The essential function of
Rrp44p and the exosome is likely not the processing of rRNA, snRNA, or snoRNAs because
when the exonuclease activity of Rrp44p is abolished or any of the exosome subunits are
depleted, these mature RNAs are still produced (Allmang et al., 1999a; Allmang et al., 1999b; de
la Cruz et al., 1998; Dziembowski et al., 2007; LaCava et al., 2005; Lebreton et al., 2008;
Mitchell et al., 1997; Mitchell et al., 1996; Schaeffer et al., 2009; Schneider et al., 2009; van
Hoof et al., 2000a). This is likely because there are redundant pathways for nuclear RNA
processing.
The nuclear exosome is also involved in nuclear RNA surveillance, whereby it degrades
aberrantly processed forms of RNA, as well as CUTs, and the 5’ ETS of the 35S rRNA
precursor. Therefore, it is possible that the essential function of Rrp44p, and the exosome, is the
degradation of aberrant nuclear RNAs. In support of this, the degradation of these RNAs requires
the TRAMP complex, a nuclear cofactor complex that is also essential for cell survival (Castano
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et al., 1996; Inoue et al., 2000; Liang et al., 1996). To test whether the degradation of aberrant
RNAs is required for viability is difficult given that these aberrant RNAs arise spontaneously
and are present at low levels. Additionally, this would be difficult to test because there are so
many aberrant RNAs that are degraded by the nuclear exosome. If the essential function of
Rrp44p and the exosome is the degradation of aberrant RNAs, cell viability would likely require
the efficient degradation of more than one aberrant RNA.
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CONCLUDING REMARKS
This dissertation has contributed to the field of eukaryotic RNA metabolism by
providing a detailed genetic and biochemical analysis of the catalytic subunit of the eukaryotic
RNA degrading exosome, Rrp44p. Specifically, this work has described a novel nuclease
activity of Rrp44p and has shown that the regions/domains of Rrp44p have specific functions in
both the cytoplasmic and nuclear exosome. Further, this work has uncovered the roles of Rrp44p
in eukaryotic RNA metabolism, as a post-transcriptional regulator of gene expression and as an
RNA surveillance protein to maintain the fidelity of gene expression.
Finally, this dissertation work provides a foundation on which to develop further
experiments to elucidate the RNA substrates of Rrp44p and to structurally, and functionally,
define the CR3 region of Rrp44p.
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Appendix: The essential function of Rrp44p cannot be carried out by
other 3’ to 5’ exoribonucleases.
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INTRODUCTION
The crystal structure of the eukaryotic exosome shows homology to two RNA
degradation complexes, bacterial PNPase and the archaeal exosome. Specifically, PNPase and
the archaeal and eukaryotic exosomes contain a PH ring that consists of six PH domains, or
subunits (Liu et al., 2006), that are homologous to RNase PH (Zuo and Deutscher, 2001). In
bacteria, RNase PH is a phosphorolytic 3’ to 5’ exoribonuclease that uses inorganic phosphate to
process, or trim, tRNA precursors to form mature tRNA species (Wen et al., 2005). In PNPase
and the archaeal exosome, three of the PH domains have 3’ to 5’ exoribonuclease activity
(Buttner et al., 2005; Lorentzen and Conti, 2005; Navarro et al., 2008; Symmons et al., 2000).
Because of the similarity between these RNA degradation complexes, it was initially thought
that the PH ring of the eukaryotic exosome was the site of RNA degradation. However, recent
studies have shown that despite the sequence and structural similarity to PNPase and the archaeal
exosome, the six PH subunits of the eukaryotic exosome are catalytically inactive due to
mutations the RNase PH-like active sites. Therefore, unlike PNPase and the archaeal exosome,
the PH ring of the yeast and human exosome does not have exonuclease activity (Dziembowski
et al., 2007; Liu et al., 2006).
Interestingly, however, a PH subunit in the Arabidopsis thaliana exosome, Rrp41p
(AtRrp41p), displays phosphorolytic 3’ to 5’ exoribonuclease activity in vitro and can also
rescue the rRNA processing and mRNA degradation defects of a yeast rrp41 mutant. AtRrp41p
can also interact with several of the yeast exosome subunits in vivo and in vitro (Chekanova et
al., 2000), which suggests that this catalytically active subunit can participate in the
evolutionarily conserved interactions that are needed for the structural integrity of the exosome.
Three of the ten exosome subunits bind to one side of the PH ring, forming a cap. These
subunits contain multiple RNA binding domains and are, therefore, thought to bind the RNA
substrates of the exosome. The last remaining subunit, Rrp44p, is the only catalytically active
subunit of the yeast and Drosophila exosome (Dziembowski et al., 2007; Mamolen and
Andrulis, 2009). This is also likely the case in humans, where the other nine exosome subunits
are catalytically inactive (Liu et al., 2006). Rrp44p is homologous to bacterial RNase II and
RNase R, two hydrolytic 3’ to 5’ exoribonucleases. Specifically, these enzymes use a water
molecule to degrade mRNA from the 3’-end (Cannistraro and Kennell, 1994; Cheng and
Deutscher, 2002).
Rrp44p has a similar domain organization and is, thus structurally similar, to RNase II
and RNase R. Specifically, E. coli RNase II has 44% amino acid similarity and 22% amino acid
identity to yeast Rrp44p, whereas E. coli RNase R has 48% amino acid similarity and 25%
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amino acid identity to Rrp44p. These proteins have two consecutive N-terminal cold shock
domains (CSDs), a central catalytic domain (RNB), that is responsible for the 3’ to 5’
exoribonuclease activity of the proteins, and a C-terminal S1 domain (Figure A.2A). The CSDs
and S1 domain are putative RNA binding domains that are positioned on one side of the RNB
domain. In all three proteins, ssRNA is threaded through the putative RNA binding domains,
such that the 3’-end of the RNA rests in the catalytic site of the RNB domain (Bonneau et al.,
2009; Frazao et al., 2006; Lorentzen et al., 2008; Zuo et al., 2006). Biochemically, Rrp44p is
more similar to RNase R. Unlike RNase II, RNase R and Rrp44p are able to degrade structured
RNAs and double stranded RNAs that contain a single stranded 3’ overhang (Dziembowski et
al., 2007; Vincent and Deutscher, 2006).
The eukaryotic exosome is involved in RNA processing and degradation in the nucleus
and cytoplasm. Because Rrp44p is the catalytic subunit, Rrp44p is most likely responsible for
these RNA processing and degradation reactions. Specifically in the nucleus, the pairing of
Rrp44p with another hydrolytic 3’ to 5’ exoribonuclease, Rrp6p (Briggs et al., 1998), is required
for efficient RNA processing of RNA precursors to form small, stable, mature RNAs (Allmang
et al., 1999a; Allmang et al., 1999b; Mitchell et al., 1997; Mitchell et al., 1996), and for the rapid
degradation of aberrantly processed RNAs (Bousquet-Antonelli et al., 2000; Davis and Ares,
2006; Kadaba et al., 2004; Libri et al., 2002; Torchet et al., 2002). Although these proteins are
structurally dissimilar, it has recently been reported that these enzymes are functionally
redundant (Lebreton et al., 2008).
In this Appendix, AtRrp41p, E. coli RNase II and RNase R, and S. cerevisiae Rrp6p,
were tested individually for complementation of a yeast rrp44 deletion strain. Here, the data
indicate that none of these 3’ to 5’ exonucleases can carry out the essential function of Rrp44p.
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RESULTS
A. thaliana Rrp41p cannot carry out the essential function of Rrp44p.
Although none of the PH subunits of the yeast exosome are catalytically active,
AtRrp41p has 3’ to 5’ exonuclease activity in vitro. In addition, AtRrp41p can complement the
RNA processing and degradation defects of a yeast rrp41 mutant (Chekanova et al., 2000). To
determine whether AtRrp41p can carry out the essential function of Rrp44p, a plasmid
containing A. thaliana RRP41 under the control of the constitutively active glyceraldehyde-3phosphate dehydrogenase (GPD) promoter was generated and transformed into an rrp44!
[RRP44, URA3] strain. Transformants were spotted onto media containing 5-FOA and grown for
several days. Growth of AtRrp41p was compared to two controls, wild-type RRP44 and empty
vector. Similar to the empty vector control, AtRrp41p was not able to suppress the rrp44
deletion (Figure A.1A). This lack of suppression was not due to a lack of expression, as
AtRrp41p was able to complement a yeast rrp41 deletion strain (Figure A.1B). This suggests
that although AtRrp41p is catalytically active, it is not able to carry out the essential function of
Rrp44p.
E. coli RNase II and RNase R cannot carry out the essential function of Rrp44p.
E. coli RNase II and RNase R are structurally and functionally similar to yeast Rrp44p
(Frazao et al., 2006; Zuo et al., 2006). To determine whether these bacterial exonucleases can
carry out the essential function of Rrp44p, plasmids containing E. coli RNase II and RNase R
under the control of the constitutively active GPD promoter were generated and transformed into
an rrp44! [RRP44, URA3] strain. Transformants were spotted onto media containing 5-FOA and
grown for several days. Growth of the bacterial exonucleases was compared to two controls,
wild-type RRP44 and empty vector. Despite their similarities to Rrp44p, overexpression of
RNase II or RNase R did not suppress the rrp44 deletion (Figure A.2B). This suggests that
neither of these bacterial exonucleases can carry out the essential function of yeast Rrp44p.
The data presented in Chapter 3 indicate that cells lacking the exonuclease activity of
Rrp44p have a slow growth phenotype, indicating that this nuclease activity is not needed for
viability but rather for optimal cell growth. Although RNase II and RNase R cannot carry out the
essential function of Rrp44p, the exonuclease activities of these proteins may be interchangeable
with the exonuclease activity of Rrp44p. Under this hypothesis, coupling RNase II and/or RNase
R in trans with a truncation of Rrp44p that lacks exonuclease activity should restore optimal cell
growth. To test this, plasmids that overexpress RNase II and RNase R were individually
transformed into an rrp44! [RRP44, URA3] strain that also contains a plasmid encoding a C171
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Figure A.1: A. thaliana Rrp41p does not suppress a yeast rrp44 deletion.
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Figure A.1: A. thaliana Rrp41p does not suppress a yeast rrp44 deletion. A, An rrp44
deletion strain complemented by full-length RRP44 on a plasmid with a URA3 marker was
transformed with a plasmid that overexpressed A. thaliana RRP41. Transformants were spotted
onto media containing 5-FOA and control media (SC –HIS –URA + 2% dextrose), and grown
for several days. Growth of A. thaliana RRP41 was compared to two controls, wild-type RRP44
and empty vector. Growth on 5-FOA would suggest that A. thaliana Rrp41p can carry out the
essential function of Rrp44p. B, An S. cerevisiae rrp41 deletion strain complemented by fulllength S. cerevisiae RRP41 on a plasmid with a URA3 marker was transformed with a plasmid
that overexpressed A. thaliana RRP41. Transformants were spotted onto media containing 5FOA and control media (SC –HIS –URA + 2% dextrose), and grown for several days. Growth of
A. thaliana RRP41 was compared to empty vector. Growth on 5-FOA would suggest that A.
thaliana Rrp41p can carry out the essential function of yeast Rrp41p.
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terminal truncation that lacks the exonucleolytic RNB domain of Rrp44p. Transformants were
then spotted onto media containing 5-FOA and grown for several days. Growth of the strains
containing the bacterial exonucleases and truncated Rrp44p were compared to three controls,
wild-type RRP44, a strain containing only the C-terminal truncation of Rrp44p, and empty
vector. Despite the lack of suppression of an rrp44 deletion strain, overexpressed RNase R was
able to restore optimal growth in a strain that lacked Rrp44p exonuclease activity. In contrast,
overexpressing RNase II in trans with the same C-terminal truncation of Rrp44p did not restore
optimal growth (Figure A.2C). The lack of in trans suppression by RNase II is not due to a lack
of protein expression, as RNase II is expressed in yeast (Figure A.2D). These results suggest that
the exonuclease activity of E. coli RNase R, but not RNase II, may be able to substitute for yeast
Rrp44p exonuclease activity. Additionally, these results are consistent with the 34-1001
truncation and triple CR3 mutant of Rrp44p being able to complement an rrp44 deletion, but not
being able to interact with the exosome.
S. cerevisiae Rrp6p cannot carry out the essential function of Rrp44p.
Rrp6p and Rrp44p share some overlapping functions in the nucleus (Chapter 3; Lebreton
et al., 2008). Since the essential function of Rrp44p is likely nuclear, Rrp6p may be redundant
with the essential function of Rrp44p. To test this, a plasmid encoding S. cerevisiae Rrp6p under
the control of the constitutively active GPD promoter was generated and transformed into an
rrp44! [RRP44, URA3] strain. Transformants were spotted onto media containing 5-FOA and
grown for several days. Growth of yeast Rrp6p was compared to two controls, wild-type RRP44
and empty vector. Similar to the empty vector control, Rrp6p did not support viability (Figure
A.3A). The lack of suppression by yeast Rrp6p was not due to a lack of expression, as Rrp6p
was able to complement an rrp6 deletion strain (Figure A.3B). Therefore, although Rrp6p and
Rrp44p may share some overlapping functions in the nucleus, none of these functions are the
essential function of Rrp44p.
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Figure A.2: E. coli RNase II or RNase R does not suppress a yeast rrp44 deletion.
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Figure A.2: E. coli RNase II or RNase R does not suppress a yeast rrp44 deletion.
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Figure A.2: E. coli RNase II or RNase R does not suppress a yeast rrp44 deletion. A, A
schematic representation of the domain organization of S. cerevisiae Rrp44p and E. coli RNase
II and RNase R. Also shown are the percent amino acid similarity and identity between the three
homologs. B, An rrp44 deletion strain complemented by full-length RRP44 on a plasmid with a
URA3 marker was transformed with plasmids that overexpressed E. coli RNase II and RNase R.
Transformants were spotted onto media containing 5-FOA and control media (SC –HIS –URA +
2% dextrose), and grown for several days. Growth of the yeast strains containing E. coli RNase
II and RNase R was compared to two controls, wild-type RRP44 and empty vector. Growth on 5FOA would suggest that the E. coli RNases can carry out the essential function of Rrp44p. C, An
rrp44 deletion strain complemented by full-length RRP44 on a plasmid with a URA3 marker was
transformed with a C-terminal truncation of rrp44 that lacks the region that is homologous to
RNase II and RNase R and a plasmid that overexpressed E. coli RNase II or RNase R.
Transformants were spotted onto media containing 5-FOA and control media (SC –HIS –URA +
2% dextrose), and grown for several days. Growth of the mutants was compared to two controls,
wild-type RRP44 and empty vector. Growth on 5-FOA indicates that the N-terminus of Rrp44p,
in trans with an E. coli RNase, can carry out the essential function of Rrp44p. C, Whole-cell
lysate was obtained from a strain containing a plasmid that overexpressed E. coli RNase II and
was analyzed by Western blot analysis with antibodies specific to the His tag to detect RNase II.
Expression of E. coli RNase II was compared to empty vector.
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Figure A.3: S. cereivisiae Rrp6p does not suppress an rrp44 deletion.
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Figure A.3: S. cerevisiae Rrp6p does not suppress an rrp44 deletion. An rrp44 deletion strain
complemented by full-length RRP44 on a plasmid with a URA3 marker was transformed with a
plasmid that overexpressed S. cerevisiae RRP6. Transformants were spotted onto media
containing 5-FOA and control media (SC –HIS –URA + 2% dextrose), and grown for several
days. Growth of RRP6 was compared to two controls, wild-type RRP44 and empty vector.
Growth on 5-FOA would suggest that S. cerevisiae Rrp6p can carry out the essential function of
Rrp44p. B, An S. cerevisiae rrp6 deletion strain was transformed with a plasmid that
overexpressed S. cerevisiae RRP6. Transformants were spotted onto selection media and grown
for several days at the indicated temperatures. Growth of RRP6 was compared to empty vector.
Growth at 37°C indicates that Rrp6p can rescue the temperature-sensitive phenotype of the rrp6
deletion strain.
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DISCUSSION
The data presented in this Appendix indicate that AtRrp41p, E. coli RNase II and RNase
R, and yeast Rrp6p, were not able to carry out the essential function(s) of yeast Rrp44p. Because
each of these enzymes is distinct, they were tested for suppression of an rrp44 deletion strain for
different reasons.
AtRrp41p was tested for suppression of an rrp44 deletion strain because it has 3’ to 5’
exonuclease activity in vitro and can interact with the yeast exosome in vivo and in vitro. In
addition, AtRrp41p is able to rescue the RNA processing defects of a yeast rrp41 mutant
(Chekanova et al., 2000), which suggests that it localizes to the nucleus. This assumed
localization is important as the essential function of Rrp44p is likely nuclear. Despite these
observations, AtRrp41p was not able to suppress an rrp44 deletion. There are several possible
explanations for this lack of suppression. First, it may be that AtRrp41p and yeast Rrp44p have
different essential functions. For example, if AtRrp41p is required for RNA processing and yeast
Rrp44p is required for the degradation of aberrant RNAs in the nucleus, overexpressing
AtRrp41p in an rrp44 deletion strain would not restore viability. Another explanation is that,
although AtRrp41p can associate with yeast Rrp4p and Rrp44p (Chekanova et al., 2000),
AtRrp41p may have weak or non-existent interactions with the exosome in the rrp44 deletion
strain.
E. coli RNase II and RNase R were tested for suppression of an rrp44 deletion strain
because these enzymes are biochemically similar to Rrp44p. More importantly for these
suppression studies, Rrp44p, RNase II, and RNase R share a similar domain organization of the
same three RNA binding domains and catalytic RNB domain (Bonneau et al., 2009; Frazao et
al., 2006; Lorentzen et al., 2008; Zuo et al., 2006). If these domains of Rrp44p were required for
the protein’s essential function, RNase II and RNase R should be able to suppress an rrp44
deletion. The data presented in Chapter 3, however, indicate that the N-terminus of Rrp44p,
specifically the CR3 region and PIN domain, are required for viability. Since RNase II and
RNase R do not have these regions, it is not surprising that these proteins are unable to carry out
the essential function of Rrp44p. Unexpectedly, however, overexpressing RNase R in trans with
a C-terminal truncation of Rrp44p that lacks exonuclease activity restored optimal growth. This
suggests that Rrp44p functions as an exonuclease independent of its association with the
exosome. In support of this, the triple CR3 mutant of Rrp44p and a truncation lacking the first 33
residues of Rrp44p can complement an rrp44 deletion, however, these mutant proteins do not
interact with the exosome. Similarly, although human Rrp44p is essential, its interaction with the
exosome is not required for viability (Allmang et al., 1999b; Raijmakers et al., 2004). Another
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study also indicates that the interaction between yeast Rrp44p and the exosome is not required
for viability, since human Rrp44p can complement a yeast rrp44 mutant (Shiomi et al., 1998).
Therefore, a general theme that has emerged from these, and other, studies is that the interaction
between Rrp44p and the exosome is not required for Rrp44p exonuclease activity or for cell
survival.
In the in trans RNase R overexpression studies, a C-terminal truncation that consisted of
residues 1-440 was used. Because this truncation includes a portion of the RNase II/R homology
region, specifically CSD1 and a portion of CSD2, this truncation does not accurately address
whether overexpressing RNase R in trans with the N-terminus of Rrp44p (including the CR3
region and PIN domain) can restore optimal cell growth. To better test this, an rrp44 deletion
strain that is complemented by a plasmid encoding only the regions of Rrp44p that are not
homologous to RNase II/R (residues 1-235) should be transformed with a plasmid that
overexpresses E. coli RNase R.
Lastly, yeast Rrp6p was tested for suppression of an rrp44 deletion strain because these
proteins share some overlapping functions, as demonstrated in Chapter 3 and in previous studies
(Lebreton et al., 2008). Specifically, combining the catalytically inactive exonuclease point
mutant of Rrp44p, D551N, with an rrp6 deletion, results in a synthetic sick phenotype.
Additionally, these proteins are known to be required for some of the same RNA processing and
degradation reactions in the nucleus (Briggs et al., 1998). Despite this, yeast Rrp6p cannot carry
out the essential function of Rrp44p. This may be because these proteins have different essential
functions. In support of this, the functional interaction between Rrp44p and Rrp6p is important
for only certain Rrp6p substrates (Callahan and Butler, 2008).
Because the exonucleolytic RNB domain of Rrp44p interacts with Rrp6, future studies
should focus on whether the exonuclease activity of Rrp6p can substitute for the exonuclease
activity of Rrp44p. Briefly, Rrp6p should be overexpressed in yeast strains that contain the
D551N mutant or a C-terminal truncation of Rrp44p that lacks exonuclease activity. If
overexpressing Rrp6p is able to restore optimal growth in these strains, this would suggest that
overexpression of Rrp6p abrogates the need for the 3’ to 5’ exonuclease activity of Rrp44p in the
nucleus.
Moreover, although AtRrp41p, E. coli RNase II and RNase R, and yeast Rrp6p are
expressed in yeast and are catalytically active, these proteins cannot carry out the essential
function of Rrp44p. This is likely because the exonuclease activity of the catalytic subunit is not
needed for viability and may be because AtRrp41p and yeast Rrp6p have different essential
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functions. Until the essential function(s) of Rrp44p is known, it will be difficult to find a single
protein that is redundant for the essential function of the catalytic subunit of the exosome.
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